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Otitis media (OM), an infection of the middle ear, is one of the most common 
reasons for children to seek medical care and receive antibiotics. While typically 
identified and diagnosed through the visual examination of the ear with an otoscope, 
this method provides limited quantitative information and relies on the skill level of the 
observer. Previous investigation of pediatric subjects using optical coherence 
tomography (OCT), a noninvasive cross-sectional imaging modality that uses low-power 
near-infrared light to provide depth-resolved structural images of tissue, characterized 
and established normative bounds for in vivo acute and chronic OM infection states. 
While it is known that biofilms are present on the middle ear mucosa during chronic OM, 
similar microbial-related structures were observed to be affixed on the internal mucosal 
surface of the tympanic membrane (TM) using OCT. These structures have not been 
identified or analyzed by any characterization technique, or observed for the response 
to standard of care treatment of OM. Furthermore, OCT experts have been primarily 
responsible for the assessment of OCT images of OM, with little translation of this 
technique outside of well-controlled academic-led studies.   
This dissertation establishes (1) the presence and characterization of biofilms 
adhered to the TM through direct observation, sampling, and analysis,  
(2) tympanostomy tube surgery as an effective therapeutic treatment to clear biofilms on 
the TM, and finally demonstrates (3) automated classification methods to identify 
features of OM infection in OCT data. Collectively, these results provide new insight into 
the pathogenesis and treatment of OM and demonstrate new quantitative tools that are 
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Chapter 1: Introduction 
1.1: Overview  
Infections and inflammation of the middle ear, commonly referred to as otitis media 
(OM), affect up to 95% of children worldwide1,2, with combined direct and indirect 
annual costs estimated to be 4 billion USD3. The commonality of this disease imposes a 
significant financial burden on families and healthcare providers to provide time- and 
cost-effective treatment4. Unfortunately, the primary diagnostic instrument for this 
disease, commonly known as the otoscope, is a relatively simple illuminated magnifier 
that helps to visualize the surface of the ear drum5. Current studies estimate the 
diagnostic accuracy for OM by an expert physician using standard otoscopy at 60-70%6.  
Microbial infection-related structures, speculated to be middle ear biofilms, were 
recently identified on the tympanic membrane (TM) in cases of chronic OM with optical 
coherence tomography (OCT)7. However, little is currently known about how they affect 
the etiology and pathology of recurrent OM infection or are affected by standard-of-care 
treatment. The tools and techniques used to diagnose OM and that are available to a 
physician do not provide specific quantitative information related to the presence of a 
bacterial biofilm. It is nearly impossible to accurately identify, observe, and prospectively 
track middle ear fluid and biofilms in vivo without resorting to invasive methods with 
currently available equipment and protocols8. While accurately assessing for the 
presence of middle ear biofilms is a critical advancement, there is no recommended 
course of action for treatment of biofilms within current OM clinical guidelines if 




efficient and precise diagnosis of infection, and subsequently, efficient treatment and 
management of OM. 
A clear disconnect exists between the existing symptom-based management of OM 
and the suspected underlying causes for recurrent infection9. Furthermore, there is 
currently no existing tool that can accurately and simultaneously distinguish between 
different presentations of otitis media, independent of user knowledge of OM, and 
identify the presence of fluid, middle ear biofilms, and other diagnostic markers 
quantitatively.  
 
1.2: Scope of Research 
 
This dissertation catalogues the planning, methodology, results, and relevant 
discussion of three distinct but related projects. First, the identification and 
characterization of microbial-related structures adhered to the TM during chronic OM 
through direct observation, sampling, and analysis. This work definitively identifies these 
structures in this cohort of subjects as middle ear biofilms (MEB) and demonstrates 
OCT as an effective tool to identify MEBs in regular clinical practice. Second, to 
evaluate the efficacy of standard of care treatments, such as tympanostomy tube (TT) 
surgery to eliminate MEBs. This project establishes that chronic OM is a biofilm-
mediated disease in some cases and that OCT can be used as a longitudinal monitoring 
tool for the management of OM. Third, the development of a machine-learning based 
classification platform to automatically classify OCT images for OM, including the 




translation and ultimate clinical acceptance: the lack of any diagnostic criteria for OM in 
OCT images, and the need for an expert familiar with OCT, OM, and middle ear imaging 
to acquire and analyze data. Guidelines to implement this platform onto any suitable 




Aim 1: Detect and characterize suspected middle ear biofilms affixed to the TM 
This aim will focus on the analysis and characterization of infection-related 
structures affixed to the TM as identified with OCT during chronic OM infection. A 
portable OCT system and handheld probe will be used to observe subjects receiving TT 
placement surgery. Suspected biofilm samples will be directly sampled and analyzed 
using advanced cytogenic and genomic analysis techniques, including polymerase 
chain reaction (PCR) and fluorescence in situ hybridization (FISH), to verify biofilm 
presence and correlate with OCT image-based biomarkers. The properties of this 
structure will be characterized through the use of these three techniques, and presented 
as a potentially new OCT diagnostic metric to easily identify chronic OM in patients.  
With more conclusive evidence for the presence of biofilms affixed to the TM 
during chronic OM infection, OCT could then be used as a fast, noninvasive tool to 
quickly assess for biofilm presence or absence. This work also provides further 
evidence that chronic OM is linked with the presence of a middle ear biofilm. This 
knowledge will likely stimulate further research to investigate changes in diagnostic 




new strategies to seek more effective and potentially biofilm-focused treatments for 
chronic OM can be researched and further related questions explored. 
 
Aim 2: Characterize response of middle ear biofilm to surgical intervention  
In this aim, a second-generation portable OCT system will be used to 
prospectively observe subjects receiving standard-of-care TT placement surgery for 
chronic OM. Subjects will be prospectively observed with OCT before, during, and after 
a one-month recovery period from surgery to track the presence or absence of a middle 
ear biofilm in response to treatment, and correlate these findings with the resolution of 
physical symptoms and clinical diagnosis.  
This aim will firmly establish OCT as a technique that can assist physicians in 
diagnosing chronic OM based on a primary indicator of infection, the presence of a 
biofilm, rather than secondary qualitative features of the TM as is done using otoscopy. 
Clinically, it will establish that surgical intervention is providing a means to clear any 
biofilm and associated fluid from the middle ear, and when unsuccessful, that this 








Aim 3: Establish guidelines for and validate feasibility of automated classification 
of otitis media using optical coherence tomography images  
To promote the successful translation and dissemination of OCT imaging 
technology to clinicians and non-expert users, an automated algorithm has been 
developed which established guidelines for and provides a means to interpret and 
classify OCT images of OM. Machine learning algorithms are utilized in tandem with 
custom designed features extracted from data to classify morphological changes in 
OCT images of tissue associated with various phases of OM infection.  
Development of this automated classification algorithm of middle ear tissue will 
provide a framework for an untrained user to collect OCT data and receive information 
that is diagnostically relevant for OM, such as the presence of middle ear fluid and 
biofilms. Eventually, an automated diagnostic platform is envisioned. Although this final 
goal will require substantial testing and development as well as additional data for 
training libraries, the feasibility of using observed morphological differences in tissue 
with OCT in a classification platform to accurately identify these changes is explored 









Chapter 2 provides a helpful review of background information to better understand 
the advancements presented in this dissertation. OM literature is reviewed in the 
context of biofilm-mediated infections, as well as standard of care treatment tools, 
methods, and guidelines. The principles of OCT imaging in the ear are reviewed for 
readers unfamiliar with its utility and capability. State-of-the-art biofilm analysis 
techniques are reviewed, as well as a brief introduction and history of machine learning 
and classification. Chapter 3 then reviews the clinical development and optical design of 
handheld OCT probes and portable systems, and related points of discussion such as 
cost, tradeoffs in OCT imaging modality, and optical design. An additional retrospective 
look at the development of portable and handheld OCT systems for clinical research 
use is also included. Each subsequent chapter focuses on one of the three aims 
detailed above. The dissertation concludes with reflections on the impact and future 





Chapter 2: Background Information 
2.1: Otitis Media 
Otitis media (OM), a broad term used to refer to any inflammation typically due to 
infection of the middle ear2,10, very commonly occurs in children under the age of 5 in 
the United States, and to an extent all over the world11. The physical symptoms of OM 
include: the acute inflammation of tissue (Acute OM, AOM)2, fluid buildup in the middle 
ear by constriction or blockage of the Eustachian tube (OM with effusion, OME)3, and 
persistent or repeated/chronic infections (recurrent acute or chronic otitis media, RAOM 
or COM)12. Representative otoscopy images of these states11 are included in 
Figure 2.1, although in daily practice, these states are rarely as discrete in clinical 
presentation.  
 
Acute ear infections are generally singular, rapid-onset ear infections that cause 
pain, inflammation, and/or redness of the tympanic membrane (TM) and Eustachian 
tube (ET), which can be treated with prescribed courses of antibiotics. Pathogenic 
Figure 2.1: Representative 
otoscopy images demonstrating 
the range of presentation of OM. 
A: Normal, healthy ear with a 
clear or transparent TM and 
normal position. B: A subject 
diagnosed with AOM, with 
erythema (redness). C: Purulent 
fluid is visible in this subject with 
OME, with some mild erythema. 
D: A ventilation tube inserted into 




antibiotic resistance due to misdiagnosis or misuse of prescription treatments is a 
growing concern in all medical specialties13, especially for OM since this is recognized 
as the most common disease that is prescribed antibiotics2,11. In a subset of patients, 
this treatment is ineffective and recurrent episodes of OM are common, which leads to 
prolonged hearing loss and developmental speech delays due to the chronic presence 
of a middle ear effusion (MEE)14-16.  
If 3 or more episodes of AOM occur within 6 months, or 4 or more within one 
year, the diagnosis of RAOM is made. Similarly, when middle ear fluid persists for 3 
months or longer, this is diagnosed as chronic OME (COME). The surgical placement of 
tympanostomy tubes (TT)17 can be used to treat these conditions to allow for aeration 
into the middle ear cavity, and drainage of any fluid. Recent statistics from the US 
National Survey of Ambulatory Surgery quote 668,245 TT surgeries performed on 
pediatric subjects in 2006, with 64% of surgeries being performed on children 0-2 years 
of age, and 24% on children 3-5 years of age18. While the average cost of a single TT 
surgery is estimated to be one thousand to several thousand dollars19, this total does 
not include lost income due to travel time and physician appointments for caretakers, 
and the impact on development from missed schooling time and potentially 
unnecessary speech and hearing impairment for children20,21. Approximately 6% of all 
children in the US receive TT before the age of 2, and there are reports that physicians 
often inconsistently recommend TT placement when verified against treatment 
guidelines21, although varying subpopulations and differing treatment implementation 
strategies across the US explain this variance21-25. As such, TT placement is one of the 




Even after this invasive treatment, there are patients that require multiple repeat 
TT surgeries to maintain a clear and aerated middle ear26,27 and to ensure unimpeded 
hearing function. It has been theorized28,29 that middle ear biofilms play a significant role 
in the persistence of RAOM30,31 and COME32. While biofilms were of particular research 
interest several years ago33, they are difficult to observe noninvasively or when 
quantifying the effectiveness of treatments, simply because there is no tool that can 
easily and rapidly assess for its presence or absence, and severity. Recent studies 
focusing on the development and testing of new classes of treatments have provided 
researchers new exposure to this topic, and a renewed link to why biofilms are an 
important target for diagnosis in OM30.  
There has also been substantial research into the epidemiology of OM and 
vaccines. Recent research has shown that AOM intensity is partially derived from a lack 
of immune function or immune system immaturity34 and an increased production of 
mucin35,36 in subjects with RAOM. In this regard, the pneumococcal vaccine has 
provided some improvement in OM incidence rates37-39. Otherwise, existing oral and 
ototopical antibiotic therapies have remained largely unchanged over the last 50 years. 
A visual summary of recommended diagnosis and treatment practices is available from 






2.1.1: Diagnostic tools for otitis media 
Existing technology used to diagnose OM is limited to primarily illumination and 
magnification devices40 such as otoscopes or surgical microscopes. Observing the TM 
to diagnose middle ear infections seems to have originated in France, where a 
speculum shaped for the ear canal and nasal cavity was first described by Guy de 
Chauliac in 1363. Ignaz Gruber later described a similar funnel-shaped speculum 
device in 1838. The auriscope, invented by John Brunton in 1862 in England, more 
closely resembles what we now consider to be a modern otoscope. Following this 
development, the first improvement to this device was described in 1864 by E. Siegel of 
Germany. This instrument was designed to impart differential pressure into the ear 
canal, while allowing the user to view the degree of deflection of the TM. Since then, 
design changes have been rather incremental, including the addition of a longer handle, 
safer and more powerful illumination devices, better optical designs for a larger view of 
the TM, and in modern times, a CCD camera, LED lighting, and a digital USB interface.   
Diagnosis using these tools relies on accurately interpreting visual features of the 
TM, or the accurate detection of the presence of any MEE, along with the coloration, 
transparency, and position of the TM. These factors are qualitatively interpreted by a 
physician42, who in general have variable amounts of training and expertise43,44. The 
average diagnostic accuracy of otoscopy by an expert user is limited to approximately 
~70%45, due to non-uniform illumination of the TM, a potentially obstructed view of the 




otoscopists46, undergoing a rigorous training and testing program to ensure future 
accurate diagnosis.  
Pneumatic otoscopy, while considered the gold standard for OM diagnosis, is 
difficult to perform correctly, and not often utilized in daily clinical practice47. A 
pneumatic otoscope, shown in 
Figure 2.2, modifies the traditional 
otoscope with the addition of an 
insufflation bulb and speculum tip 
that seals the ear canal to allow for 
pressure modulation and 
observation of any TM deflection, 
which helps to determine fluid presence or altered middle ear pressure. Acoustic 
techniques, such as tympanometry48 and acoustic reflectometry49, provide additional 
insight into functional behavior of the TM and middle ear mobility. While tympanometry 
can help to infer middle ear dysfunction and provide slightly improved diagnostic 
accuracy over otoscopy alone, results from these techniques are still recommended to 
be considered alongside otoscopy findings48. Invasive diagnostic techniques, such as 
tympanocentesis50, are typically avoided in daily practice due to cost concerns and to 
prevent unnecessary risk from anesthesia and surgery51. While a recent publication 
shows that it is possible to insert TT in an office setting52 as long as related risks are 
appropriately managed, this is quite uncommon. This method has significant 
advantages, since the subject does not need to be placed under anesthesia. It is only 
employed when the subject would have normally undergone standard TT surgery.  
Figure 2.2: Optical and 
digital Welch Allyn 
macroview pneumatic 
otoscopes. This device 
is commonly used by 
physicians to inspect 
and assess the TM for 
signs of OM. Digital 
versions of this replace 





Moreover, few new noninvasive technologies are being developed to better 
diagnose OM. Ultrasound has been used with limited success in the past, although 
practical concerns of water-coupling the transducer to the TM often take precedence53. 
One group has developed a short-wave infrared (SWIR) scope that relies on the 
absorption properties of water to very clearly detect middle ear effusions54. Middle ear 
power analysis (MEPA)15,55 provides more in-depth acoustic characterization of the ear 
than tympanometry, but this device is still in development. A recent development of a 
light field otoscope takes advantage of different focal planes to reconstruct 3D surface 
features on the TM at high resolution56. Yet, these techniques do not provide specific 
information related to the presence of a biofilm, the purulence of the effusion, or any 
optical and structural properties of the ear.  
A clear disconnect exists between current symptom-based infection management 
and the underlying causes for recurrent infection9 for OM. There is no tool that can 
accurately and simultaneously distinguish between different presentations of OM, 
independent of user skill, and identify the presence of fluid, middle ear biofilms, and 
other diagnostic markers quantitatively. Overall, there is an unmet need for a tool that 
provides a straightforward quantitative assessment of middle ear pathology for a 






2.1.2: Clinical practice guidelines 
To effectively treat patients diagnosed with OM, optimized and up to date 
treatment protocols aim to provide recommended best practices for antibiotic 
prescription and TT surgery by integrating evidence-based medicine though a 
systematic review of past studies and data3. Clinicians tend to follow these guidelines 
provided by the American Academy of Otolaryngology, which include recommendations 
for diagnosing and treating all stages of OM: AOM2, OME3, TT surgery17, as well as 
earwax removal57 and adenoidectomy58, among many other topics. Similar guidelines 
have been generated in various regions across the USA6 and around the world59, 
depending on the specific local population and etiology of OM. These guidelines, shown 
in a simplified list in Table 2.1, are helpful and necessary for clinicians to provide up to 
date diagnostic and therapeutic guidance and ultimately limit the incidence of 
misdiagnosis of OM as best as possible. However, given the difficulty in properly 
diagnosing OM, AOM is frequently misdiagnosed. Treatment protocols take this into 
account, and are designed to curb the current trend of antibiotic over-prescription60 in 
efforts to prevent the increasing risk of antimicrobial resistance12,61,62. Nevertheless, the 
distribution of antibiotics remains high63. These guidelines do not contain any 
information related to middle ear biofilms (MEB), since they have only recently been 
detected with optical coherence tomography (OCT). No clinical trials have explored 
alternative and specific biofilm therapies, or have investigated the efficacy of existing 






Table 2.1: Simplified recommended practice guidelines2,3,17.  
 
Simplified recommended practice guidelines
Diagnostic criteria
Acute otitis media (AOM)
Moderate-severe bulging of TM, ear pain (not caused by otitis externa), 
or mild bulging with rapid onset of pain (< 48 hr., otoscopy)
Otitis media with effusion (OME)
Hearing loss (tympanometry),  presence of fluid (pneumatic otoscopy)
Recurrent acute otitis media (RAOM), sometimes referred as chronic otitis media
3 or more episodes of AOM w/in 6 mo., or 4 w/in 1 yr. 
Chronic otitis media with effusion (COME)
Persistent fluid for 3+ mo., concerns of speech and language delays
Treatment
Watchful waiting
Follow-up visit in near future to re-evaluate conditions for treatment in hope
of spontaneous resolution of symptoms or cases of uncertain diagnosis
Analgesics (painkillers)
Paracetamol or a non-steroidal anti-inflammatory to ease pain
Antibiotics
High-dose amoxicillin (40-45 mg/kg twice daily)
*Many other variants can be prescribed. 
Surgery (tympanostomy tube placement)
Placement of a small grommet in the ear to allow for drainage and 
aeration of the middle ear for severe RAOM or COME only. 
Do not utilize: 




2.1.3: Middle ear biofilms 
Planktonic bacteria often aggregate and form dense colonies known as biofilms 
to survive and proliferate in harsh environments64, including the human body. After 
coming in contact with a suitable surface, and when other planktonic bacteria are 
nearby, bacteria enter a genetically altered state65 to proliferate communally, with 
radically different metabolic and chemical profiles28. Quorum sensing via the N-acyl-
homoserine-lactone (AHL) class of particles is the primary mechanism that bacteria 
utilize to communicate and enter 
this altered state, where pili and 
flagella essential for single cell 
motility are traded for other 
components66. Biofilms are 
comprised of a self-excreted and 
sticky exo-polymeric substance 
(EPS) or matrix that encapsulates the bacteria, which grants significantly increased 
resistance to antibiotics and host immune system activity67. As a result, biofilm-
mediated infections are notoriously difficult to treat68, and form in the human body and 
on implanted catheters and prosthetics. The biofilm life-cycle is shown in Figure 2.369.  
The viscous and column-like structures biofilms exhibit will cause the formation of 
chemical, pH, or oxygen gradients70 within the biofilm, which drastically changes the 
efficacy of antibiotics71. These gradients provide a means for multi-species biofilms, and 
even allowing bacterial strains to proliferate that would otherwise prefer a different pH or 
oxygen concentration than its current host local microbiological microenvironment. 
Figure 2.3: The five stages of the biofilm life-cycle.  
1: Initial attachment. 2: Irreversible attachment.  
3: Maturation I. 4: Maturation II. 5: Dispersion. Once 
biofilms reach a critical mass, dispersal occurs to aid 
in spreading the biofilm. Adapted from Ref. #69.  




Superficial biofilm layers that are exposed to antibiotics can confer antibiotic resistance 
to the rest of the colony in deeper levels through horizontal gene transfer72. In addition, 
host immune defenses have difficulty removing biofilms, due to their innate 
characteristics for survival73. Similarly, when immune cells penetrate into the biofilm, 
they are often unable to phagocytose bacteria74. Surprising recent work proposes that 
certain immune responses even assist in the formation of a biofilm75. This work 
postulates that the ability to form an EPS matrix was evolved to stimulate an immune 
response, where immune cells are used as anchor points to support biofilm growth.   
In the middle ear, it has been shown that MEBs inhabit the middle ear mucosa 
during RAOM29, and are thought to be the cause of other recurrent infections in the 
upper respiratory system76. It is speculated that foreign bacteria enter the middle ear 
cavity (MEC) through the ET from an unrelated upper respiratory infection. This causes 
local inflammation, which in turn constricts the already predominantly horizontal ET in 
children, to provide a mostly sealed environment for bacterial biofilm proliferation within 
the MEC. This may explain why TT surgery is effective at reducing symptoms of RAOM, 
as it forcibly changes the microenvironment and provides an avenue for aeration and 
drainage of fluid. Biofilms in the MEC detected during OM are often comprised of 
multiple strains of bacteria33, which is unsurprising, given that OM is known to be 
caused by multiple bacterial strains59.  
MEBs are not a part of the current clinical management of OM67, likely given 
there is no cost-effective and noninvasive diagnostic tool available to physicians that 




COME, and the parallels in infection progression and difficulty in treatment to other 
biofilm-mediated diseases77, there is renewed interest in this topic.  
 
2.2: Principles of OCT imaging in the middle ear 
Optical coherence tomography (OCT), a noninvasive cross-sectional imaging 
technique, is an effective tool that can quantitatively assess the TM and adjacent middle 
ear space7,19 for OM. OCT operates using a similar principle as ultrasound imaging, 
detecting back-reflections of near-infrared light scattering from within tissue, and 
provides high-spatial resolution images of tissue at the micrometer scale. Cross-
sectional images, or B-mode images, are formed by combining multiple A-lines scanned 
from adjacent positions in tissue. Advancements in OCT imaging systems have allowed 
for numerous discoveries in disease diagnostics and treatment applications in both 
commercial and clinical applications, driven forward by academic research and 
development. For example, OCT is currently the only technique that provides an optical 
means to generate non-invasive high-resolution cross-sectional images and depth-
resolved measurements of the human eye78-80. Over time, OCT system development 
has continued to reduce form factor and cost, while improving on imaging performance 
(speed, resolution, etc.) and offering more flexibility for applications in a variety of 
clinical subspecialties beyond ophthalmology81.  
OCT has followed a similar development trajectory82 as that of other clinically 
useful medical imaging techniques, albeit at a much more accelerated pace. Ultrasound 




around the 1920s, and impactful clinical utility demonstrated in approximately 195883. 
US systems as we know them today began being released commercially in cart-based 
systems around 1970-1980, with improvements in form factor, utility, and capability over 
time to its present appearance as a compact, well designed, and optimized tool for 
specialized clinical exams84. Recently, ultra-compact, battery powered, and completely 
self-contained US handheld units have been released that are used in routine 
checkups, low resource settings, and emergency situations (EMT type)85. Over a span 
of approximately 80 years, US became recognized as the gold standard imaging 
modality for a wide range of clinically useful diagnostic tests.  
In comparison, the rate of development and clinical adoption of OCT has 
exceeded that pace, given the acceptance of OCT into the ophthalmic community86 as 
now a gold-standard technique for retinal evaluation approximately 20-25 years after 
inception. The adoption of OCT into the clinical pathways of ophthalmology has allowed 
investigation into numerous pathologies87,88, and the structure and function of the 
individual components of the eye, including the cornea89,90, lens91,92, iris93,94, ciliary 
body95,96, retina97-100, micro-vasculature101,102, contact lens design and fit103,104, and 
even changes in the retina with exposure to space flight105. It is often more effective to 
use a desktop or benchtop based system for these high-resolution commercial systems, 
since they usually require more precise optical stability during imaging to provide high-
quality images106, or have complex feedback loops, such as in adaptive optics 
systems107,108. OCT has been utilized in other medical specialties, with 
cardiovascular109, dermatological110, and ophthalmic111 applications as recent 




In a general OCT system, an interferometer splits the emission from a broadband 
near-infrared light source: 
 ( t kz)is e   , (2.1) 
where s is the amplitude (typically the laser source power), and ( t kz)ie   is the complex 
exponential form of a propagating plane wave of angular frequency  , wavenumber k, 
and propagation distance z. This emission (2.1) is split into 2 paths, to what are typically 
named the ‘reference arm’ and ‘sample arm’. One beam is sent through the reference 
path, and on its return to the fiber coupler contains the time delayed ( t ) pulse of light 
through a path of known length and optical properties: 
 (( ) t kz)Ris e    . (2.2) 
The second beam similarly enters and reflects/backscatters from the sample of interest, 
and on returning to the interferometer contains backscattered and reflected light from 
various structures within the sample: 
 (( ) t kz)SiH s e     , (2.3) 
where H is the scattering function of the sample. If both the sample and reference 
beams have traveled the same optical path length, and a deterministic phase 
relationship exists between the beams, they are temporally coherent with one another. 
When this coherence condition is met, the beams interfere and produce a meaningful 
signal that can be then reconstructed by the detector. The exact setup and detection 
mechanism depends on the specific OCT modality employed. Figure 2.4112 depicts 






In low-coherence interferometry or time-domain OCT (TD-OCT) systems, a 
photodiode collects the intensity ( )signalI t  of an interference pattern from the 
recombined interference or cross-correlation between these two signals113: 
 
reference sample( ) I I 2
i t
signal ref sampleI t I I e
        (2.4) 
Figure 2.4: Optical coherence tomography overview. OCT is available in a flexible 
range of modalities and layouts, with tradeoffs possible between imaging capability and 
cost. Imaging spatial resolution is defined by the objective lens used, while depth 
resolution is dependent on the bandwidth of the low coherence source used in the 
system. Single A-line scans can be taken, or scanned and combined into a cross-




Temporarily ignoring the first two terms, which are DC signal terms, the third term is the 
cross-correlation term containing information relevant to the sample of interest. The DC 
terms give rise to a background signal that is a result of the reflectivity associated in the 
reference and sample arms113. With appropriate processing, it is possible to reconstruct 
the signal from the sample at a single depth point due to the information contained in 
this third term.  
The optics in the sample arm of an OCT system play an important role in sending 
(focusing) light to the sample and collecting backscattered light for processing. The 
numerical aperture (NA) of the sample arm limits the axial and lateral fields-of-view and 




   ,  (2.5) 
where 0  is the center wavelength of the source. Lower NA systems will focus the beam 
less, giving larger depth-of-field, but reducing transverse resolution, as depicted in 
Figure 2.4 (bottom left). In OCT, lateral and axial resolutions are decoupled from one 
another. While the lateral resolution is dependent on the objective lens used, whereas 
the axial resolution is dependent on the coherent optical bandwidth or coherence length 
of the light source113: 
 








,  (2.6) 
where n is the refractive index of the medium, and   is the bandwidth at full-width at 




This coherence length c  is effectively the probing volume of the imaging 
system, and can be used to reconstruct the relative optical scattering at a specific 
location in tissue. To take advantage of this fine coherence gating, TD-OCT systems 
with a low NA (~ 0.01 – 0.1) utilize a scanning reference arm that translates the 
reference mirror to axially adjust the position of the coherence gate in depth, which 
allows for optical sectioning of the sample. Typically, small volumes on the order of 
several micrometers are being probed, with signal from outside these regions being 
rejected, much like in confocal microscopy. Through this process, A-line scans (in 
depth) can be reconstructed. Cross sectional scans can be generated by laterally 
scanning the beam as it scans each depth, and with an additional scanning axis 
generating 3D volumes.   
Fourier domain OCT systems (FD-OCT) operate in a slightly different manner, 
and enable collection of information from all depths without adjustment of the reference 
arm through the use of the Wiener-Khinchin theorem. This theorem states that the 
correlation of two signals is directly related to the spectral power density by a Fourier 
transform (FT). Therefore, if an inverse FT of the detected spectrum can be taken, the 
data of interest can be recovered:   
 1
Reference Sample(z) ( ( )) ~ 2
i z
signal signalI FT I k I I e
      (2.7) 
The ability to quickly translate from a power spectrum to a full depth profile greatly 
increases imaging speed over a typical time-domain OCT system, which given its 




FD-OCT processing also provides access to both the intensity and phase terms of this 
signal via the Fourier transform.  
There are two main configurations of FD-OCT systems114 that reconstruct the 
spectrum using distinct methods. Spectral-domain OCT (SD-OCT) systems employ a 
dispersive optical grating that splits the broad-bandwidth signal onto multiple 
photodetectors in a line-scan camera, effectively allowing for spectrally-binned detection 
of this power spectrum, and reconstruction of the entire depth-scattering profile, or A-
line, using the Hilbert transform. Resulting image quality is dependent on the SNR of the 
system115, which can be measured by setting up a mirror as the sample at the focus of 









   (2.8) 
where 𝜌 is the responsivity of the spectrometer detector, a coefficient that measures the 
efficiency of the conversion of optical to electronic signal, and assumed to be consistent 
across all elements, 𝑅𝑠𝑎𝑚𝑝𝑙𝑒 is the mirror reflectivity at the sample arm, 𝑃𝑠𝑎𝑚𝑝𝑙𝑒 is the 
power incident upon the sample, and 𝜏 is the integration time of the spectrometer. This 
modality was the most popular configuration for a time since broad-bandwidth optical 
sources were already available from TD-OCT systems and other telecommunications 
hardware.  
An alternate configuration named swept source OCT (SS-OCT) is a hybrid 
between TD-OCT and SD-OCT, where the reference arm is fixed but the broadband 
laser is swept and detected by a fast photodiode. By rapidly sweeping a narrow 




can be digitally reconstructed. SS-OCT SNR formulism is similar to SD-OCT systems, 
but now dependent on the average power of each swept wavelength peak, rather than 
the average power of the source. SS-OCT has become possible in recent years, as 
stable, coherent, and economically priced laser sources have come on the market112 
with sweep speeds or effective A-line imaging rates of up to 200 kHz. Further in-depth 
technical information related to the development and optimization of OCT imaging for 
general use116,117 can be found elsewhere. 
Imaging depth is limited by several factors. Ultimately, all systems are limited by 
the multiple scattering of light118, which severely degrades signal quality with depth119. 
Beyond that, accessing the full imaging depth relies on accurately sampling the power 













  (2.9) 
where N is number of sampling points in the spectrum, 0  is the center wavelength of 
the source, aven  is the average refractive index of the sample, and   is the bandwidth. 
In an average system, aven = 1.4 and N = 2048 pixels, with a system at 800 nm with a 
bandwidth of 80 nm, and image dimensions of approximately ~2.93 mm in depth x ~4 
mm transverse. In some swept source systems, this can be expanded to 12 mm120 in 
depth, given the effectively increased number of sampling points provided by the narrow 
linewidth that is swept over the laser bandwidth. 
From a biological imaging perspective, reconstructing the maximum imaging 




power of the light source on the tissue and the range of wavelengths used. However, 
limits for the maximum optical power density, or maximum permissible exposure of 
radiation, able to be used around different sites in the body tissue safety have been 
studied for most general imaging applications to ensure safety for imaging subjects121, 
commonly known as the ANSI safety standards. Each component in tissue absorbs and 
scatters light to a different degree, which will lead to local interactions with the light 
through scattering, as well as overall attenuation of light propagation through 
absorption. Different tissues will have different scattering and absorptive optical 
properties, which also can affect imaging depth. Figure 2.5122 plots the optical 
absorption coefficient across a wide range of wavelengths in the human body. The 
decrease in the absorption coefficient near 800 nm is commonly referred to as the 
diagnostic or biological window, which spans the red/near-infrared (700 nm ~1300 nm) 
wavelength spectrum. OCT utilizes light sources in this range to image deep into tissue. 
While the properties for hemoglobin and water are shown below, the properties of many 
biological constituents have a differential signal that can be quantified through the 









The optical qualities or properties of a sample can be similarly described using 
the refractive index, which is formally defined as the wavelength-dependent ratio of the 








    (2.10) 
The refractive index is a unit-less number, and is somewhat related to the density of the 
sample or medium. Typical values can range from 1.000277 in air (1.0 in vacuum), 1.36 
(MEE from a subject with RAOM at 860 nm), 1.44 (tympanic membrane, ex vivo, 
average of 4 subjects at 1080 nm123) to as large as 4.0 (natural metals, crystals, or 
polymers).  Refractive index can also have a negative value, but typically only in exotic 
lab-created samples often referred to as negative index metamaterials124 that have both 
negative dielectric permittivity and permeability. The refractive index of both biological 
and non-biological sample types have been characterized at many wavelengths and 
some are available online in several databases, although mainly for chemical 
Figure 2.5: Absorption coefficient 
versus wavelength for water, 
melanin, and oxygenated 
hemoglobin. Near 800 nm, there 
exists the “biological window”, 
where light propagation in tissue 
is limited by scattering rather than 
absorption. Using OCT, this 
allows deep imaging into tissue. 





compounds and thin films. However, the refractive indices of most materials at the near-
infrared wavelengths used in OCT often remain uncharacterized, although many OCT 
research groups have reported relevant values for specific tissue sites123,125,126. Most 
biological tissues have a refractive index near the range of n =  1.3 – 1.5127,128. OCT has 
been shown to be sensitive to changes in refractive index of as low as approximately 
0.01129, although there are more effective tools to precisely measure refractive index130.  
Since OCT directly measures optical path length in structures (not physical 
distance) as shown in Figure 2.6, it is important to characterize the refractive index of 
any materials or samples of interest if the accurate calculation of physical thickness 
measurements is needed. When imaging biological structures, it is often possible to 
differentiate interfaces between structures based on the physical layout and differing 
refractive index properties of its constituents. For instance, the refractive index of the 
outer and inner linings of a blood vessel may be slightly different than the vessel itself, 
or when comparing bulk muscle tissue to tendons, fascia, or mucosal layers that may be 
present in and around any structure of interest. Adjusting processed imaging data for 
refractive index is typically not performed in complex biological structures, as this would 
require the precise calculation of the local in situ refractive index across the entire 
sample. While possible in theory131, in practice it is difficult to achieve and not often 
performed due to the additional complexity and cost that would be required in the OCT 
system and related image processing. Therefore, images are left uncorrected, bulk 
averages are often used for similar materials, and thicknesses can be precisely 






Occasionally, given the similar optical properties of two structures, or similarly if 
the spacing between structures are finer than the resolution of the system, it is difficult 
to determine the presence of any interfaces under OCT. In a real in vivo example, 
middle ear fluid may partially match the refractive index of the tympanic membrane, 
making the differentiation of the exact interface difficult in the cross-sectional image. 
However, the A-line (depth profile) often reveals its location, as shown in a 
representative cross-sectional OCT scan of the TM and middle ear space in Figure 2.7. 
Another example is the interfaces between the three known layers of the tympanic 
membrane as previously determined with histology132, which often cannot be easily 
visualized. Still, the overall or combined thickness of the TM and any biofilm and middle 
ear fluid is typically used to distinguish infection states, as observing structures in a 
Figure 2.6: A diagram comparing the physical orientation of a sample 
and its refractive index alongside the resultant OCT A-line (depth 
profile) of the sample. A: Imaging a solid cube of a material with an 
index of n=1.4 yields a depth profile with a spacing dependent on the 
optical path length (OPL) of the sample. B: Similar principles apply 
when imaging biological tissue, although often the refractive index is 




specific region in tissue is rarely indicative of its general presentation. While it is 
possible to precisely calculate the interface between these two tissues, it has previously 
been shown that overall thickness is a reliable and statistically significant indicator of 
infection7, specifically because in healthy subjects these additional structures do not 
appear. Many non-invasive and high-resolution optical techniques manage similar 
challenges to ensure accurate detection of infection states and cope with new data that 




 There are tradeoffs that play an important role in determining the best application 
of the various OCT imaging modalities for a specific task. TD-OCT is viewed as a low-
cost OCT variant given its low overall complexity, as there is no need for an expensive 
spectrometer or swept laser source, and offers reasonable resolution and imaging 
parameters. Typical TD-OCT systems can be constructed for approximately $10,000 to 
Figure 2.7: Determining interfaces in OCT images. Left: Cross-
sectional image of a human TM with effusion present. The boundary 
between the TM and MEE is difficult to visually determine. Right: The 
A-line (depth profile, white-dotted line) often reveals the location of any 
interfaces. Comparing adjacent A-lines can ensure consistency, and 
known averages of thickness of the TM or other structures can be 




$15,000 USD. However, TD-OCT has a lower theoretical maximum SNR than other 
OCT modalities117. For imaging, scanning considerations limit the maximum speed 
possible to observe dynamic biological processes133. Requirements for the object, 
tissue, or sample of interest play a role in selecting the modality. Biological or live 
samples are better served with a Fourier-domain OCT system, given the SNR and 
imaging speed advantage. Given the flexibility of these systems, TD-OCT has largely 
fallen out of favor134, although development to improve its capabilities is still ongoing. 
Table 2.2 shows the approximate cost of average OCT systems from each modality, 
although much higher and lower end systems can be designed of any type depending 
on the desired imaging parameters. It has recently been shown that a SD-OCT system 
of reasonable quality can be constructed for approximately $8,000 USD135, with fierce 
competition aiming to push this cost even lower136.  
 
Between SS-OCT and SD-OCT, there are even more nuanced tradeoffs.  
SD-OCT has robust parts from many established vendors, and for acceptable 
performance, the spectrometer requires a high-performance dispersive grating and 
sensitive line-scan camera. For the stated cost in Table 2.2, an average performance 
Table 2.2: Cost breakdown for each major OCT modality for off-the-shelf components. Prices 




SD-OCT system may have an 80 nm bandwidth, a spectral resolution of ~0.04-0.1 
nm/pixel, and a 2048 pixel line scan camera running at 70 kHz, with an axial resolution 
of approximately 3 μm. The phase stability is inherently better than other modalities due 
to the lack of additional scanning elements in the system. SS-OCT relies on high-end 
laser sources and electronics to operate, and thus raises the price commensurately. 
However, once fully developed, many of these components (laser + detector, digitizer) 
can be made using a semiconductor process at scale, which may reduce costs in the 
future.  
The physical size of a completed system may also play a role in certain situations 
where a lightweight or portable system is required. While SS-OCT systems can be more 
expensive than SD-OCT systems, the laser and detector are typically combined into a 
single engine, since many of the counters and clocks for the laser sweep can be reused 
for the detector. In an all fiber-optic based system, this significantly reduces the total 
physical form factor needed for the components. The smaller form factor of the SS-OCT 
system has no bearing on the performance it can achieve, while in most SD-OCT 
systems, the size of the spectrometer has some correlation to its performance, as the 






2.3: Imaging techniques for biofilm detection and characterization 
Bacterial biofilms can be identified with a variety of techniques that identify 
structural, morphological, or chemical markers of bacteria and biofilm components137. 
Histological stains, dyes, and fluorescent labels used in conjunction with microscopy are 
most popular. Samples can similarly be sputter-coated with precious metals to perform 
scanning electron microscopy138. Typically, all of these techniques focus on 
visualization of the spatial morphology of biofilms, or the shape and distribution of 
bacteria within the biofilm matrix. However, few of these techniques can be used in vivo, 
as most require some kind of destructive preparation of samples. Here, a brief summary 
of state-of-the-art observation tools and techniques is provided.  
 
2.3.1: Histological analysis of biofilms 
Bacteria can be identified in lab-based cultures using a variety of commercially 
available stains, tags, and dyes139. Although many more exist, a selection of commonly 
used dyes for biofilm and bacterial staining are included in Table 2.3.  
 Table 2.3: Commonly used stains and dyes for biofilm imaging. 
Dye name Binding target Excitation/emission Notes
Syto 9 Genetic material 483 / 503 nm Permeates cell membrane
Propium Iodide Genetic material 535 / 617 nm Cannot permeate intact membrane
Sypro Orange Protein 470 / 570 nm ~1 ng sensitivity, 6.5 kDa+
ConA Alexa 633 Polysaccharide subunits 632 / 647 nm
WGA Alexa 633 Polysaccharide subunits 632 / 647 nm
DAPI Genetic material 358 / 461 nm
Crystal Violet Gram-positive bacteria 550 / 636 nm Inefficient fluorescence
(Low quantum yield)
Acridine Orange Genetic material DNA: 502 / 525




Techniques that rely on the histological staining of tissue rely on a differential 
feature found in the structure of the sample, such as in some strains of bacteria for the 
Gram stain process140,141, which can differentiate bacterial structures that are Gram-
positive or -negative depending on an additional outer membrane that encases some 
bacteria. DAPI (4',6-diamidino-2-phenylindole)142, a fluorescent stain with peak 
absorption at 358 nm light and peak emission at 461 nm, binds to adenine-thymine 
regions in genetic material, which is concentrated in the nucleus of bacteria and other 
cells, with fragments distributed in and around a biofilm matrix. Acridine orange143, a 
fluorochrome dye with peak absorption and emission dependent on the binding target 
(DNA: 502:525; RNA: 460/650 nm), can similarly be used. Numerous other dyes and 
stains adhere to specific polysaccharide components in the biofilm matrix77,144, utilize 
cell metabolism to cleave fluorescent dyes and change emission145, or probe cell 
membrane integrity to infer viability146.   
These techniques work well with pure, controlled samples in the laboratory where 
the composition of the sample can be restricted to known components. Figure 2.8 
similarly shows a lab-grown bacterial biofilm smear stained with both Acridine orange 
and Gram stain. Unfortunately, the usefulness of these staining techniques is limited 
when characterizing unknown samples or those collected from an in vivo animal or 
human model, such as samples collected from the middle ear during chronic OM. The 
dyes used in these techniques are not functionalized and will non-specifically adhere to 
components with similar binding targets, such as similar polysaccharide molecules that 
exist in both human mucous and biofilm EPS. An example of this is shown in  




serous MEE sample with biofilm matrix stain where unknown aggregate of cells were 
identified. Fortunately, another class of techniques has been developed that targets and 







Figure 2.8: Microscopy images 
from a lab-grown Pseudomonas 
aeruginosa biofilm smear dual-
stained with Gram’s stain and 
Acridine Orange. A: Streaks of 
crystal violet and Acridine orange 
are visible. B: A composite 
fluorescent image showing a 
visible red haze from single-
stranded RNA and DNA loosely 
distributed in the biofilm. In 
addition, green granules are 
visualized, which are the Acridine 
bound to double-stranded DNA 
and RNA within nuclei, on top of a 
blue background from unbound 
components. Taken at 40X, Scale 
bar is 100 μm.  
Figure 2.9: An example figure of non-
specific fluorescence binding to a 
collection of cells within a MEE. While 
the intended target of this dye was 
biofilm matrix, blood and other 
immune cells non-specifically 
fluoresce as well. Identities of these 
components were approximated 
using general morphological cues. 
Taken at 100x, scale bar is 40 μm. 







2.3.2: Biofilm imaging with OCT 
 OCT is a useful technique for biofilm metrology in that it does not require the use 
of any labels or dyes to visualize structural, functional, and optical properties of biofilms, 
including those cultured in vitro or observed in vivo147. Furthermore, it does not suffer 
from the same imaging or penetration depth limitations as confocal microscopy. If 
appropriate setups are used for in vitro imaging that seal the biofilm inside a sample 
chamber, OCT can observe biofilms noninvasively in situ and allow for longitudinal 
tracking and characterization of biofilm growth. Biofilm imaging with OCT was first 
demonstrated in 2006148. Since then, OCT has been applied to characterize biofilm 
properties149-151, and observe biofilms in various settings, including: distributed drinking 
water systems152-155, the oral cavity156, endotracheal tubes157, orthodontic braces158, 
contact lenses159,160, neonatal feeding tubes161, and catheters162. The refractive index of 
various biofilms has also been characterized and collected into Table 2.4. 
Several considerations must be managed to properly image biofilms, primarily 
related to the sample chamber or imaging setup. When using a typical flow cell or 
sample chamber, the cover slip used must be of a reasonable thickness to prevent 
distortion of the OCT imaging beam. Furthermore, the gap between the coverslip 
surface and biofilm growth 
area must be sufficient to 
allow for unimpeded growth of 
the biofilm. A coverslip placed 
gently on top of the biofilm 
sample will otherwise crush 
Table 2.4: Refractive indices of several species of biofilms 
in water as calculated by different wavelength systems.  
RI: Refractive index, λc: Central wavelength of OCT system.  
Strain (cultured) RI λ c  (nm)
P. aeruginosa 1.48 1310
L. pneumophilius 1.40 810
Groundwater (UIUC aquifer) 3-6 mo. 1.36 1310
Groundwater (UIUC aquifer) 15 mo.+ 1.52 1320
Silicate growth inhibitor (Na 2 SiO 3 ) 1.36 1320




and deform the structure and preclude an accurate measurement. If sample coupons 
are removed from the growth chamber and imaged directly, samples must be observed 
in as close to the growth conditions as possible, preferably observed in situ. Samples 
can be easily damaged with mild (loss of pore structure) or severe (complete 
desiccation) dehydration. Similarly, samples can be damaged by inadvertently scraping 
the sample during transfer of the sample coupon to the transport vessel or imaging 
platform, or by disrupting the biofilm’s natural adhesion on the sample coupon. When 
imaging biofilms for thickness measurements, a refractive index characterization of the 
growth media, fluid, or buffer liquid must be performed separately from the biomass128 
and taken into account, as this liquid permeates the biofilm pore structure. A sample 
biofilm holder and imaging setup is shown in Figure 2.10 to better illustrate this setup.  
Figure 2.10: Representative biofilm sample chamber and imaging conditions. Sample 
chambers can be sealed or have access ports to allow for flow cell setups and growth. 
Biofilm coupons can be observed in situ or removed and imaged with appropriate hydration. 
OCT imaging can proceed unimpeded if an appropriate coverslip is present if the imaging 
depth is sufficient to capture both the coverslip and sample, or spaced sufficiently far away 




2.3.3: Genetic and cytogenic techniques 
Techniques of this class are commonly known as immunohistochemistry or 
immunostaining163 and utilize genetic material in the sample to help target fluorophores 
to specific components of the cell or tissue structure, accomplished by in situ 
hybridization of antibodies. Genetic material can also be transcribed, amplified if 
desired, and compared to known libraries. Polymerase chain reaction (PCR) is 
commonly used and amplifies genetic material from human cells or bacteria in the 
samples for accurate and direct sequencing for identification164. Recent advances in 
genetic manipulation have set the stage for the development of a new technique, called 
fluorescence in situ hybridization (FISH), where a complementary and fluorescently 
labeled strand of DNA or RNA binds with a known target strand. The complimentary 
strand can be chosen to specifically target conserved genetic components to label all 
microorganisms of a specific class, or using a strain-specific sequence to target a 
particular bacteria of interest, especially known infection-related strains165.  
 The specificity afforded by these techniques is extremely useful when 
characterizing samples with mixed or unknown particulates or sources of noise, such as 
confounding proteins or cellular components with similar binding properties as the target 
of interest, as well as dust or other contaminants. PCR can be employed to characterize 
genetic information present in a sample, which is useful when trying to identify a 
potential infection from various human systems166. FISH is similarly useful for the 
morphological visualization of specific genetic or chromosomal components and 




human MEE harvested during TT surgery, where bacterial components have been 






Several other techniques and methods exist that can visualize biofilms, albeit 
using various forms of contrast and none as specific. Crystal violet can be added to 
biofilm assays that provide a general measure of biomass to the naked eye167. 
Scanning electron microscopy is a technique that first sputter-coats samples in precious 
metal to look at ultrastructure at the nanometer length scale168,169. The sample 
preparation process is typically destructive and permanently alters the appearance of 
the sample during preparation. To optically identify the chemical signature of samples, 
Raman spectroscopy is one technique170 that can be used which detects the chemical 
vibrations and rotations of various elemental components, providing a ‘fingerprint’ 
unique to each sample. However, in complex samples, getting a clear precise signal or 
measure of any one specific component is difficult. Few other techniques offer the 
specificity afforded by FISH.  
Figure 2.11: Microscopy image of 
a human MEE at 63X. Both rod 
and spherically-shaped bacteria 
are visible, while nearly no 
background fluorescence is 
present. The tag is targeted using 
a genetic sequence conserved in 
all bacterial RNA. Scale bar 




2.4: Machine learning for automated image analysis 
Machine learning (ML) as it is known today171 has its roots in statistical 
processing, classification, and prediction, where data can be used to create distributions 
or formula and compare against some kind of cost function or optimization constraint. 
These outputs are in turn utilized by a human operator to infer results on new (presently 
unknown) data. A classic example is in determining the expected wait time for a bus, 
given past bus arrival data172. In reality, there was no single moment when these 
methods coalesced into ML, but rather these methods were developed slowly over time 
alongside computational statistics and programming, starting in the 1980s. Initial testing 
using primitive forms of what is now considered ML was performed initially on board 
games, where a computer would learn how to play games like checkers173 or tic-tac-
toe174. Chess came much later, given the large number of permutations and 
combinations of potential moves and the related computational overhead and 
complexity175 required for processing, which was not possible to manage until more 
recently given the improvements in processor and memory speed and size176.  
With the more recent advent of large databases of unique user-generated 
images, purchase histories, or watched movie lists, implementing ML at a commercial 
scale became too advantageous to ignore. Google, Netflix, Facebook, and Amazon are 
some examples of corporations utilizing ML to improve the usefulness of their platform 
with respect to the accuracy of targeting ads or products, predicting future trends, or 
connecting friends in a network. Various contests and challenges have been promoted 
to improve these platforms for image identification and search ranking lists, to improve 




or automatically identifying cats on YouTube178. Since then, various achievements and 
advancements have demonstrated the utility of these techniques for tasks such as 
playing Go179 or identifying cancer in pathology slides180.    
ML at its core is most succinctly described as statistical classifiers that can 
“learn” without direct influence by creators. This refers to the ability of a program to 
improve performance over time with self-directed training, without being explicitly 
programmed to accomplish a certain prediction or training task. ML descriptors can be 
broken into two main categories depending on how the classifiers “learn” and how data 
is presented as output. An instructive analogy is to imagine classifiers as a student in a 
classroom. When taught by an ‘instructor’181, example problems and a framework for 
thinking is crafted by the instructor and provided to the student as ‘supervised learning’, 
which is then abstracted to new but related ‘homework’ problems for reinforcement. In 
more specific terms, supervised learning programs are provided with training data that 
is analyzed and used to make predictions on future data, and labels indicating a 
corresponding ground-truth or grouping. Contemporary examples of supervised learning 
include home price estimation models and classification of normal and abnormal 
medical image data. ‘Unsupervised learning’182 occurs when no teacher is present, and 
the student is free to make any associations that seem to make sense using available 
data and inputs. Unsupervised learning classifiers are provided only with data, and 
commonalities found in data, features, or results are clustered together to produce 
generalized predictions for future data. Modern examples of this include the suggested 




you know on Facebook or LinkedIn. Detailed history and further background on this 
topic can be found elsewhere, and is beyond the scope of this dissertation183.  
 
2.4.1: Using a Random Forest classifier for prediction 
 Human recognition and perception184 of complex patterns was initially considered 
a unique trait for biological lifeforms, and initially little was comprehended of the exact 
mechanism or capability, or even limit, of this ability. With the advent of programming 
and digitized statistics, this perception has been utterly destroyed. Predictions on 
complex datasets can now be rapidly computed, and in turn adapted by researchers to 
solve problems once considered impossible to solve programmatically, such as the 
identification of an animal or shape in an image. However, there are limitations to ML, 
and it should not be considered as a catch-all or snake-oil solution for any and all 
classification challenges.  
 To demonstrate how a classifier is set up and functions, a classic thought 
experiment is often employed: a company sells both sea-bass and salmon and must 
differentiate and sort these fish on a conveyor belt for shipping. This example has since 
been practically demonstrated185. Classification begins with understanding the available 
sources of data and desired outcome. In this example, there is an infra-red camera 
aimed at the conveyor belt. This data typically must be pre-processed to ensure it is 
input in a uniform format for analysis by the program. Then, more advanced processing 
and metrics can be interpreted from each of these data points and extract relevant 




reflectivity from the belly of the fish. Then, images of fish coming down the conveyor belt 
in various orientations are collected and organized into a database. From this data, a 
prediction on what kind of fish is in the image can be computed, which is then used to 
automatically sort the fish into a bin at the end of the conveyor belt. The performance of 
this algorithm is reviewed and refined if needed. A continuous process of refinement 
and testing is undertaken until a reasonably successful classifier (typically 80% at 
minimum) is created. Representative images and data from this example are shown in 
Figure 2.12187. This situation is a classic teaching example, as the method used to 
detect the fish, the metrics derived from this method, and the classification algorithm 
can all be adjusted as needed, and a complete classification example can be reviewed.  
 
Figure 2.12: A binary classic example in machine learning and pattern recognition. Fish on a 
conveyor belt must be accurately sorted for shipping. On the right, two sets of histograms 
displaying classification results are shown. In the top right plot, the sorting of these fish leaves 
something to be desired. With additional metrics added and refinement of existing features, the 




 While the discussion of feature extraction or creation is only tangentially 
described here, in principle any data that can be converted into a real number can be 
utilized for classification. Furthermore, the differences observed using any technique 
must be able to distinguish the expected classification groups. In the fish sorting 
example, additional metrics can be added by employing a color CCD camera to observe 
coloration differences in the fish species, a scale if one species is known to be lighter 
than the other, etc., to extract additional details related to the differential properties of 
the fish. Additional discussion of feature creation can be found elsewhere188. Once data 
and features are collected and pre-processed, classification algorithms take this data 
and begin clustering or forming statistical correlations on the data for future prediction, 
depending on the method used.  
One robust method is called Random Forests189 (RF), and generally can be 
considered a collection of single classification trees. Each tree is constructed by using a 
different random subset of the total data, with a size of #featuresm    with 
replacement (bootstrapping) from the overall dataset190:  
  m n( , ,D ), 1nTree r x m     (2.11) 
 n m n( ,D ) [ ( , ,D )]n nForest r X E r x     (2.12) 
where D is the entire dataset, x is a specific data point, θ is a random number generated 
to randomize data selection, and Eθ is the expected value of the forest output. The 
forest is the term for the collection of these single trees. Branch points split based on 
features used in the tree and are decided by the specified splitting metric (typically Gini 
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Where Pi is proportion of class in the left and right sides of the tree (always calculated 
downwards), nc is number of classes in the system. In principle, other splitting metrics 
can be used, but the Gini index has been shown to provide roughly the same accuracy 
as other metrics with a lower computational complexity191.  
To determine the expected class output of a new piece of data, each tree in the 
forest is traversed. By creating hundreds of trees, numerous random feature subsets of 
the data are run and replicate many trials for the expected output class. A final 
classification output is typically computed by averaging (regression) or more commonly 
taking a consensus measure – a vote of all the trees. These qualities make RF 
classifiers accurate and robust to missing data or unbalanced datasets. When using the 
Gini index, the system can also generate an unbiased estimate of error and feature 
importance as the tree is created. This is called the out-of-bag error estimate, which 
calculates the accuracy of each tree given which features are randomly missing. Since 
many trails are being computed, this provides a real-time estimate for the importance of 
each feature. Depending on the relative change in accuracy, the importance of this 
feature can be deduced relative to other features currently in the dataset. This process 
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where iY  is the output of the system with the feature, and ˆiY  without the feature. This 




After an output is computed by the classifier, accuracy statistics can be analyzed 
to evaluate feature and classifier performance, generally shown in Figure 2.13. A 
confusion matrix can be constructed that helps visually break down the accuracy of the 
classifier. Sensitivity is defined as the True Positive rate (the correctly predicted 







  (2.15) 
Where TP  is the number of correctly predicted members of the true class (True 
Positives), and FN  is the number of incorrectly predicted members of the true class (all 
members of the true class, regardless of prediction accuracy, or False Negatives). 








  (2.16) 
Where TN  is the number of correctly predicted members of the false class (True 
Negatives), and FP  is the number of incorrectly predicted members of the false class 
(all members of the false class, regardless of prediction accuracy, or False Positives). 
The formulism for these values is broken down visually in Figure 2.13.  
These values rate the ability of the classifier to accurately detect members of 
each class correctly. A receiver operating characteristic (ROC) curve can be calculated, 
which visually represents the diagnostic accuracy of a classifier. The area under the 
ROC curve represents the accuracy, with increased performance as the curve bends 




minimum baseline performance of a random 50:50 guess. With two-group classification, 
classifier performance and statistics can be directly computed. However, when 3 or 
more classes are required, visually displaying accuracy using ROC curves becomes 
more complicated, since a single curve represents the comparison between 2 classes. 
Often, the confusion matrix is the most efficient method to display results, although 
sensitivity and specificity can still be computed for each class.  
There are many other classification methods that can be used to solve machine 
learning problems. Ensemble, k-Nearest Neighbor (kNN), and support-vector machine 
(SVM) classifier types are the most popular and useful, with their own strengths and 
weaknesses. Ensemble classifiers, including the RF method described above, create a 
model with a weighted mixture of multiple classifiers to increase predictive accuracy. A 
kNN classifier finds a group of k objects in the training set that is closest to the test 
Figure 2.13: Confusion matrix and ROC curve construction. In a two 
group classification test, training data is used to compare the predicted 
class against the known class label. This is visualized by plotting the 
distribution of these two groups on a common axis (top right). An ROC 
curve (representing the distribution of the two groups at the red line in 
the distribution plot) helps to select the best position to divide the 




objects, and the class labels of these nearest neighbors is used to determine the class 
label of the object. kNN are well suited for multiple classes, as well as objects with many 
features192 although predictive accuracy may not be good in high dimensional datasets. 
Support-vector machines (SVM)193 classifiers find the maximum-margin hyperplane 
using only those data closest to a separation boundary. SVM uses a risk minimization 
(SRM) principle and is a superior method compared to traditional empirical risk 
minimization. Theoretically, SVM is better at generalizing training data and making 
predictions. Though the prediction accuracy is high, this classifier typically requires a 
substantial amount of training time that may prove difficult with larger image databases. 
It is also difficult to understand the classification functions after training194. The tradeoffs 
for these classifiers are well known and are suitable for many applications where 
multiple types of data are utilized for classification. Further in-depth sources of 
background material are available elsewhere171,187,195. 
 
2.4.2: Machine learning with OCT  
Machine learning techniques for image analysis and classification are an intense 
area of study for all medical subspecialties and imaging techniques. The earliest study 
combining ML and OCT appears to have been published in 2005194,  testing the ability 
to identify glaucoma. ML for OCT has seen the most growth in ophthalmology, as it is 
one of the largest areas of research, and includes the automated detection of 
glaucoma196, age-related macular degeneration (AMD)197, or macular edema198,199. ML 
is typically used to perform segmentation or identification of abnormal and suspicious 




from OCT. A broad array of structural and functional metrics can be utilized, such as 
Doppler, polarization, or blood flow.   
More recently, OCT data is being used to classify and identify specific expected 
pathological disease states in the subject, rather than the presence of disease overall. 
Generally, this is a difficult challenge, as both the data of pathological conditions and 
the corresponding clinical diagnoses of hundreds of patients must be collected and 
correlated. However, if diagnosis is the ultimate goal for these software packages, 
amassing a large and accurate database must be undertaken. Open-source image 
databases200,201 are starting to be made publicly available to catalogue some major eye 
pathologies, which easily allows researchers to develop ML algorithms to detect them. 
ML is expanding to other clinical OCT application areas, including intravascular and 
cardiology202, skin203-205, teeth193,206.   
 One current limitation for ML applications in OCT is the lack of available data, 
which is truly a case of different perspectives of scale. In any one study, a dataset of 
several hundred OCT images is used, which is already an incredible amount of data for 
a typical OCT research lab. However, machine learning can take advantage of larger 
datasets and efficiently analyze them, and in commercial applications, have millions of 
data points. In the future, these larger datasets would also ensure that the variation 
among the population is accurately captured in the statistics. Yet, there is currently no 
mechanism to acquire or combine shared datasets on the required needed scale. Many 
companies are slowly and individually building such repositories, whereas larger 
commercial companies have the resources and ability to partner with larger healthcare 




 There is enormous potential for ML to make an impact in OCT and in medical 
image diagnostics as a field. While previous clinical applications were developed after 
standard-of-care techniques and tests were developed for other imaging modalities, 
OCT has the advantage of integrating ML techniques alongside development for more 
advanced data analysis and classification from the start. There may never need to be a 
radiologist that is trained to understand an OCT image or volume given potential future 
advances in ML. However, a more likely scenario is that trained physicians will review 
scans that have first been preprocessed by an algorithm, rather than raw data, as is 




Chapter 3: Foundations of clinical OCT imaging and system development for OM 
OCT has been utilized in many previous studies to investigate and observe the 
structure and dynamics of the inner ear. The cochlear response to changes in sound 
pressure in the middle ear was investigated in guinea pigs209, and a 3-D model of the 
murine cochlea has been reconstructed210, both taken in vivo. Previous studies in 
humans have largely been restricted to ex vivo studies, due to the technical difficulties 
of imaging the ear in vivo, including developing an appropriate beam-delivery system. 
However, initial studies in the middle ear have only shown basic structural 
characterization of healthy and diseased ears211-213.  
The scientific exploration contained in this dissertation of the middle ear and the 
development of OCT imaging tools and probes for clinical research for improved OM 
diagnosis is a major component of a concerted effort over the past ten years to bring 
this technology to fruition. This section will cover some of the important advancements 
and decisions that must be taken into account when designing, building, and developing 
a handheld OCT system. This section also includes a historical look at the development 
of these systems in the Biophotonics Imaging Laboratory at the University of Illinois at 






3.1: Optical design considerations for handheld OCT probe development  
Primary care is one clinical specialty that is commonly overlooked by device 
manufacturers, primarily because the operating margins are very slim, and 
subsequently only absolutely essential equipment can be purchased and utilized214. 
However, primary care physicians are on the front line of care, seeing patients and 
referring to a specialist, and must be knowledgeable about a wide variety of injuries, 
diseases, infections, and community or societal trends. Physicians often rely on the 
physical exam and tools that typically only provide a subjective analysis of patient 
status. While there are significant advancements in laboratory diagnostic tests of blood, 
fluids, tissues, and in medical imaging, similar advancements have not commensurately 
followed for primary care. Through the use of new tools to provide quantification of 
many of the conditions they regularly see and qualitatively assess, physicians could 
more accurately detect and diagnose disease, and more appropriately refer patients to 
specialists using quantitative, evidence-based data. In the primary care office, 
precedents of optical imaging instruments exist, including the ophthalmoscope to 
visualize the retina, and the otoscope to visualize the tympanic membrane (TM) (ear 
drum).  
OCT is well suited to image and characterize the TM and middle ear space to 
provide clinically useful discrimination of infection states. The TM itself is a conical bowl-
shaped thin membrane, and has been shown to be approximately 100 micrometers 
thick at the light reflex and spatially varying across different regions of the TM, shown in 
both histology215 and prior studies using optical characterization techniques123. The 




eardrum sitting at an approximately 30-45 degree angle in the ear canal and relative to 
the OCT beam. OCT provides structural contrast sensitive to the optical refractive index 
differences encountered in tissue116 with sufficient sensitivity and resolution to resolve 
structural and morphological changes that occur with various stages of OM infection7.  
To better understand the TM during infection, characterization of a normal TM 
can provide important baseline parameters. Therefore, a fresh human cadaver temporal 
bone was acquired from a healthy adult human subject (Tissue for Research, 
http://tissue4research.com) and the TM was recovered and characterized for its 
structural (thickness) and optical properties (absorption, refractive index, non-linear 
response) when both unfixed and fixed at both 860 nm and 1310 nm. Figure 3.1 details 
the harvesting and findings of this characterization. The structure of the TM is consistent 
with published data, demonstrating a spatially varying thickness depending on the 
region of observation123. Figure 3.1D shows a cross-sectional OCT scan of the TM near 
the light reflex, which shows the thickness is approximately 100 μm as previously 
observed7. In general, the refractive index of the sample (~1.43 @ 860 nm, ~1.42 @ 
1310 nm) was similar to previously published data (~1.44 @ 1050 nm)123, The TM was 
then observed using the slide-free label-free auto-fluorescence multi-harmonic (SLAM) 
microscopy217 to observe both second-harmonic generation (SHG, excitation/emission 
at 1080 - 1140 / 540 – 570 nm) and 2-photon fluorescence (1080 - 1140 / 580 – 640 
nm). Both techniques showed the delicate fibrous collagen structure of the TM, with 
SHG shown in Figure 3.1H. The refractive index of the TM did not significantly change 
after fixation (+/- 1%, after immersion in 4% paraformaldehyde for 4 hours at 23 °C) at 





Figure 3.1: Optical characterization of a fresh ex-vivo human TM. A: A human 
temporal bone was acquired (Tissue4Research). B: The TM was recovered, and C: 
suspended in liquid to retain its shape without tension from the annulus. The TM was 
optically characterized to characterize its optical (OCT, Spectrophotometry, non-linear 
microscopy) and structural (OCT) properties. D-F: OCT scans at 1310 nm across the 
TM that show scans from the D: light reflex, E: umbo adjacent, and F: malleus. G: 
Spectrophotometry scan (175 - 3300 nm) of the TM light reflex. H: Representative 
non-linear microscopy image showing second-harmonic generation, revealing the 
collagen structure of the TM. Scale bars: D-F = 100 μm, H = 450 μm. Panel H courtesy 




Physiological changes with infection, often the addition of a middle ear effusion, 
biofilm, etc. as previously demonstrated7, cause a significant change in the TM and 
MEC, transitioning from an empty and aerated middle ear space, to an inflamed TM and 
serous fluid, to one eventually filled with fluid and biofilm. Furthermore, visualization of 
fluid with OCT can provide some evidence of the degree of purulence or scattering, 
which often correlates to the length and degree of infection218. Therefore, continued 
characterization of middle ear pathology with OCT may aid in resolving the disconnect 
between existing symptom-based management and the true underlying causes of 
disease, and provide clinical researchers with new quantitative diagnostic metrics for 
chronic OM.  
To successfully observe the TM in vivo, an OCT beam must have line-of-sight to 
the tissue of interest. The ear canal provides access to the TM, but is often curved or 
twisted and obscures a direct line of sight to the TM. Beam delivery devices, typically 
and most effective as handheld probes, must then utilize a speculum, a tapered, rigid, 
conical tube of plastic or metal, to visualize the TM in a subject. The ear canal is 
relatively pliable, and the use of a speculum does not introduce significant pain in most 
subjects. While earwax can partially occlude visualization of the TM, an OCT beam has 
a small cross-section and can typically avoid these occlusions. Finally, patient comfort 
and ideally interest in OCT imaging of their ears, is the most useful means of distraction 
to help collect images successfully, especially in younger subjects. A cross-sectional 
view of a representative imaging layout involving an ear model and handheld probe is 




Another point of consideration for engineering any OCT-based imaging probe is 
managing component level capabilities and requirements. The use of a color camera is 
essential for positioning the OCT beam on the TM, as well as the visual examination 
and cataloguing of tissue qualities for later analysis. Integrating such a system becomes 
more of a challenge, as the wavelength range that optics in the handheld probe must 
now support can include the low-visible (~380 nm) to the infrared (~1400 nm), 
depending on the optical source utilized in the system. Thankfully, high performance 
“cold” or “hot” mirrors, essentially dichroic mirrors manufactured for specific wavelength 
bands, are available that efficiently split the OCT imaging and visible wavelengths.  
Apart from the axial resolution of the OCT system (set by the light source) and 
the depth and resolution tradeoff between 800 nm and 1300 nm-based OCT systems, 
the imaging parameters of the handheld probe itself must be designed to meet certain 
design constraints. A previously developed handheld probe will be used here as an 
example, with design constraints detailed in Table 3.1219.  
 
Figure 3.2:  Imaging setup in the 
middle ear. A speculum provides 
direct access to the TM and MEC. 
The OCT imaging beam must 
focus on the surface of the TM or 
directly adjacent to it, such that the 
imaging volume includes the TM 
and as much of the MEC as 
possible. The TM can be treated 
as skin for purposes of maximum 





System Parameter Acceptable performance 
Spot size 30 µm 
Axial Resolution 5-10 µm 
OCT Imaging speed 20 fps @ 700 A-lines 
CCD resolution 3 MP 
Light source bandwidth Centered 800 nm, +/- 40 nm 
Spectrometer camera 2048 pixels, 70 kHz 
Spectrometer Resolution 0.05 nm / pixel 
Field-of-View 2 mm x 2 mm 
Probe output power > 2 mW 
Probe Dimensions D x W x H (cm): 4 x 10 x 15 
Probe Weight  < 500 g 
Cart Dimensions D x W x H (cm): 40 x 50 x 200  
 
The OCT subsystem is a standard Michelson interferometer, employing a  
super-luminescent diode light source (T-860HP, Superlum, Ireland (Ie) ) with 135 nm 
bandwidth at the FWHM with 12 mW at the output fiber port. Moving to any higher 
bandwidth sources will increase the difficulty in managing dispersion. As an example, 
most commercially available 2 x 2 couplers are only guaranteed to work efficiently over 
a ~100 nm bandwidth. Although custom products can be found and purchased, the cost 
and difficulty in acquiring these parts increases substantially. For this reason, 
customized fused fiber collimators were custom ordered (OZ Optics, CA) to minimize 
coupling losses and alteration of the spectral profile. A custom fabricated spectrometer 
(Wasatch Photonics, UT) with a 0.05 nm / pix resolution and a high-speed line-scan 
camera (spl4096-140km, Basler, Germany (De)) was used to ensure excellent 
sensitivity.   
Table 3.1: Design specifications for the second-generation Primary 




The remainder of the system design is an exercise in optimized collection of light 
to the spectrometer. Optical components with suitable anti-reflection coatings were 
chosen to limit losses from back reflections and absorption. The amount of fiber mating 
sleeves was minimized to allow for modularity within the optical system for a more 
simplified repair process, but avoid unnecessary coupling junctions that are a large 
source of optical power loss. A Labview-based program (National Instruments, TX) with 
associated DAQ (Model #6353) and IMAQ (Model #1433) cards were used to interface 
with and drive the scanning micro-electrical-mechanical system (MEMS) mirror. The 
MEMS mirror (AdvancedMEMS, CA) is a 3.6 mm diameter, Al-evaporated coated silicon 
mirror that requires differential voltage pair inputs, centered around 4.67 V, to properly 
drive scanning patterns.  
 The handheld probe was modeled in Zemax (RadianZemax, WA) and Solidworks 
(Dassault Systems, MA) to ensure precise positioning of all components after 
fabrication. In general, there are several pieces of advice that were useful to begin the 
design process. The objective lens should be chosen such that the working distance, or 
the spacing between the lens and the sample of interest, is sufficient for the given 
application. In the ear, the imaging plane is efficiently set for approximately 12 mm past 
the speculum tip fully inserted into the ear canal in children. The numerical aperture 
must be balanced with the working distance, such that the OCT lateral resolution is 
approximately 20-30 µm, and that any digital CCD camera depth of focus is reasonable 
such that the handheld probe does not require overly precise positioning to acquire a 
clear image. A sense of balance must exist, which seems to be found using a 0.5 inch – 




beam diameter (1/ 2e ) of 2.4 µm. Finally, the wave front curvature of the output beam 
should be relatively flat across the objective lens if using a scanning element, such that 
a cross-sectional scan would have less than 0.1λ flatness (ideal). A local dentistry 
company (R-cad Milling, IL) was contracted to perform 3D printing of this handheld 
probe enclosure, with a printing resolution of 20 µm droplets. A final design and layout 
of the probe and portable system is shown in Figure 3.381,219. This was the first 
complete system designed with somewhat modular digital assets in Zemax and 
Solidworks. Through the construction of this system, the design and construction of 
numerous other systems was possible. In the next section, a retrospective look at 
previous systems, and systems that evolved from this system, are reviewed.   
Figure 3.3: Handheld probe and portable system optical design and construction. The 
handheld probe Zemax design is shown in A, with the Solidworks model in B, and the 
final assembled probe (cover removed) in C. The portable system design is shown in 
D, and final assembled version in E. This system was designed to serve as a 
cornerstone of the experiments presented within this dissertation, employing high-end 
components, designed for long-term use and stability, and portability to multiple clinical 




3.2: A historical look at clinical imaging system development at BIL  
Over the past several years, multiple handheld probes have been designed that 
can image the ear, eye, skin, and teeth. This section details a brief overview of these 
portable OCT systems and their use at the time of development.  
In the first TD-OCT ear imaging handheld probe design, a fiber and fused GRIN 
lens were added to the inside of a plastic ear speculum tip that attached to a 
commercial RCA-based video otoscope without modifying any of the internal 
components. The lens properties were chosen to focus light through the ear canal and 
onto and through the TM of a human subject. A low-coherence interferometry (LCI) 
system that utilized a laptop as the control and processing computer was constructed 
and placed into a portable cart for use first in the otolaryngologist specialist office 
(Figure 3.414). This system provided single A-scans at a rate of 35 kHz through the TM 
and into any content within the middle ear (effusion, biofilm). This system provided one 
of the first in vivo characterizations of the TM in an animal model45 and in adult human 
subjects14, and helped develop a normative library of the depth-resolved scattering 
characteristics or profiles of various infection states for OM. As fragile and exposed as 
the GRIN lens and optical fiber were to potential damage, they remained intact through 
major animal and human studies and regular use. Modifying an existing commercial 




Considering the regular use of both the otoscope and ophthalmoscope in the 
primary care office, we realized that it would be possible to retain the existing 
capabilities for ear imaging, while also expanding to imaging the eye (both anterior and 
posterior), as well as the skin and oral cavity. A system with this expanded capability 
could improve upon not only the ophthalmoscope or otoscope, but also provide a more 
comprehensive point-of-care imaging system for all the tissue sites commonly examined 
in primary care. This truly portable and multi-site primary care imaging system and 
handheld probe, shown in Figure 3.5220, enabled optical characterization of these 
different sites with interchangeable attachments to the probe tip and simple 
modifications to the reference arm. An interchangeable adapter used a modified cutout 
that simulated the device head on a commercial otoscope, such that it would be 
possible to use standard otoscope tips for TM imaging. To observe the skin, oral cavity, 
or cornea, a metal standoff and eye cup were used, if applicable, which also had the 
same fitment. To image the retina, an additional adjustable lens and eyecup was 
developed, along with a flip mirror in the reference arm to have the proper (longer) 
pathlength for imaging in the retina, as well as provide suitable dispersion compensation 
Figure 3.4: A: Portable LCI-otoscopy 
system. B: Schematic and 
photograph of the integration of the 
LCI fiber-based micro-optic probe 
into an ear speculum tip that would 
attach to the otoscope head.  
C: Schematic and beam profile of the 
long-working-distance LCI probe, 
which used a gradient-index (GRIN) 





to improve image quality. This initial system and probe design lacked a way to visualize 
the real-time acquired video and OCT scans on the handheld probe, and had the optical 
patch cable exposed near the grip, both of which increased the difficulty of using the 
probe. Although the tradeoffs from the combination and implementation of this hardware 
were apparent during use, this system and handheld probe was the first of its kind.  
 
 
Later, the internal hardware of the handheld probe was redesigned to improve 
functionality in clinical settings, although the cart stayed the same. A MEMS scanner 
replaced the pair of galvanometers to reduce the form factor of the handheld probe and 
provide more stable and adjustable scans. With the smaller components, a color CCD 
camera was also able to be included, although still at a fairly low 480p resolution, for 
Figure 3.5: Schematic diagram and photograph of the first-generation 
primary care portable OCT system and handheld scanner. The cart 
included a broadband source, spectrometer, and optical hardware. The 
handheld scanner contained the sample optical path with galvanometer-
based scanning mirrors. With interchangeable tip attachments, the 
physicians could easily access multiple tissue sites on a patient. Users were 
able to monitor both video and OCT images of the tissue, and save images 
with a button mounted on the probe handle. Abbreviations: DG, diffraction 
grating; PC, polarization controller; DC, dispersion compensation materials; 




color surface imaging. A commercial spectrometer and light source helped bring further 
reliability to this system, which did not require regular maintenance or cleaning to 
maintain performance, especially when moving the system to different clinical sites. This 
improved system was first used for research in the human eye at a local eye clinic9,221, 
and later was used to investigate ear infections in adult subjects220. After working at 
these locations, the Labview operating software was refined for a clinical environment – 
larger and more accessible on-screen buttons, clearer display of relevant information, 
and simplified image and information display of only what was needed when imaging 
subjects. A separate version of the software was available to test and diagnose 
problems should they arise, and provided information regarding system stability and 
base function. The system was then used at the outpatient otolaryngologist clinic to 
observe pediatric subjects, and catalogued a normative database of different types and 
stages of ear infections there as well. Notably, inflammatory changes in the TM, and 
middle ear biofilms were regularly identified in human subjects with acute and chronic 


















Figure 3.6: Redesigned first generation primary care handheld OCT probe with representative 
data from pediatric human subjects with normal and infected ears. Left: Handheld unit was 
upgraded to include a MEMS-based scanning unit, new optics layout, and a small 5-inch LCD 
screen to display both surface video and cross-sectional OCT images during acquisition.  
A-C: Representative cross-sectional OCT images of a normal ear, and ones with acute and 
chronic ear infections, respectively. D-F: Representative corresponding digital otoscopy 
images. Adapted from Ref. #7.  
 
Figure 3.7: Analysis of TM thickness between diagnostic 
groups. Top: Histogram of TM thickness between three 
diagnostic groups. The chronic OM group has been 
subdivided to show the thickness of the TM and the thickness 
of the biofilm. Bottom: Measured average thickness and 
statistical analysis presented by group. Mean and standard 
deviation (error bars) of thickness measurements in microns.  




For the next generation of handheld OCT probes for use in primary care, I set out 
to refine the physical properties of the handheld probe and portable cart design 
including ease of assembly and optical alignment, lighter yet robust material choices, 
and system form factor reduction. Designing the optical layout and form factor of the 
probe in digital CAD programs allowed for a rapid iterative design process without 
purchasing a costly lens library and mounting equipment for testing. Another major 
consideration during design was in the portability of the system. A system may need to 
be at a surgical center one day and at the outpatient clinic across town the next day. To 
utilize the minivan transportation available to us at our institution, the height of the cart 
was limited, although the monitor mount had the ability to lower into the portable cart. 
Even with this reduced size, it is prudent for a research-based system to maintain 
access and flexibility to easily repair or realign components, if necessary. Finally, no 
single industry provided the components needed to construct this system, and future 
system builders are encouraged to creatively use components and parts from as many 
suppliers as possible, ranging from standard optics suppliers, electronics suppliers, and 
hardware suppliers, but also medical supply companies, plumbing fixture resellers, and 
the automobile industry.  
Ergonomic and user-focused designs are largely missing in many commercial 
products. Recognizing this, a collaboration with a faculty member in Industrial Design 
was established early in the development process to explore the usage of our own 
system with actual users. Our collaborating physicians were observed when using their 
own typical instruments during procedures, were questioned as to how and why certain 




understand the design, intended use, and actual use of the instruments. With this 
information in hand, the design of items used in different fields was then examined to 
find inspiration for our system and particularly our handheld probes. Our team 
investigated a range of product types and categories including children’s toys, 
consumer healthcare products, hand tools for construction, and even to kitchen tools, all 
of which had excellent ergonomics for their intended use, and likely better than currently 
designed medical instruments. Representative images from this investigation are shown 
in Figure 3.881. Mood and feel, often 
difficult to quantify, were also considered, 
focusing on how an individual interprets 
any subconscious cues by using, 
touching, and feeling a tool. The weighting 
of the handheld probes was also explored 
to try to find a comfortable grip and 
balance using the same mass and 
location of optical components used in the 
design, and for users with different hand 
sizes and shapes.  
Aesthetics are also often 
overlooked in the development and 
design of portable carts and handheld 
probes. Any system intended for 
academic research in a clinical 
Figure 3.8: Photos representing various 
handling techniques of an otoscope during 
use by an experienced ENT otolaryngologist 
(left column), and different grip shapes, 
materials, and textures in various 
commercial products (right column). 





environment should look like it belongs in a clinical environment. The exterior 
appearance of the system should reflect the technical development efforts undoubtedly 
within. This equates to no visible loose wires or fitments of any kind, and no visible glue, 
tape, or other temporary measures for construction. As system designers, we are 
intimately familiar with our own systems. Yet, clinical staff and especially imaging 
subjects are confronted with a completely new situation with a new instrument and new 
procedures, and carry their own perceptions, doubts, curiosity, and hesitation about any 
unproven research system or instrument. A unified system appearance will help inspire 
confidence in clinical staff and imaging subjects that the system is safe, well-designed, 
and robust, and more importantly that it will provide new helpful data and not fail during 
operation. To reinforce this in our own work, the color of our portable carts and 
handheld probes were modeled after current medical products. Powder-coated panels 
also provided a visually appealing and robust appearance on our portable carts.  
Working with our Industrial Design collaborator, nature-inspired designs for future 
handheld probes were created, with some concept designs shown in Figure 3.981. 
Other interaction spaces and encounters in the patient workflow were explored that 
could be re-designed to incorporate next-generation technologies such as OCT systems 
and probes in primary care, and designed a “Doctor’s office of the future” where lab 
space was remodeled to support human subject imaging studies, and where visitors 
would feel as if they walked into a real clinical environment. Colors, textures, layout, 
furniture, and the available equipment in the room were concepts taken into account 
during the design and renovation of this space. Three-dimensional plastic models and 




display helped provide 
background information to 
subjects before their exam 
as well as an opportunity 
for self-teaching. The large 
display also allowed 
imaging results to be 
efficiently displayed, 
relayed, and explained to 
the subject post-
examination. In addition, 
instead of relying on 
unclear or incorrect online 
sources, websites could be 
shared and explained transparently. This “Shared Care” concept would allow the 
imaging subject or patient to feel more comfortable and involved in the clinical exam.  
Following design planning, a modified version of the newly designed handheld 
probe for otologic imaging was used in our laboratory. Through the use of a customized 
3-D printed enclosure, the probe form factor was reduced by approximately 30% over 
the previous iteration by designing only the needed support structures and outer 
enclosure, moving away from bulky metal fixtures. In total, these changes and 
modifications reduced the weight of the probe to less than 250 g. The visualization 
screen on the handheld probe was also removed to reduce bulk and weight, and other 
Figure 3.9: Left: Nature-inspired designs for handheld probes. 
Many designs were considered for an ergonomic handheld 
probe. Right: A “Doctor’s office of the future”. This lab space 
was redesigned for human subject imaging, with special 
attention given to color, layout, and function. The room 
included standard clinical equipment: otoscope, 
ophthalmoscope, blood pressure, pulse oximetry 
measurement systems, and sterile healthcare supplies, our 
portable primary care imaging systems, and teaching tools. 




display and visualization platforms were explored, such as displays strapped to the 
operator’s forearms. While many integrated display options were available, all that were 
identified were either limiting or did not have the desired appearance. For example, 
high-quality replacement screens for mobile devices are available to purchase, but 
driver boards and USB interfaces are rarely available. Other components were too 
compromised at that time, and had large bezels, or were too heavy to attach onto a 
handheld device. Finally, all electrical wiring and optical fiber were routed within a 
protective sheath that also provided some minor strain relief on the cabling.  
During imaging sessions using our handheld probes, it was challenging for 
pediatric subjects to remain completely still and attentive. Subjects inadvertently moved 
through the imaging range of the probe, which was only several millimeters, even while 
sitting relatively still. While images could be stably acquired, motion was often erratic, 
making the collection of single scans by manipulating the on-screen “stop” and “record” 
buttons no longer possible, as commonly done in benchtop systems. Similarly, 
continuously recording all data was too intensive on computer resources. The operating 
software of this system was redesigned to provide improved saving functionality and file 
management by implementing a trigger system that allowed the operator to save a 
buffered queue of tens to hundreds of previously visualized on-screen images at a time. 
Operation using this trigger would ensure any data acquired provided useful information 
for later analysis. In cases where subjects could sit still – high-quality image stacks were 
acquired. Other improvements included an automated thickness measurement 
algorithm for rapid analysis of the TM222, shown in Figure 3.10218,222, and a Google 




handheld. This system was later used to evaluate the in vivo viscosity of middle ear 
effusions, fluid that often accumulates behind the TM in subjects with OM218.  
 
With the successful implementation of this system, additional studies were 
conducted to further characterize the anatomical and biomechanical properties of the 
ear when infected with OM. One study sought to characterize the viscosity properties of 
an effusion noninvasively.  
The viscosity of an effusion is highly correlated with the incidence of chronic 
OM224, and therefore is highly clinically relevant to the diagnosis and treatment of OM. 
To characterize the mechanical and viscoelastic properties of an effusion, the 
Figure 3.10: Second-generation primary care system and 
handheld probe. A, B: Portable system and handheld probe in the 
primary care clinic. C: System in use within our clinical imaging 
suite. D: Automated segmentation and thickness analysis of an in 
vivo human TM. E: Real-time thickness measurement tracking 




decorrelation time of scatterers within an effusion were characterized by observing the 
Brownian motion of particles as they randomly walk throughout the effusion. Quantifying 
the decorrelation of particles relies on the relationship between the Einstein-stokes 
diffusion constant and the measured signal from a Fourier-domain OCT system225. This 
relationship has several assumptions, such as that all particles in the solution or 
suspension are a hard sphere with a hydrodynamic radius R, and that there is no added 
external forces, excluding Brownian motion. The hydrodynamic radius is defined as the 
radius of a particle that diffuses at the same rate as the particles of interest. This is an 
abstraction that helps to account for non-spherical particles in the solution.  
A solution detects movement from Brownian motion when no external energy is 
applied to the solution, such as mixing or currents.  A customized algorithm can recover 
the diffusion constant of a solution: the Fourier transform of a data vector comprised of 
repeated M-mode OCT scans at a single spatial position in time forms a Lorentzian 






 is the Einstein-Stokes 








  , 𝑘𝐵 is the Boltzmann constant, 𝜂 is viscosity, T is 
temperature in Kelvin, and r is the hydrodynamic radius227. From these formulas, the 
diffusion constant of a fluid can be calculated. While an in-depth description of this work 
can be found elsewhere218, representative results from this study are shown in 






Figure 3.11: Results from a MEE phantom. A thin plastic sheet was used as 
an analogue to the human TM, petroleum jelly as a biofilm, and water and 
glycerol mixtures full of polystyrene beads as a scattering effusion phantom. 
The data here shows 4 regions in this phantom being probed: Above the 
sample (Blue), the surface of the sample (Green), Inside the sample (Red), 
and finally the fluid (Teal). Only the fluid itself provides an observable signal, 
although the phase from other regions may randomly be fluctuating. Scale 
bar represents 100 µm. Adapted from Ref. #218. 
Figure 3.12: Comparison of two subjects with MEE. Subjects were observed 
in vivo (A, B) to confirm the presence of a MEE. Samples were aspirated during 
TT surgery, observed (C, D), analyzed, and directly compared. Scale bars are 
approximately 100 μm in depth. Right: Decay curves for both C (Blue, Γ = 
101.58 s−1) and D (Green, Γ = 48.01 s−1) ex vivo MEE samples. Adapted from 




In later iterations of this handheld probe design, pneumatic capabilities were 
added to the probe, as shown in Figure 3.13228, that allowed the first demonstration of 
high-resolution depth-resolved characterization of the TM using fast low-coherence 
interferometry (LCI) axial scans with a pneumatic stimulus228. Subsequently, lower cost 
system components were implemented in attempts to reduce the overall cost, both in 
software229,230 and hardware231.  
For the next 
generation of primary 
care systems, the focus 
centered on further 
reducing form factor and 
significantly reducing 
cost, such that primary 
care offices could 
potentially afford a 
shared system that 
retained the capabilities 
of previous generations. Initially, we set out to build two new systems utilizing different 
OCT engines and construction materials, to reduce cost and weight. For ruggedness, 
powder coated aluminum carts and side panels are both functionally and aesthetically 
appropriate against transport and daily use, especially when compared to carts created 
with aluminum frames and plastic panels. Wheel size is also an important consideration, 
mainly to ensure that moving the system could be done smoothly and safely without 
Figure 3.13: Second-generation primary care imaging handheld 
probe modified to accommodate pneumatic functionality. A: A 
rubber ear-bud tip was added to the ear speculum to ensure a 
pressure seal within the ear canal, along with a pressure sealed 
probe tip. B: System schematic showing an input port for the 
computer-controlled air pressure stimulus (dotted box). This fast 
axial-scanning LCI system replaced the 2-D scanning MEMS-
driven mirror to lower costs and capture fast dynamic transients 
of the TM following the pressure stimulus. Abbreviations: M, gold 
mirror; C, collimator; DM, dichroic mirror; OBJ, objective. Adapted 




fear of getting caught on gaps in elevators, or on door jambs, or even simply thick 
carpet. Larger 4- or 5-inch diameter medical wheels were found to be optimal for our 
portable cart designs.  
Realizing that repairs and alignment often required access to almost every part of 
the cart, we used a CAD program to design an aesthetically pleasing exterior that could 
still offer unrestricted access to every component in the cart by removing side panels. 
The reference arm of the OCT system transitioned to a cage-based system, which 
greatly reduced the footprint needed to maintain its stability over time. On early 
handheld probes, we used commercial otoscope replacement bulbs to illuminate a fiber 
bundle within the probe tip. As technology evolved and became available to us, we 
added a customized LED ring and MEMS-collimator alignment package to this probe, 
developed by AdvancedMEMS, and thus were able to shrink form factor even further 
than the previous generation.  
The overall cost of these system designs were considered in relation to the 
choice of OCT engine and application. Spectral-domain OCT was often the preferred 
engine to maximize phase stability, and similar compact systems were built in the past. 
New research opportunities utilizing swept-source OCT were also possible when 
imaging deeper into the middle ear cavity. While middle ear biofilms were found to be 
affixed to the TM in our previous studies, the middle ear mucosa was first shown to 
support biofilm growth29. Having the capability to detect the presence and extent of 
biofilms simultaneously on the TM and on the mucosa at a potentially lower cost was a 
significant benefit. The tradeoffs explored between these two system designs allowed 




tradeoffs between system design and form factor, and the capability for our intended 
application versus cost. Studies with these system designs are currently ongoing. When 
comparing the newer generation to the early generations, the portable cart was reduced 
in size by nearly 40%, and the handheld probe was reduced by 10-20%, depending on 




Figure 3.14: Third-generation primary care imaging portable 
system and handheld probe. A: CAD schematic of cart layout and 
interior organization. B: Portable systems testing different material 
choices (Left: powder coated metal frame and side panels; Right: 
aluminum frame and plastic panels). C: Schematic of handheld 
probe layout and final 3-D printed enclosure. FM: fold mirror. CO: 
collimation optics. OBJ: objective lens. DM: dichroic mirror. 





3.3: Avenues to reduce OCT system size and cost 
Handheld OCT systems have demonstrated comprehensive clinical utility for the 
early diagnosis of infection and disease. Unfortunately, no fully developed pocket-sized 
or self-contained systems exist to date. Researchers are actively working to reduce the 
size and cost of OCT systems by considering alternate detection methods232,233 and 
light sources234,235, as well as exploring costs and tradeoffs between various OCT 
platforms. For specific clinical imaging applications, it may be more practical to reduce 
the performance requirements of the OCT system to save costs and reduce system 
complexity and size, while still providing the needed data for clinical decision making.  
The original configuration for OCT systems was named time-domain OCT (TD-
OCT), given its detection scheme. Researchers have continued system development 
since inception, pushing the limits of these TD-OCT systems236,237. However, TD-OCT 
systems have been used less frequently in the last decade because of the improved 
imaging speed and SNR afforded by Fourier-domain OCT (FD-OCT) systems115,117. 
One important advantage of TD-OCT systems, however, is their potential cost 
advantage over FD-OCT systems, as they do not require expensive spectrometers or 
fast swept laser sources.  
Recently, an integrated handheld LCI system has been developed and 
demonstrated for in vivo ear imaging231, based on the principle of Linear-OCT238. The 
overall cost to develop this system was significantly lower than portable cart-based FD-
OCT systems, roughly by a factor of four218. Other than the light source, all components 
needed for this initial system design were housed in a 3D printed handheld probe, as 




were around 5.2 µm and 80 dB, respectively, which considering its configuration and 
cost, is a worthy achievement. 
Multiple reference OCT (MROCT) systems are another low-cost TD-OCT 
technology, based on the optical system within a CD/DVD computer drive. This platform 
has the potential to enable a wide range of point-of-care and personal care 
applications239. In MROCT, a depth scan is achieved by utilizing a partial mirror and 
actuator to generate a recirculating optical delay line, which extends the axial scan 
range. The overall cost and size of a typical MROCT system is anticipated to be similar 
to a CD/DVD unit, although these units are still in the early stages of development 240. 
Given the advantages of Fourier-based systems over TD-OCT, miniaturizing a 
FD-OCT system has great potential to be useful in clinical applications, especially in 
low-resource settings. Instead of utilizing standard spectrometers and CCD cameras, 
systems developed on a miniaturized silicon-based photonics platform can ideally utilize 
the cost-savings from mass production capabilities in the semiconductor industry. 
Figure 3.15: Reduced cost linear-OCT 
handheld probe for ear imaging. A: Optical 
layout of handheld probe. B: An averaged 
A-line from a tympanic membrane 
recorded from an in vivo human subject. 
C: Completed (cover removed) hand-held 
LCI imaging probe. Abbreviations: SLD, 
super-luminescent diode; COL, collimation 
optics; BS1/BS2, 50:50 beam splitter; OBJ, 
objective lens; DM, dichroic mirror; DC, 
dispersion compensation; TS, translation 
stage; C1/C2, 2-D CCD camera for 
recording interference and surface 





Recently, a commercial entity created an OCT system that retails for less than $10,000 
USD241. Although limited information is currently available on its design, this 
achievement was possible given the use of components manufactured at scale for other 
industries, paired with cost-reduction in other key OCT components such as a reflective 
parabolic mirror to collimate the light, a liquid lens to scan the beam over a sample, a 
“loop design” spectrometer, and a low cost line-scan array detector used for scanning 
and reading bar-codes. 
One research group created an integrated silicon-based arrayed-waveguide 
(AWG) spectrometer242, although it still required an external line-scan camera. Later, a 
“TriPleX” interferometer platform for swept-source OCT (SS-OCT) was fabricated on a 
chip platform, which integrates a Michelson interferometer, sample and reference arms, 
and ports for external balanced photo diode detectors243. Soon after, these two systems 
were combined to provide a combined high quality silicon-based FD-OCT interferometer 
and spectrometer unit 244, which provided high quality images of in vivo human skin with 
an SNR of 74 dB. Another system for SS-OCT integrated the complete dual balanced 
quadrature detection system on a chip245, with a detection sensitivity of 94 dB. Often, 
these systems are unexpectedly limited by their compact size, as useful working 
distances for biomedical applications frequently require an external reference arm to 
properly match optical delay. To overcome this issue, one system added an on-chip 
long-path reference arm for SD-OCT systems246, and later incorporated grating couplers 
to be compatible with SS-OCT systems247. In both designs, the light source and 
spectrometer or detectors were separate from the integrated optical paths and 




single integrated platform. Recently, an integrated platform for SS-OCT combined a 
significant amount of detector and interferometer components onto a single platform248, 
although an external laser system was still required. Systems like these aim to have a 
design that encourages a silicon-based fabrication process that can be scaled to 
commercial levels and significantly reduce the unit cost.  
With the continual size reduction and improvement of these silicon based OCT 
chips, as well as the expanding OCT ecosystem, it is feasible that an entire OCT 
system could one day be miniaturized into a fully-contained battery-powered handheld 
package. Situations that will benefit enormously from this technical development of 
miniaturized OCT systems are users and subjects in remote areas where a 
decentralized, tiered, and distributed healthcare system exists, or in emergency 
situations where a quick observational tool could rapidly determine care in a time-critical 
environment. Similarly, cost-effective access to OCT imaging technology can only 
benefit future adopters of this technology, for any application.  
 
The final version of a review paper used across various sections in this dissertation was 
published here81:  
Clinical translation of handheld optical coherence tomography: Practical considerations 
and recent advancements, Monroy G.L., et al. Journal of Biomedical optics, 22(12) 




Chapter 4: Detection of biofilms on the mucosal surface of the eardrum 
4.1: Introduction and Motivation 
Although it is known that biofilms are a source of recurrent and persistent 
infection throughout the body28,249, especially in the respiratory tract141,250, a mounting 
body of evidence also supports that RAOM is a biofilm-associated 
infection12,29,31,67,251,252. Biofilms are collections of bacteria encapsulated in a self-
generated EPS. This conformation provides bacteria with increased resistance to host 
defense mechanisms253,254 and antibiotic treatments72. Previous observational and 
clinical studies have characterized biofilms growing on the MEM in vivo in animals255, 
and on the MEM of pediatric subjects with RAOM29. Currently, there is a lack of practical 
non-invasive diagnostic techniques to determine biofilm presence, and provide 
quantitative metrics for evidence-based treatment decisions. 
Through numerous previous clinical studies7,14,15,45,218,228,256,257, our group has 
observed and imaged subjects receiving treatment for AOM, RAOM, and COME, with 
patients seeking physicals or other unrelated treatment as normal controls. Additional 
microbial-related structures thought to be middle ear biofilms affixed to the MEM of the 
TM have been regularly identified with OCT in most if not all subjects with RAOM and 
COME. Normative OCT image-based features from a normal ear and in RAOM are 
provided in Figure 4.1258. In cross-section, a normal TM (Figure 4.1A) is a thin highly-
scattering ribbon of tissue, approximately 100 µmthick. When observed near the light 
reflex, no other structures such as the ossicles appear in the MEC behind the TM, and 




Figure 4.1B from a subject with ETD and RAOM. A microbial infection-related structure 
is found adhered to the medial mucosal surface of the TM and within the MEC, with a 
thickness of ~350+ µm. Digital otoscopy images are inset in each panel.  
Past studies using our custom-built handheld 
probes and portable OCT systems have identified 
and characterized infection states and properties of 
OM with OCT in vivo7,9,218,222, the physical and 
functional properties of the TM using pneumatic-
enabled OCT228, and longitudinally tracked the 
effects of TT surgery on the middle ear cavity 
(MEC)257. In this latest study257, TT placement was 
shown to be directly associated with the elimination 
of biofilm components from the TM and MEC. 
However, no direct sampling or biological 
characterization of these OCT-observed biofilm 
structures has been performed to date. 
In this work, I sought to image, identify, and 
characterize these suspected middle ear biofilms, 
both in vivo with intraoperative OCT imaging, and 
through the in vitro identification of surgically recovered samples using confocal laser 
scanning microscope (CLSM) images of FISH-tagged samples and PCR. This direct 
validation study will determine if the structures observed with OCT and directly adhered 
Figure 4.1: OCT images 
demonstrating optical and micro-
structural differences of a (A) 
normal ear and (B) RAOM. EC: 
ear canal; TM: tympanic 
membrane; MEC: middle ear 




to the TM during chronic OM are associated with the presence of active bacteria that 
have formed into a middle ear biofilm. This study will also provide confirmation that in 
the future OCT can provide a means to quickly and non-invasively assess the TM for 
the presence of any affixed biofilms.  
 
4.2: Materials and Methods  
In this study, 40 pediatric subjects diagnosed with chronic OM and previously 
scheduled for surgical treatment (myringotomy and TT placement) were recruited from 
Urbana-Champaign, IL, receiving care at Carle Foundation Hospital in the Department 
of Otolaryngology. All participants provided informed consent and assent in accordance 
with protocols approved by the Institutional Review Boards (IRBs) of Carle Foundation 
Hospital and the University of Illinois at Urbana-Champaign. There were no other 
recruiting restrictions for gender, or race.  
Standard-of-care treatment followed established definitions and guidelines for 
AOM2, OME3, and RAOM17. Subjects were diagnosed with RAOM if multiple infections 
occurred over at least 3-6 months, with resolution of symptoms between episodes, 
alongside concerns of developmental delays and hearing loss. Subjects with COME 
additionally had a persistent middle ear effusion (MEE) identified for 3+ months. No 
subjects were excluded based on ethnicity, gender, or race, or recruited based on the 





4.2.1: Imaging and sample collection 
Immediately after making a surgical incision in the TM (myringotomy), a handheld 
OCT probe was used to assess both TMs for the presence of a middle ear biofilm. 
Cross-sectional OCT images (~5 mm (transverse) x 3 mm (depth)) were acquired at 30 
frames per second, with a depth resolution of 2.4 micrometers in air. The imaging beam 
was positioned near the incision using real-time video otoscopy images from a color 
camera integrated in the probe. Further system details are in a prior publication222. Any 
blood that obscured the TM was aspirated as per standard-of-care. However, the MEC 
was not aspirated before sampling to prevent disruption of any biofilm structure adhered 
to the TM.  
A digital video otoscope (Welch Allyn, USA) was used to record color surface 
images of each TM. A 90-degree gross curette was inserted through the myringotomy 
incision of each ear to collect samples of middle ear content from the imaging site 
(mucosal surface of TM). The sampled site was subsequently re-imaged with OCT to 
confirm sample collection from the original imaging site on the TM. Multiple stacks of 40 
previously-visualized scans were saved during pre- and post-sampling time points for 
later analysis.  
All subsequent steps in the surgical procedure were performed following 
standard-of-care. Figure 4.2258 shows the portable OCT system and handheld probe, 
and visually presents the imaging and sampling protocol. OCT imaging was performed 
immediately post-myringotomy and pre-TT placement to avoid structural tissue 




correlation and visualization of biofilm sampling in OCT data. No more than 5 minutes 
(on average) of surgery and anesthesia time was added when imaging each ear.  
OCT imaging and sample collection was successful in a majority of subjects, 
while unsuccessful sample collection was likely due to the limited grip of the curette on 
the amorphous microbial-related structures. Collected samples were immediately 
placed into 4% paraformaldehyde (PFA), stored at 4 ºC overnight, and transferred to a 
50/50 phosphate buffered saline (PBS) and ethanol solution for longer-term storage. 
In vitro FISH and PCR analysis provided microbiological characterization. 
 
4.2.2: OCT image analysis 
Representative OCT images were extracted from image stacks to compare 
structures present on the TM at both pre- and post-sampling time points. Using 
previously developed OCT image processing protocols, images were collected257 and 
analyzed7 by readers experienced with OCT and middle ear imaging, although there 
Figure 4.2: (Left) Portable OCT system and handheld probe. This system was used to 
longitudinally follow subjects throughout their treatment in both office and outpatient 
settings. For scale comparison, the system is shown in the operating theater alongside 
standard visualization equipment. (Right) Imaging and sampling protocol. Biofilm sampling 
was primarily achieved using fine otolaryngology tools, such as a right angle hook as 





was no specific training for this study. Pre-sampling OCT images showed the presence 
of a biofilm (as detected by OCT) adhered to the TM. Post-sampling OCT images from 
the same site provided evidence of biofilm sampling from the mucosal surface of the TM 
and were used to correlate with PCR and CLSM/FISH data. OCT image interpretation 
was blinded from any clinical or surgical reports, and physicians were blinded to OCT 
imaging results.  
 
4.2.3: FISH and PCR processing protocol 
Samples were analyzed for the three most common microorganisms responsible 
for OM259, specifically Moraxella catarrhalis (Mcat), non-typeable Haemophilus 
influenzae (NTHi), and Streptococcus pneumoniae (SP), in addition to a universal 
domain bacteria probe (EUB335) that detected all bacterial strains. Samples were 
rinsed of storage media in PBS and divided for both PCR and FISH processing.  
Half of each sample was embedded for cryo-sectioning. Six micrometer sections 
were prepared and detected by FISH with bacterial 16s rRNA probes as described 
previously29. Briefly, slides were washed sequentially with PBS, PBS-ethanol (1:1), 80% 
ethanol, and 100% ethanol, then treated with 10 mg/ml of lysozyme (Sigma-Aldrich, 
USA) in 0.1M Tris - 0.05M EDTA at 37°C for 1 hour and washed with ultrapure water. 
Slides were then blocked with non-specific DNA (human Cot-1 DNA, Life Technologies, 





Specimens were stained with a 16s rRNA probe mixture of universal probe P-
Eub335 (cy3-GCTGCCTCCCGTAGGAGT) and probe of  
P-Hinf (GCCATGATGAGCCCAAGTGG-C3-fluorecein, H. influenzae), or  
P-Spn (Cy5-GTGATGCAAGTGCACCTT, S. pneumoniae) and  
P-Mcat (TGAAAGGGGGCTTTTAGCTC-Cal-fluor orange 560, M. catarrhalis). 
Specimens were mounted with SlowFade Gold anti-fade reagent with DAPI (Life 
Technologies, USA) and examined using CLSM (LSM 510, Carl Zeiss, DE) and 
software (Zeiss LSM Image Browser). 
For PCR processing, bacterial DNA was extracted from biofilm samples using a 
QIAamp UCP Pathogen mini kit (QIAGEN, DE), using the manufacturer’s protocol. 
Fragments from 16S rRNA of the three bacteria (NTHi, SP, and Mcat) were amplified in 
a 25-microliter reaction using 30-300 ng of the isolated DNA as template. A no-template 
negative control and a species-specific positive control were included. The assay was 
performed on an MJ Mini thermal cycler (Biorad, USA). The PCR primers and 





4.3: Results and Discussion 
Forty (40) patients participated in this study that concluded without any adverse 
events. A brief description of the samples analyzed is provided in Table 4.1258. OCT 
imaging was performed in 38/40 subjects. One subject was found to have a collapsed, 
inaccessible ear canal, preventing proper 
insertion of the handheld probe speculum. 
In the other subject, due to delays 
unrelated to this study, there were 
concerns about over-extending 
anesthesia time, so only sample collection 
was performed (no OCT imaging). 
Analysis of OCT images identified image-
based biomarkers of biofilms in 100% 
(38/38) of subjects observed. A total of 34 
small (~1 mm3) biological samples were 
successfully collected from the interior 
(medial) mucosal surface of the TM. 
Samples were divided for analysis for 
both CLSM (33/34) and PCR (31/34). One of the 34 samples had poor quality FISH 
staining, and thus no CLSM data was obtained from this sample. Three of the 34 
samples were too small for analysis by both CLSM and PCR processing, and thus were 
only analyzed with CLSM/FISH.  
Table 4.1: Study results of middle ear biofilm 
detection and validation using OCT, 
FISH/CLSM, and PCR analysis of samples. 
COME: chronic otitis media with effusion; 




40/40 Diagnosed with COME/RAOM 
       and observed intraoperatively 
38/40 OCT imaging achieved 
  38/38 OCT identified biofilm 
      
CLSM (FISH-labeled) 
32/33 Universal probe EUB335 
28/33 Universal + at least 1 probe 
24/33 Polymicrobial population 
  19/24 H. influenzae 
  21/24 S. pneumoniae 
  18/24 M. catarrhalis 
      
PCR 
11/31 Insufficient DNA for identification  
20/31 OM-related bacteria identified 
  14/20 H. influenzae 
  7/20 S. pneumoniae 





Table 4.2258 presents data related to each sample that was collected and 
analyzed, detailing patient history from the physician’s report, intraoperative 
observations from the surgical microscope, the identified presence of a biofilm using 
OCT, and FISH and PCR results. Analysis of CLSM images identified active bacterial 
biofilms in 32/33 samples with the universal domain probe, in 28/33 samples with the 
universal domain probe and at least one other probe, while 24/33 contained 
polymicrobial populations. A total of 20/31 samples yielded sufficient DNA for PCR 
analysis, although 11/31 samples were negative for specific genetic bacteria markers. 
Overall, 100% of samples (34/34) had bacteria positively detected by either PCR or 
FISH.  
Table 4.2: Data from all samples collected and processed in this study249. (See following page). 
PM = polymicrobial; Positive identification of a biofilm or bacterial strain as: OCT is marked as 
‘Biofilm’, FISH as ‘+’, and PCR as ‘Δ’ for each genetic probe. Key (Patient history): ETD = 
Eustachian tube dysfunction; RAOM = recurrent acute otitis media; COME = chronic otitis 
media with effusion,  further differentiated as CMOM = chronic mucoid otitis media and CSOM = 
chronic serous otitis media; past tympanostomy tubes (TT) - extruded (Ex), or resolved (R – 
extruded and healed); S&L = hearing or speech and language delay concerns; DS - Down 
Syndrome; OSA = obstructive sleep apnea; Key (Surgical findings): MPE = mucopurulent 




















Figure 4.3258 shows representative imaging data. This subject was diagnosed 
with chronic ETD and COME and was scheduled for surgery. Acquired immediately 
after myringotomy, Figure 4.3A shows an 
annotated digital otoscopy image of the TM 
that identifies the imaging region (red dashed 
line) and sampling region (white dashed circle). 
Figure 4.3B shows an annotated pre-sampling 
OCT image of the TM. The post-sampling OCT 
image (Figure 4.3C) demonstrates 
microstructural changes to the sampled region 
(white dashed circle), and confirms sampling 
was performed near the original imaging site. 
Sample #12 was collected from this ear.  
CLSM images of samples were 
evaluated for bacterial clustering and 
compared to known morphology29,260,261. 
Images that showed evidence of biofilm 
ultrastructure demonstrated bacterial presence 
using either the universal bacterial domain 
probe or co-localized with species-specific probes. Figure 4.4258 shows representative 
CLSM images from Sample #21. Figure 4.4A shows components identified with the 
EUB335 domain probe, which co-localizes with the NTHi probe in Figure 4.4B. Figure 
4.4C shows a nuclei stain (DAPI) that detected other unrelated and unknown genetic 
Figure 4.3: Representative results from 
the imaging and sampling protocol. (A) 
Digital otoscopy image immediately after 
myringotomy. (B) Pre- and (C) post-
sampling OCT images demonstrating 
sample collection. TM: tympanic 





components in the sample, likely originating from white blood cells, cell fragments, 
genetic components from host/immune cells, or bacterial populations outside of the 
selected FISH probes. An overlay of these channels is shown in Figure 4.4D, revealing 
the presence of bacteria dispersed throughout the sample, with little background noise. 
Figures 4.4E-H similarly show co-localized fluorescence from Mcat and SP FISH 
probes, as well as DAPI, acquired from an adjacent histological section.   
 
Collectively, OCT, CLSM, and PCR results provided compelling evidence for the 
presence of a biofilm affixed to the mucosal surface of the TM. Past characterization of 
the TM and MEC during OM using OCT identified and established optical and image-
based features for normal subjects and subjects diagnosed with acute and RAOM7. The 
microbial infection-related structures identified in this study using OCT were similar to 
those consistently identified in past subjects with severe cases of RAOM. OCT can 
Figure 4.4: Representative CLSM images from FISH-tagged Sample #21. Panels D and H 
demonstrate co-localized presence of OM-derived bacteria within biofilm-like ultrastructure. 





noninvasively identify the presence of additional microbial-related structures based on 
their inherent optical scattering properties, and without the use of any exogenous dyes 
or stains. OCT can simultaneously and quantitatively measure the thickness of these 
structures and the TM, which has been shown to be statistically different when 
comparing normal ears, ears with acute OM, and ears with RAOM / biofilms7. However, 
OCT does not provide information related to the microbiological content, as the contrast 
mechanism in OCT is sensitive only to optical refractive index differences262. Using OCT 
alone, it is difficult to precisely determine the presence of middle ear biofilms and 
differentiate this pathology from other confounding states that may appear similarly to 
middle ear biofilms. For example, the observed structures could appear structurally 
similar to inflamed/granulated mucosa or collections of immune cells, mucous, or other 
debris that have adhered to the eardrum and/or MEC during infection.  
For this reason, PCR and CLSM/FISH images were employed to provide 
biochemical and morphological characterization of sampled biofilm structures to  
1: demonstrate the observed structures were indeed biofilms and 2: validate OCT 
image-based findings. PCR provided genetic level specificity to identify the presence of 
OM-related bacteria in the collected samples. Although PCR can identify bacteria with 
sufficient available genetic material35,36, PCR does not categorize structural morphology 
to confirm a biofilm. Thus, CLSM/FISH images then provided highly-specific 
visualization of the spatial distribution of bacteria252, which demonstrated the known 
morphology of biofilms – collections of bacteria distributed within a biofilm matrix. While 
other dyes may non-specifically adsorb or absorb to other biological components 




provide this specificity. In total, the results correlated from these three complimentary 
techniques provide compelling evidence of the presence of genetically active middle ear 
biofilms in the MEC during chronic or RAOM. In the future, it may be possible to identify, 
quantify, and longitudinally track in vivo dynamics of these biofilms based solely on OCT 
image features, since the technically challenging and lengthy sample preparation for 
PCR or FISH cannot be performed for rapid point-of-care diagnosis or in vivo, and 
repeated invasive sampling of patients for monitoring OM is impractical. Care must also 
be taken to avoid jumping to the conclusion of the presence of a middle ear biofilm 
without other clinical indications of such an infection, as diagnostic criteria have yet to 
be defined.   
 While these results are promising, the clinical utility of detecting middle ear 
biofilms during OM remains unclear. Large-scale clinical trials are needed to define a 
clinical management strategy following detection of a middle ear biofilm. In this cohort of 
subjects, biofilms were identified and validated with these techniques. However, as the 
use of OCT becomes more commonplace in the management of OM and used by a 
wide range of staff with unknown familiarity with OCT and OM, diagnostic criteria will 
need to be carefully designed to ensure an accurate identification of biofilms but also 
prevent over-diagnosis of biofilms with OCT. For example, biofilms may be identified in 
some AOM cases, but resolve naturally or with the assistance of antibiotics in most 
subjects, although in others where the biofilm persists, may point to long-term issues. 
With further exploration of these situations, OCT can be used as a diagnostic and 
treatment monitoring tool in the future, and these challenges can be further explored. 




the presentation of tissue during different types or stages of infection, similar to currently 
existing medical training textbooks, along with needed correlation and validation using 
surgical intervention. This type of atlas could aid the clinical translation of this device 
and work, and prove a useful resource for physicians-in-training. While other 
confounding disease states may occur, such as the presence of a biofilm in an 
asymptomatic subject, in this cohort of subjects the clinical indications, image-based 
metrics in OCT, and biological validation using PCR and CLSM/FISH confirm the 
presence of middle ear biofilms. The findings demonstrated here provide an important 
and definitive milestone for the development of this technology and the clinical 
management of OM.  
In the future, using OCT as a treatment monitoring device, comparing OM to 
other biofilm-mediated diseases may provide insight into expectations of potential 
treatment regimens65,173-176. Typically, both single and multi-species biofilms act as 
reservoirs for re-seeding infections in recurrent cases. As biofilms mature and expand, 
encapsulated bacteria multiply, are protected from the host immune system263,264, and 
develop antibiotic resistance265. Eventually a “critical-mass” is reached and bacteria are 
dispersed. Recent research has verified biofilm dispersal mechanisms are directly 
related to proliferation of infection, demonstrated in a mouse and indwelling catheter 
model266. Another study found evidence of biofilms within the MEE of patients with 
COME32, which is likely caused by biofilm dispersal. Consequently, episodes of 
recurrent OM are likely the result of a biofilm within the MEC. Correlation of the various 
qualities of middle ear fluid with OCT may provide useful image-based biomarkers 




More effective methods of treating severe and persistent cases of OM and any 
biofilm would then perhaps include disruption of biofilm signaling, formation capability, 
or its structural integrity, thereby exposing pathogens to the host immune system and 
possibly to concurrently utilized antibiotics64173,174. Novel treatments that specifically 
target biofilms are an active area of development, including hydrogel-mediated trans-
tympanic delivery of antibiotics267, techniques for photo irradiation268, acoustic 
disruption269, cold plasma-based irradiation270, ionic liquid based penetration for 
enhanced antimicrobial activity271, and even bacteriophage therapy272. Non-invasively 
assessing the presence and characteristics of middle-ear biofilms with OCT offers an 
opportunity to readily perform in vivo human studies and trials compared to animal 
studies with ex vivo histological endpoints, or invasive surgical sampling studies in 
humans. 
During this study, there were no instances of confounding ear pathology, such as 
myringo-/tympanosclerosis, cholesteotoma, dimeric TMs, or retraction pockets that 
would affect the assessment of OCT images for the presence or absence of a middle 
ear biofilm. These conditions arise from separate physiological processes and have 
distinct OCT image-based features that distinguish them from middle ear biofilms, as 
they occur primarily in the TM as previously demonstrated123,212,213.  
There are several limitations in this study. First, there was no control group. No 
TM mucosa samples were collected for analysis from normal, healthy pediatric subjects 
undergoing non-OM related surgeries. However, it has previously been shown that 




normal ears lack biofilm-related structures, shown using OCT and histology in a rat 
model45, and in normal ears in adult14 and pediatric7 subjects  with OCT. Furthermore, 
there is no existing mechanism nor valid clinical benefit to patients to harvest healthy 
TM tissue for this study.  
Prior to sample collection, the MEC was not aspirated to remove any effusion, 
and samples were not washed before being placed in fixative. Given the numerous 
FISH processing steps, it is unlikely that an effusion had any significant effect on these 
results. Moreover, positive CLSM images were evaluated by consistent and repeated 
fluorescent signal from bacteria embedded within the biofilm matrix, not from the 
exterior of the structure. Aspiration of any MEE before imaging and sampling may also 
inadvertently remove biofilm material and confound sample collection.  
It is possible that some samples, once divided for PCR and FISH/CLSM, did not 
have active bacterial populations. However, it is likely that in other samples, the amount 
of genetic material for analysis was simply limited. Some recovered samples were small 
(~1 mm3), and no additional culturing to expand bacterial concentration was performed. 
While FISH results were able to identify single bacteria, PCR requires a minimum 
amount of genetic material273,274, which may explain why some samples had no 
identifiable bacteria identified with PCR. Furthermore, our study analyzed the 3 most 
common bacterial species known to cause OM275, although many other bacterial strains 
have been identified59. In aggregate, these factors may explain why some samples did 
not confirm our hypothesis with combined PCR or CLSM/FISH imaging results. 




these techniques provided measurements that were not degraded by the 
heterogeneous composition of these samples that can also include white and red blood 
cells, MEE fluid, other bacteria, and cell and biofilm fragments. The OCT system 
provided an imaging depth up to ~2 mm into and through tissue, even semi-transparent 
or highly scattering tissues such as the TM. This capability allows cross-sectional depth-
resolved visualization and quantification of the TM and any adjacent structure in the 
MEC.  
Based on the direct observation, sampling, and analysis of structures that extend 
across the mucosal surface of the TM, this study confirmed that OCT image-based 
findings of microbial infection-related structures in this cohort of subjects with RAOM 
and/or COME are indeed middle ear biofilms. Furthermore, results demonstrated that 
OCT provides a means to quickly and non-invasively assess the middle ear and TM for 
the presence of these biofilms. With careful preparation of diagnostic criteria, OCT could 
be used to rapidly and quantitatively assess for the presence of a middle ear biofilm 
without invasive sampling, such as in the primary care office. This capability allows for 
the longitudinal tracking of middle ear biofilms, specifically their formation and resolution 
at different stages of OM, and when exposed to existing or newly developed 
pharmacological or surgical treatment strategies.  
The final, definitive version of this paper has been published258 in Otolaryngology – 






Chapter 5: Response of middle ear biofilms to surgical intervention 
5.1: Introduction and Motivation 
This study is motivated by previous efforts which used OCT, a noninvasive and 
high-resolution medical imaging technology, to visualize the TM and middle ear. Past 
studies have used OCT in surgical settings276-278, although its use has previously been 
limited mainly to ex vivo123,211,279,280 tissue due to technical challenges and physical 
limitations of light delivery to the ear. Our group has addressed many of these 
challenges, and performed both animal45,256 and human7,9,14,15,218,281 studies . Recently, 
one study7 identified and visualized additional infection-related structures affixed to the 
TM in nearly every case of chronic OM, which led to our current interest to understand 
longitudinal changes in the additional observed structures following surgical 
intervention.  
The presence of biofilms during infection in the respiratory tract and upper 
airway, including the adenoids and MEC, is understood and well 
established29,30,141,250,252,256,282-285. Given the advancements detailed in Chapter 4, the 
pathogenesis of these additional infection-related structures observed in OCT images is 
now known to be an indication of middle ear biofilms. Biofilms are communities of 
bacteria enclosed in a self-produced extra-cellular polymeric substance (EPS)286. 
Biofilms protect bacteria from host immune response mechanisms69,73,249,287-291 and 
antibiotic treatments. Given the possible virulence, persistence, and/or recurrence of 
biofilm-associated infection in the ear, understanding the mechanisms that drive the 
infection process was recently declared a grand challenge in pediatric otolaryngology31. 




biofilms play during ‘healthy’ or ‘infected’ conditions in the middle ear. Previously, it has 
not been possible to easily and longitudinally observe these biofilms in vivo.  
In this study, an OCT system combined with video-based surface imaging of the 
TM was used to prospectively observe patients through consecutive pre-operative, 
surgical, and post-operative visits to quantitatively characterize and assess the efficacy 
of surgical TT placement to clear middle ear infection. It is expected that a patient with a 
successful surgical intervention would have no further clinical symptoms, and OCT 
images would be clear of any image-based features that would be associated with OM, 
including the presence of any MEE or biofilm. In the presence of persistent or recurrent 
clinical symptoms of OM, I expect to find OCT image evidence of persistent or recurrent 
MEE and/or middle ear biofilm.  
 
5.2: Materials and Methods 
5.2.1: Subject population and recruitment 
Subjects were recruited from the outpatient pediatric population of Urbana-
Champaign, Illinois, visiting Carle Foundation Hospital for treatment in the Department 
of Otolaryngology. Twenty-five (25) subjects were prospectively observed at both 
secondary care and outpatient surgical centers for approximately 6 months, with 6 
months of additional medical record-based follow-up. Subjects were imaged with OCT 
at up to three possible time points in their treatment: 1) patient evaluation and pre-
operative surgical consultation, 2) surgery (intra-operative imaging), and 3) post-




All participants provided informed consent and assent in accordance with 
protocols approved by the Institutional Review Boards of Carle Foundation Hospital and 
the University of Illinois at Urbana-Champaign. The standard-of-care treatment provided 
was according to recommended national treatment guidelines for acute OM2, OM with 
effusion (OME)3, and TT placement17. Subjects diagnosed with chronic or recurrent OM 
and participating in this study had, at a minimum, multiple infections within a 3-6 month 
time period and/or a persistent effusion for 3 months, as well as concerns about 
hearing, speech, and/or cognitive development. All subjects were less than 18 years of 
age, and were excluded if their temperament or discomfort prohibited imaging with the 
handheld OCT probe. No exclusions were made based on gender or race.  
 
5.2.2: Handheld probe and portable OCT system 
A custom-built handheld probe and portable OCT system (Figure 5.1292) was 
used to image subjects. The system utilized a broadband optical source (Superlum, 
Ireland) centered at 860 nm with an approximate bandwidth of 135 nm at full width at 
half maximum, which provides an axial resolution of approximately 2.4 µm and a 
transverse resolution of 15 µm, in air. A line scan camera-based spectrometer (Wasatch 
Photonics, USA) provided data to process cross-sectional B-mode images. The OCT 
system emitted an optical power of 2.5 mW onto the TM, which is well below ANSI 
standard safety limits121. A separate, commercial video otoscope (Welch Allyn, USA) 
was used to document surface images of the TM. Additional details regarding the 





5.2.3: Image collection protocol 
The imaging protocol design aimed to minimize any interruption to the standard-
of-care examination procedures at each imaging site, and ensure that pediatric subjects 
would remain as calm and attentive as possible to minimize artifacts in the collected 
data. At each imaging time point, the handheld probe was inserted into the ear canal 
and positioned to bring the TM into the field-of-view. The light reflex region of the TM 
was then identified and observed with OCT, using the malleus and umbo as anatomical 
landmarks for positioning. The OCT system utilized a buffer to constantly process and 
display images for real-time viewing, with a trigger on the handheld probe to save 
images. Depressing the trigger stored the 40 most recently visualized OCT images for 
later analysis. Multiple stacks of B-scans were typically acquired at each time point, 
which later allowed a representative image to be selected for analysis. In place of 
saving all visualized data, or needing to manipulate on-screen buttons to initiate saving, 
the use of a constantly updating buffer and trigger method allowed for more efficient 
Figure 5.1: Portable optical 
imaging system and handheld 
OCT probe within the specialist’s 
clinic (A) and within the operating 
theater (B). Hand held probe (C) 
utilizes standard interchangeable 
ear specula tips that are replaced 





collection of high-quality images. Primarily, this ensured collected OCT images were 
taken from the light reflex region of the TM, and avoided saving empty or unrelated 
images during positioning of the handheld probe in the ear canal and around any 
earwax that may have been present. This also allowed the operator to more 
successfully manage patient movement that occurs throughout the examination, and 
limit the acquisition of images with artifacts when possible. OCT images were not 
interpreted or analyzed for content before or during collection. Physicians did not utilize 
OCT images for clinical decision making.  
In the otolaryngology clinic, imaging was performed after regularly scheduled 
examinations, such that the physician could first formulate an unbiased treatment plan. 
During surgery, OCT imaging was performed intraoperatively after clearing of any 
cerumen, part of the standard-of-care procedure in this setting, and prior to 
myringotomy or TT placement. Otoscopic examination of the TM requires an 
unobscured line of sight through the ear canal, although a view that is not entirely clear 
of cerumen (ear wax) or small hairs is common. However, additional cerumen removal 
specifically to improve OCT imaging in the otolaryngology clinic was not performed. 
Standard-of-care practices in the clinic dictate that cerumen is removed only if there is a 
severe obstruction of the physicians’ view of the TM for otoscopy57. Furthermore, 
cerumen removal incurs additional costs for the patient, estimated in 2012 to be 
approximately $35 USD293. In either clinic or surgical setting, imaging both ears took 





5.2.4: Image processing and analysis protocol 
OCT image processing and analysis was performed by experienced readers 
familiar with OCT and OCT ear imaging, although there was no training specific to this 
study. Readers were provided with sequentially numbered OCT image stack files and 
digital otoscopy images from a single time point for analysis, and were blinded to the 
imaging time point and clinical diagnoses during analysis. Images were removed from 
consideration if they contained artifacts (saturations, reflections, or wrapping), or were 
acquired from the ear canal, positions on the TM other than the light reflex, or were out 
of focus. From the remaining set of images, a representative image that best 
demonstrated the overall findings from the time point was selected by the reader to 
maximize image quality and clarity for display and analysis. 
Representative images were analyzed to determine the presence or absence of 
a biofilm or middle-ear effusion at each time point for each subject using methods 
determined in a previous publication7. Quantitative features in OCT images that 
demonstrated the morphological changes of chronic OM include the presence of 
additional structures within the MEC, such as overall thickening due to the presence of 
biofilm or MEE, presenting as dense layered structures adhered to the TM, or point-like 
scatterers within the MEC, respectively. 
 Clearly defining the interior mucosal surface of the TM and interface between 
these additional structures can be difficult in some cases if refractive index matching 
occurs between the TM and middle ear fluid or biofilm. Similarly, it may not be possible 




middle ear fluid. Structures external to the MEC and within the ear canal, such as 
earwax, were not considered and were mostly unrelated to OM infection status.  
After analysis, images were sorted into a secure repository and organized by 
subject number, date, and time point. Reports containing clinical diagnosis and findings 
were collected, organized, and analyzed separately from OCT data at a later time. OCT 
imaging results were then analyzed in conjunction with findings from patient medical 
and/or surgical reports to correlate the presence or absence of a middle ear biofilm with 
clinical symptoms of OM and patient outcomes. 
 
5.3: Results and Discussion 
Twenty-five subjects (Table 5.1292) were imaged in this study, which concluded 
without any adverse events. Patient history was available for any performed 
examination or procedure. Risk factors indicate an increased likelihood of recurrent OM. 
Subjects were split into 2 groups: the ‘C’ (complete) group, and ‘P’ (partial) group. Six 
subjects in the ‘C’ group (C1-6) were observed at all 3 time points: pre-operative 
consultation, intraoperatively, and at the follow-up exam.  
Nineteen subjects in the P group (P1-19) were observed at the pre-operative 
consultation visit, and then either did not receive surgery (5/19), did not return for follow-
up exam after surgery (5/19), or were unable to be imaged given scheduling conflicts 




indicates treatment outcome through any OM-related visit after surgery to the primary 
care or otolaryngology clinic, which are further described in the footnote of Table 5.1. 
  
Table 5.1: Summary of Imaging Subjects and Clinical History292. (See following page) 
Key: Observed visits (1,2,3) : attended and scanned participant, X : participant did not 
attend; –: participant received treatment but OCT imaging was not performed, ABx: 
Antibiotic, AOM: Acute otitis media, ETD: Eustachian tube dysfunction, OME: Otitis media 
with effusion, TT: Tympanostomy Tube, URS: Upper respiratory system. 
1Risk Factors (if reported) - 1: Recurrent or persistent issues with OM or ETD, 2: Has had 
tympanostomy tubes in the past, 3: Suspect tympanogram or hearing test (hearing loss), 
4: Family history or URS issues with asthma/allergies. 2Recurrence factors (if reported) - 
1: Multiple placements of tympanostomy tube, 2: No recurrent infection after treatment, 3: 





















 A simplified visual breakdown of subjects enrolled in this study is presented in  
Figure 5.2292, organized by the day of observation. All subjects presented initially with a 
history of recurrent OM or ETD, and were observed throughout their treatment with 
OCT. On their day of pre-operative consultation, 92% (23/25) of subjects had a biofilm 
identified with OCT. On the day of surgery, 11 subjects were observed with OCT, and 
91% (10/11) of subjects had a biofilm identified with OCT immediately prior to surgical 
intervention. At the follow-up examination, 6 subjects returned for OCT imaging. These 
subjects were compliant with the study schedule and comprised the ‘C’ (Complete) 
group, with OCT data and clinical reports available from each time point. Of the subjects 
in the ‘C’ group, 2 of 6 subjects had additional structures identified with OCT (subjects 
C4 and C5), and subject C5 reported recurrence issues of OM. In 67% (4/6) of subjects, 
surgery was effective at clearing symptoms of OM, and had no biofilm identified with 
OCT. For the remaining 19 subjects that were non-compliant with the study schedule, 
only partial data was able to be collected. The ‘P’ (Partial) group (blue) included clinical 
reports and OCT data from the day of consultation, and reports if/when care was 
received at a later unscheduled visit. While 8 of 19 subjects returned for all care, 88% 
(7/8) of subjects later reported persistent OM symptoms and had biofilm-like structures 
previously identified with OCT at an earlier visit. 6 of 19 subjects did not return for 
follow-up care after receiving TT surgery during the study observation period. While 
follow-up visits and care are recommended as standard practice and included in the 
cost of surgery, one review found that only 25% of patients return for follow up care, 
despite guidelines that recommend patients regularly follow-up with otolaryngologists 




extrude on their own within a year295, though follow-up care may still be needed in the 
future if complications occur. Five (5) of 19 subjects did not receive TT surgery or have 




Figure 5.2: Graphical breakdown of subjects enrolled in this study. On the 
day of pre-operative consultation, 23 out of 25 subjects had a biofilm 
identified with OCT. On the day of surgery, 11 subjects were observed with 
OCT, and 10 out of 11 subjects had biofilms identified with OCT prior to 
surgical intervention. On the final day of follow-up, 6 subjects returned for 
OCT imaging. These subjects comprised the Complete group identified 
Table 1, with OCT data and clinical reports available from each time point. 2 
out of 6 subjects had additional structures visible in OCT images at follow-
up, and subject C5 reported persistent OM symptoms. 4 out of 6 subjects 
had no reported OM symptoms, and had no biofilm identified with OCT. 
Only partial data was able to be collected from the remaining 19 subjects 
who were non-compliant with the study schedule. The Partial group 
included OCT data from the day of consultation, and patient reports if/when 
care was received at an unscheduled visit. 8 out of 19 subjects that 
returned for unscheduled visits reported persistent OM symptoms, and 7 
out of 8 of these subjects had a biofilm previously identified at the day of 
consultation. 6 out of 19 subjects did not return for follow-up care after 
receiving TT surgery, and 5 out of 19 did not receive TT surgery or have a 
follow-up visit scheduled. OM: otitis media; TT: tympanostomy tube. 




In the ‘C’ group, 5 out of 6 subjects (83%) had no recurrence of symptoms after 
TT surgery. In 4 out of 6 subjects, cross-sectional OCT images at the post-operative 
follow-up visit showed that the MEC was free of biofilm and MEE, although a biofilm had 
been visualized with OCT during the pre-operative visit and intraoperatively during TT 
surgery. Figure 5.3292 highlights a representative case where subject C3 presented with 
chronic OME and ETD, and was prospectively imaged with OCT to identify changes 
following TT surgery. Figure 5.3A shows data from the first visit to the otolaryngology 
clinic (patient evaluation and pre-operative consultation). Cross-sectional OCT shows a 
bright, scattering biofilm structure (green arrow) affixed to the medial mucosal surface of 
the TM, as well as evidence of suspended, optically scattering particles in the MEC, 
indicative of a MEE (white arrow, dashed). The corresponding video otoscope surface 
image shows a dull and relatively featureless TM (inset). Here, and in subsequent 
figures, yellow and green bars denote the location and thickness of the TM and biofilm, 
respectively, as determined using a previous method7. Figure 5.3B shows 
intraoperative image data from this same subject and ear (second visit) prior to 
myringotomy, aspiration of the MEC, and TT placement. OCT imaging confirmed the 
persistence of infection-related image-based features including the biofilm (green arrow, 
green line) and MEE (white arrow, dashed) imaged at the consultation visit, although 
scanned at a slightly different TM location within the light reflex region.  
Approximately one month later, the same subject was imaged at the third visit 
(post-operative follow-up) following standard post-surgical care. Here, the 
microstructural effects of surgical intervention are visualized. In Figure 5.3C, the MEC 




the MEC is visualized. The TM (yellow line) appears thicker due to the presence of 
residual earwax (orange arrows, orange line) on the outer surface of the TM, and since 
the image was acquired closer to the umbo where the TM is naturally thicker230. The 
surface image (inset) shows that some transparency has returned to the TM. Otoscopic 
metrics provide visual confirmation of surgical outcomes, and in this case, indicate a 
reduction in inflammation and a fluid-free middle ear space compared to pre-surgery 
time points. The TT is observed in place and functionally venting the MEC17,296. At the 
end of the records-based observation period, this subject did not report any symptoms 









Figure 5.3: Representative longitudinal interventional data from Subject C3. 
Cross-sectional OCT images were acquired at the pre-operative evaluation and 
surgical consultation (A), the day of surgery prior to myringotomy (B), and at the 
post-operative follow-up (C). Arrows denote the additional infection-related 
components. Digital otoscopy images of the ear taken at the surgical consultation 
and follow-up are shown as insets, where white dashed lines denote where the 
cross-sectional OCT images were acquired. Biofilms (green arrows) are 
visualized as being affixed to the TM, and effusions (containing many point-like 
optically scattering particles in suspension) (white arrows, dashed) are visualized 
within the middle ear cavity (A and B). Images from the follow-up (C) show a 
cleared middle ear cavity with an image acquired near the umbo, a thicker region 
of the TM when compared to the light reflex. Earwax is also present on the outer 
surface of the TM (orange arrows, orange line), and the tympanostomy tube is 
visible deeper within the MEC (blue arrows, dashed). Surgical intervention 
appears to have cleared any biofilm and effusion components visible under OCT 
from this middle ear cavity. Scale bars represent 100 µm in depth. Yellow, green, 
and orange bars indicate the positions and thicknesses of the TM, biofilm, and 





When an infection occurred after post-operative follow-up, or perhaps when 
surgery was ineffective at clearing infection-related components, additional biofilm- or 
MEE-related structures were observed affixed to the TM and/or within the MEC, 
respectively. Figure 5.4292 highlights Subject C5, who presented with a history of 
recurrent episodes of acute OM that persisted after TT placement. Visible biofilm 
structures detected in OCT cross-sectional images persisted throughout all observation 
time points, including pre-TT placement (Figures 5.4A and 5.4B, green arrows) and 
post-TT placement (Figures 5.4C, green arrows). Yellow and green bars indicate the 
location and thickness of the TM and biofilm, respectively. Longer-term follow-up was 
possible given a recurrence of the infection in this subject, who required additional 
outpatient visits. Approximately six months after the post-operative visit, a patchy or 
spatially inconsistent biofilm was observed affixed to the TM (Figure 5.4D), while in 
some regions no biofilm was present (Figure 5.4E).  
The identification of both seemingly normal and pathological regions in these 
OCT images highlighted here was unexpected, and found in only one ear from this one 
subject. However, this finding demonstrates the complex dynamics of biofilm formation 
in OM and regression after treatment, indicating that further investigation and 
longitudinal tracking at more time points may better capture these processes. The other 
ear of this subject, and all other study subjects, had consistent findings from each time 
point. No digital otoscopy image was available due to patient discomfort. An 
indisputable and unavoidable limitation in studies involving human subjects, especially 
those in active clinical and surgical settings, is the priority of patient needs and well-




complete datasets. This subject was provided with antibiotics based on the physical 
exam, and was scheduled for re-evaluation at a later date.  
Available data from the ‘P’ dataset was typically limited to the first consultation 
visit, and included OCT images, digital otoscopy images, and patient history. Imaging 
data from subsequent visits was not available and were lost to follow-up, a common 
problem in otolaryngology294, as imaging subjects in this observational study were free 
to seek, reschedule, or not seek care as per their wishes. Almost all subjects in the ‘P’ 
group had a reported history of recurrent OM (18/19, 95%), and most (17/19, 90%) were 
Figure 5.4: Longitudinal imaging of the TM and infection-related components from study 
participant C5. Cross-sectional OCT images of the middle ear are shown at various time points in 
the progression of infection and treatment of subject C5, along with inset digital otoscopy images 
of the ear: patient evaluation and surgical consultation (A), day of surgery prior to myringotomy 
(B), post-operative follow-up (C), and at later, long-term follow-up visits (D and E). Arrows denote 
persistent additional, infection-related structures. Digital otoscopy imaging for (D) and (E) was not 
possible due to patient temperament and discomfort. Subject C5 received tympanostomy tubes to 
treat recurrent AOM and hearing loss. After a one-month recovery from tympanostomy tube 
placement (C), additional middle-ear structures were visible (green arrows). However, (D) and (E) 
show two images from long-term follow-up exams roughly six months after (C), after the subject 
revisited both the primary care office and specialists clinic for OM-related complaints. While (D) 
shows additional structure (green arrows), (E) appears normal, perhaps indicating a persistent, but 
spatially inconsistent and patchy middle ear biofilm within the light reflex region of this subject. 
Scale bars represent 100 µm in depth. Yellow and green bars indicate the position and thickness 




found with OCT to have biofilm-like structures affixed to the TM during the first visit, as 
noted in our previous studies. A total of 20 out of 25 subjects (80%) underwent TT 
surgery. However, 8 out of 25 (32%) subjects reported recurrence of infection during the 
post-operative observation period, which may have resulted from local recurrence of the 
original infection and biofilm, or from a new, discrete OM infection. While TT surgery 
was performed depending on the clinical circumstances of each patient, it is notable that 
3 out of 19 (16%) in our study had a history of multiple TT surgeries, with 2 of these 
subjects having biofilm-related structures present in OCT images.  
Figure 5.5292 shows representative data from this group (subject P3). This 
subject presented with both moderate conductive hearing loss and an identified MEE in 
each ear. This subject was observed at both the first (Figure 5.5A) and second (Figure 
5.5B) visit. Yellow and green bars indicate the location and thickness of the TM and 
biofilm, respectively. At both time points, additional infection-related structures were 
clearly visible within the MEC. This subject, like others in the ‘P’ group, was non-
compliant with scheduled follow-up exam times, and therefore only information from the 





 Figure 5.6292 shows data from subject C4, diagnosed with persistent or frequent 
recurrent acute OM and ETD. Figure 5.6A, acquired during the pre-operative visit, 
shows an overall thickened structure comprised of the TM and attached biofilm. In this 
image, delineation of the TM from the biofilm can be challenging, likely because of 
refractive index matching occurring between these structures. Figure 5.6B, acquired 
intraoperatively immediately prior to TT placement, shows that the biofilm is no longer 
present, and was replaced by a MEE (white arrows). When imaged at the post-surgical 
follow-up visit (Figure 5.6C), additional structures (green arrows) were found to be 
affixed to the TM. Although this subject had no reported symptoms of recurrent infection 
during the study period, the obstructed TT, as visualized in the inset digital otoscopy 
image, would have provided limited aeration and drainage of the MEC. This blockage 
likely prevented complete clearance of the middle ear space.  
Figure 5.5: Representative data from the Partial (‘P’) group. Subject P3 presented 
with both moderate conductive hearing loss and identified MEEs in each ear. 
Cross-sectional OCT data and inset digital otoscopy images of the ear are shown, 
if available, from the patient evaluation and surgical consultation (A) and from the 
day of surgery prior to myringotomy (B). Arrows denote persistent additional, 
infection-related structures (green arrows: biofilm, white arrows, dashed: MEEs). 
The subject did not return for post-surgical follow-up care at the originally 
scheduled time, so only notes from the physical exam were available. Scale bars 
represent 100 µm in depth. Yellow and green bars indicate the position and 



















Figure 5.6: A potentially ineffective surgical intervention 
from subject C4. Cross-sectional OCT images of the patient 
evaluation and surgical consultation (A), day of surgery prior 
to myringotomy (B), and post-operative follow-up (C) are 
shown along with digital otoscopy images (inset). White-
dashed lines on the digital otoscopy images denote where 
the cross-sectional OCT images were taken. The image in 
(A) shows an overall thickened TM, with a suspected biofilm-
like structure affixed on the mucosal surface of the TM 
(green arrows). At the day of surgery (B), this biofilm-like 
structure is no longer present, but replaced by a low-
scattering effusion (white arrows). During the post-operative 
follow-up (C), the tissue appears thickened and possibly 
inflamed or scarred, with additional middle-ear structures 
affixed to the TM (green arrows). In this specific case, the 
tympanostomy tube was found to be clogged with dark 
brown debris, likely dried discharge from the middle ear. The 
blockage likely prevented aeration and drainage from the 
middle ear cavity and complete clearance of the middle ear 
space. Scale bars represent 100 µm in depth. Yellow and 
green bars indicate the position and thickness of the TM and 




Figure 5.7292 presents images from Subject C6, who originally presented with 
ETD and recurrent acute OM. When viewed at the post-surgical follow-up, the cross-
sectional OCT images showed a TT within a cleared MEC. This again suggests that 
surgical intervention successfully clears the middle ear space of biofilm-related 
structures. Another benefit of OCT is also indirectly highlighted in the digital otoscopy 
image of the TM. Most of the ear canal in this subject was occluded with cerumen, 
which makes any accurate observation or diagnosis using standard otoscopy prohibitive 
without first cleaning the ear canal to properly view the entire TM. However, the OCT 
beam only requires a small, clear direct line-of-sight imaging path, and can propagate 






Figure 5.7: Cross-sectional OCT image and digital otoscopy image from 
subject C6, who originally presented with Eustachian tube dysfunction and 
recurrent acute OM. Viewed at the post-surgical follow-up, imaging results 
show a cleared middle ear space. OCT image (A) of a tympanic membrane 
with the TT visible below within the middle ear cavity (blue arrows). Digital 
otoscopy image (B) showing the ear canal and TM partially occluded by 
cerumen. Although cerumen prevents direct visualization of the TM, the 
OCT beam can navigate small openings in the cerumen and successfully 
image the TM and MEC. OCT image taken near the white-dashed line. 
Scale bar represents 100 µm in depth. The yellow bar denotes the position 




Subjects with repeated TT placement surgeries often present with different 
image-based TM features than those undergoing their first procedure. For instance, 
depending on the duration since the last TT surgery, thinning in the fibrous layer of the 
TM may be evident, or even a residual opening from an extruded TT may often still be 
visible in the TM. Figure 5.8292 shows such a case from subject P14, who presented 
with persistent OME after a recent TT surgery. When examined, a residual perforation 
in the TM from a previous TT was visible in the otoscopy image. OCT of the TM showed 










Figure 5.8: Cross-sectional OCT image and digital otoscopy image from 
subject P14, who presented with persistent OME and had previously 
received a TT placement. OCT image (A) of a thinned irregular TM and 
adherent biofilm (green arrows). Digital otoscopy image (B) shows a 
previous perforation from a prior TT placement. OCT image was taken at the 
location indicated by the white-dashed line in (B). Scale bar represents 




Additional infection-related structures were initially observed in OCT images from 
most subjects (92%, 23/25) diagnosed with recurrent or chronic OM and scheduled to 
undergo TT surgery, as per their standard-of-care. Through record-based follow-up of 
all subjects, surgical intervention was effective at clearing the infection and reducing or 
eliminating symptoms in 15 out of 20 subjects (75%) that received TT surgery. If 
observed with OCT, image analysis confirmed the absence of a middle ear biofilm in 
these subjects. However, 5 out of 20 subjects (25%) that received surgery had 
persistent clinical symptoms of OM infection following TT surgery, and if observed with 
OCT, infection-related structures were present. These structures were similarly 
identified in subjects that had multiple surgical interventions and had returned for 
repeated treatments. Therefore, based on OCT imaging results, if a subject did not 
respond to surgical intervention, there was likely an insufficient clearance of infectious 
material from the MEC, or a recurrence of the bacterial population and subsequent 
biofilm re-growth. A post-surgical OCT confirmation of the absence of a biofilm could 
then perhaps serve as a secondary diagnostic indicator or predictor for long-term 
success of the surgical intervention. A future study could similarly explore the 
effectiveness of pharmacological interventions to clear symptoms of OM in subjects 
identified with a middle ear biofilm. 
Surgical intervention, in this case myringotomy and TT placement, results in both 
short- and long-term effects that influence several changes in an infected MEC. With 
myringotomy, a renewed immune and healing response is stimulated297 along with 
aspiration of the MEC and insertion of a TT. These interventions aid in clearing middle-




biofilm-related infections, mechanical clearance and aspiration of the MEC disturbs any 
biofilm and its growth environment both structurally and biochemically. Ototopical drops 
placed into the MEC also provide a higher and more effective concentration of 
antibiotics directly to the site of infection298,299 when compared to oral antibiotics300. 
Successful clearance of the MEC and reduction of OM-related symptoms may indicate 
these structures are cleared by a combination of these factors.  
Regardless of any potential new diagnostic information gained with OCT, 
considering recurrent or chronic OM as a biofilm-mediated disease would also require 
investigating new or re-evaluating existing treatment options301,302. Methods that attempt 
to noninvasively weaken, disrupt, or clear a biofilm303-305 could be employed before 
invasive means are considered, or even employed in conjunction with surgical treatment 
for a more aggressive approach. However, if TT placement is found to be one of the 
most effective therapeutic interventions to treat biofilm-derived recurrent or chronic OM, 
then it will be necessary to weigh the related risks and outcomes associated with 
presumably more patients receiving tubes at a younger age. Serious consideration 
should be given to the fact that a majority of patients tend to outgrow complications 
and/or susceptibility to recurrent OM, perhaps due to improved function and increased 
diameter of the Eustachian tube with age306, or improved immune function with age307. 
Conversely, it is also important to consider that many children are unnecessarily hearing 
impaired during this time, which delays learning and speech development at a crucial 
age in young subjects. In this case, strict diagnostic metrics should be developed that 
ensure the proper diagnosis, and as best as possible, attempt to avoid the unintentional 




broader subject population demographics, as well as biochemical and genetic factors, to 
more fully understand the dominant factors of middle ear disease pathogenesis, as well 
as any physical or secondary indicators that can be used for diagnosis and monitoring. 
In this regard, tracking the reduction or clearance of biofilm biomass with OCT after 
surgical or pharmacological treatment may provide further insight into mechanisms for 
effective treatment of OM.  
To suggest any potential use of this OCT data for clinicians, further study is still 
needed and should include a randomized clinical trial with a larger subject population 
and a wider geographic and demographic distribution to capture a broader view of OM. 
With this longer-term study, diagnostic features in OCT images may be identified that 
predict a need for surgical intervention. This may allow for a quantitative and evidenced-
based referral to surgery at earlier time points in the pathogenesis of chronic OM, 
potentially shortening the duration of disease symptoms and related morbidity prior to 
treatment and successful resolution. In this regard, OCT-based treatment guidelines for 
OM will need to be proposed, established, and evaluated, as was done for clinical 
cardiovascular308 OCT and clinical ophthalmic100 OCT clinical applications. 
There are several limitations in this initial observational study. With the spectral-
domain OCT system used in these investigations, it was not technically possible to 
image deeper to the medial mucosal surfaces of the MEC. However, swept-source OCT 
systems can provide deeper imaging to over a centimeter309, which can provide 
additional information on the location, extent, and severity of any middle ear biofilm or 




mucosal surface throughout the MEC. While the light reflex region of the TM was 
interrogated in this study and used as a consistent anatomical landmark for longitudinal 
image collection, the remaining areas of the TM may provide further information related 
to the biofilm or other middle ear diseases. Techniques for rapidly generating 3D 
images of the entire TM while minimizing motion artifacts, and co-registering these 
datasets between longitudinal visits, are in development. The presence of specific 
otopathogens may ultimately govern whether surgery is effective251. However, OCT is 
not sensitive to specific bacterial species. Ongoing research in our group is investigating 
the use of Raman spectroscopy for determining microbial content of the middle ear310, 
which has previously been used to differentiate bacterial strains in culture311. Finally, 
additional studies are needed to verify longer-term outcomes of study participants with 
OCT, and the clinical relevance of the presence, or absence, of a middle ear biofilm in 














In this study, a broad subject population was prospectively observed using OCT 
to assess the efficacy of surgical intervention to clear OM-related middle ear fluid or 
biofilms and associated clinical symptoms. OCT image findings suggest that surgical 
intervention, consisting of myringotomy followed by TT placement, provides a means to 
clear the middle-ear of infection-related biofilm structures and components. OCT shows 
promise to provide a clinically viable diagnostic and monitoring platform capable of 
providing physicians with new image-based information about the disease state of the 
middle ear. With further investigation, OCT image features may aid in the diagnosis and 
management of OM, especially when interpreted alongside physical exam, otoscopy 
findings, and patient history.   
 
The final version of this paper was published here292 :  
Noninvasive in vivo optical coherence tomography tracking of chronic otitis media in 
pediatric subjects after surgical intervention, Monroy G.L., et al. Journal of Biomedical 






Chapter 6: Development of a classification algorithm to identify OM in OCT 
6.1: Introduction and Motivation 
While biofilms have been known to inhabit the MEC29 during OM infection, in 
Chapter 4, middle ear biofilms (MEB) were shown to be adhered to the TM during OM 
and can be identified with OCT258. With this finding, the longitudinal monitoring of two 
important diagnostic criteria, middle ear fluid (MEF) and MEB, is possible. Figure 6.1 
demonstrates representative cross-sectional OCT B-mode and A-line data from 
subjects with these features. Yet, two significant barriers for translation of this 
technology remain. First, there are no clinical diagnostic guidelines or criteria to assess 
OCT images of the TM and middle ear for signs of OM. And similarly, any existing 
studies that have employed OCT for OM assessment have utilized experts familiar with 
middle ear imaging, OM, and OCT to interpret and correlate OCT data to currently 
accepted clinical markers of OM. To further translate this technology, there is a need for 
diagnostic criteria to be defined for OCT images of OM, and employed without the 

































Figure 6.1: Representative OCT cross sectional images and A-line profiles.  
A: OCT and digital otoscopy (inset) data from a normal ear. B: Data from an ear 
with a MEB. The A-line profile shows additional scattering behind the TM.  
C: Subject with a MEB and MEE. The scattering profile shows three distinct 
regions in the scan. White dashed line denotes the location of the A-line scan 




Machine learning (ML)-based assessment techniques may provide one solution 
to these challenges and help to objectively interpret and provide classification of this 
data. Such approaches are currently in development to supplement radiologist and 
pathologist capabilities for most medical imaging techniques (X-ray312, MRI313, H&E 
pathology314, and Ultrasound imaging315) following existing standardized diagnostic 
criteria. Some algorithms are even beginning to exceed average radiologist 
performance, such as one recent algorithm for detecting pneumonia using chest X-
rays316. Guidelines for the identification and classification of disease states with OCT 
imaging are currently under development for ophthalmology197-199,207,317,318, 
cardiology202, intravascular imaging319, dermatology203,  and other applications320,321, 
although none exist yet for the ear or OM.  
In this work, diagnostically relevant parameters of OM infection were defined 
using existing clinical standards and data extracted from OCT images, digital otoscopy 
images, and patient reports, including morphological, optical, and clinical features of OM 
infection states commonly encountered by both primary care physicians and 
otolaryngologists. Metrics derived from 58 independent subject datasets, including 58 
OCT B-mode images, 52 digital otoscopy images, and 54 physician’s reports, were 
used in this study. After feature extraction, a database of 25,479 entries was generated 
for classification, with each entry consisting of 20 features. 12 features were unique to 
each OCT A-line scan, while six features from digital otoscopy and two from the 





An automated ML-based platform was developed to classify this dataset and 
discriminate normal, healthy ears (Nentries = 8572, Nsubjects = 17) from those with middle 
ear biofilms (Nentries = 3748, Nsubjects = 9) and middle ear biofilms and fluid  
(Nentries = 13159, Nsubjects = 32). These three initial groupings help to identify pathological 
conditions which could require pharmacological or surgical intervention for treatment, 
depending on the exact circumstances of each patient. A random-forest based method 
was used to classify OCT images, with future performance or accuracy evaluated using 
a “Leave one subject-out” 58-fold cross-validation. Class label “ground truths” for 
training data was set based using two different metrics: using the analysis of the OCT 
B-scans in a small reader study by three experts familiar with OCT imaging and OM, 
and by physician’s final diagnosis contained in the report. Results using a custom-
developed Random Forest (RF) classifier were compared against other standard 
classifier types (SVM322, KNN323, and Ensemble324 techniques) to ensure consistent 
performance.  
Successful results from the development and testing of this feature extraction 
and classification pipeline demonstrate the feasibility of this platform for automatically 
identifying different stages of OM in OCT and other data. Challenges for clinical 
translation, platform modification and improvement, and guidelines for minimum 
performance thresholds are discussed, specifically for signal-to-noise ratio (SNR) and 
resolution, such that this method can one day be further developed for use with any 
OCT system of sufficient quality for the classification of OM and other diseases of the 





6.2: Materials and Methods 
6.2.1: OCT system and human subject imaging  
A previously developed custom-designed portable and handheld OCT system, 
shown in Figure 6.2, was used to image human subjects and characterize various 
presentations of OM in past clinical studies292,325. Briefly, this system comprises of a 
spectral-domain OCT system and handheld probe, with a center wavelength of 860 nm 
and an approximate bandwidth of 135 nm at FWHM. The system has an axial resolution 
of ~2.4 μm and lateral resolution of 15 μm. The system emits an optical power of 2.5 
mW, which is well below the ANSI standard safety limits for incident exposure on tissue. 
A digital otoscope (Welch Allyn, USA) was used to collect images of the TM. Further 
details can be found in an earlier publication218.  
 
Pediatric subjects were observed when visiting Carle Foundation Hospital, 
Urbana, IL in the Department of Otolaryngology at the physician’s office, specialist 
otolaryngology clinic, and intraoperatively in the surgical ward. For this study, 58 
previously imaged subject datasets were selected from an internal data repository for 
Figure 6.2: Portable OCT imaging 
system and handheld probe. This 
system was utilized to collect human 
subject data as part of several past 
and ongoing clinical observational 
studies in both outpatient and 
intraoperative surgical environments. 
The handheld probe and digital 




use in this study. Each dataset consists of a representative cross-sectional OCT B-scan 
image, a color digital otoscopy image, and a de-identified patient report, if available. 
These subjects capture the range of patient presentation of OM, consisting of healthy 
normal controls, and subjects diagnosed with a range of OM infection states: acute otitis 
media (AOM), otitis media with effusion (OME), chronic otitis media with effusion 
(COME)3 and recurrent acute otitis media (RAOM)2. Clinical findings from each dataset 
are shown in Table 6.1, including the clinical impression of the presence of fluid as 
determined by a physician’s assessment using otoscopy (OTO), and a reader 
examining OCT data (OCT). Discrepancies in the presence of MEF between these two 








Table 6.1: Clinical findings and consensus labels for OCT. OTO: Fluid identified by the 
physician using otoscopy, and OCT: fluid identified using OCT data. Discrepancies in fluid 
identification are bolded. Group # set by OCT reader study. Bilat: Bilateral; ETD: 
Eustachian tube dysfunction; COME: Chronic otitis media with effusion; RAOM: Recurrent 





6.2.2: OCT image groupings and reader study  
To interpret and label OCT training data appropriately, a small blinded reader 
study was performed. Three expert OCT readers familiar with OCT, OM, and middle ear 
imaging were trained through the guided analysis of sample images from each group 
consisting of data not included in this study. Then, the reader evaluated and classified 
each OCT image in this dataset into one of the group classifications used in this study 
(“Normal”, “Biofilm”, “Biofilm and Fluid”). Trends identified in OCT images were used to 
develop these groupings, as no currently accepted noninvasive clinical techniques 
provides information related to the presence of middle ear biofilms8. These groupings 
were developed from our past observational clinical studies where OCT images of 
subjects with OM were correlated with a physician’s clinical findings, or intraoperative 
OCT imaging was directly compared to surgical intervention and microscopy findings 
during TT surgery. Normal cases were identified by a TM of approximately 100 µmthick 
and the lack of any additional structures observed in other infection states. The second 
grouping (“Biofilm”) was created as otoscopy does not provide an indication of the 
presence of a middle ear biofilm, perhaps only the appearance of a dull, thickened, or 
opaque TM. The third grouping (“Biofilm and Fluid”) was created due to the presence of 
a biofilm in all scans that contained MEF. These classes are shown in Figure 6.1. With 
sufficient training data, it may be possible to create a grouping that contains OCT data 
of subjects with only MEF (and no biofilm), however, in the majority of our current and 
past studies, these subjects have rarely been identified. Further discussion of these 





The consensus or majority vote of the 3 readers was used as the final label for 
this classification. Overall, there was little variation in reader assessment. In 58/58 
scans, at least 2/3 readers agreed on the group label, with all readers completely 
agreeing on 38/58 subjects. Typically, most all “Normal” were correctly identified, with 
one reader being a bit more conservative overall when deciding between “Biofilm” and 
“Biofilm and fluid” groupings.  
 
6.2.3: Defining and extracting features from data 
A broad range of statistics and metrics were developed to extract or capture 
inherent qualities of tissue, utilizing a physical, structural, or optical metric to numerically 
quantify infection states. Features used in this study are detailed below, along with a 
short description of its clinical relevance. Table 6.2 briefly summarizes these features.  
Table 6.2: Feature summary table. Features 1-12 and 15-20 are derived from the 
portable OCT system and digital otoscope shown in Figure 6.2. Features 13 and 14 
(and indirectly Features 15-20) are derived from the clinical information available to 
the physician at time of exam. σ: Standard deviation; atten.: Attenuation; DO: Digital 
otoscopy; loc: location; MAD: Median absolute distance; Sat: Saturation. 
Feature Source Feature Source
1 Radial thickness OCT 11 Fourier peak width OCT
2 σ peak loc OCT 12 Fourier peak prom. OCT
3 Mean peak width OCT 13 OMGrade Scale
4 σ peak width OCT 14 Clinical reports Keywords
5 Mean peak prom. OCT 15 Hue, average DO
6 σ peak prominence OCT 16 Hue, median DO
7 Total # peaks OCT 17 Hue, MAD DO
8 Optical atten. max OCT 18 Sat., mean DO
9 Optical atten mean OCT 19 Sat., median DO




Features derived from the OCT data 
All OCT images are first median filtered using a mild 2x2 kernel and window 
averaged by 5 pixels or columns to reduce noise or speckle and increase uniformity for 
analysis. Next, a peak-finding algorithm was used to obtain information about the 
location and distribution of scatterers in each depth scan. To avoid erroneous peaks, 
thresholds are set dynamically to ensure measurements are above the noise floor at a 
given depth, using the top 50 pixels as a reference. Then, 20 features for each A-line 
are extracted compiled into a table entry and added to a large database. 
1: Optical thickness: The optical thickness of the TM and any associated biofilm and/or 
MEF has been shown to be statistically linked to infection state7. MEF, bacterial 
components, or biofilms are present across varying infection states that are not present 
in healthy controls.  
Axial thickness for each A-line is quickly calculated by finding the distance between the 
first and last peak at the current A-line position (Eqn. 6.2).  
 , ,Peak positions at : ( , ), and ( , )m n Top m n Botx y x y   (6.1) 
 , ,Axial distance n Top n Boty y    (6.2) 
Although straightforward to implement, axial thickness does not always accurately 
quantify a naturally curved TM, shown in Figure 6.3A, which depending on the scan 
geometry of the subject and handheld OCT probe, could also be angled within the OCT 





Radial thickness takes advantage of information from adjacent A-lines in an OCT B-
scan to detect and calculate thickness through a point normal to the tissue surface. 
Each A-line is now run through the peak finding algorithm (using the 50 pixel threshold 
as before) to find the top edge of the tissue using the first peak, where a point is added 
to a mask image in the same location if it is within a separation window, described 
below. As each A-line is processed, a point-cloud like mask is generated for the top line. 
The final outline of a representative scan is shown in Figure 6.3B.   
As this algorithm traverses each A-line, each point must be within a fixed separation 
window from the previously identified point: 
 1 1( , ) ( , ),  Separation Windowm n m nx y x y y      (6.3) 
Figure 6.3: Axial and radial thickness. A: Axial fitting and statistics. B: Binary mask 
with identified points for top and bottom edges. C: Fourth-order polynomial fitting 
through the points in B. D: Radial thickness fitting and statistics. Radial fitting has a 




The surface of the TM is relatively flat when comparing adjacent pixels, even after 
window averaging, such that adjacent points that vary wildly are likely due to a 
misidentification in the peak finding algorithm. If no peak is detected, or a peak is 
detected outside this separation window, it is discarded and the separation window on 
the subsequent iteration dynamically increases until a new peak is found. This behavior 
prevents failure from occurring when processing slightly obscured regions of tissue, 
discontinuities in tissue surfaces, or in regions of low SNR, which often occur during 
imaging if the ear canal or ear wax partially obscures the cross-sectional OCT beam. 
Once a point is eventually found on a subsequent iteration, the separation window is 
reset to its original value. Once the top point mask is generated, the mask is 
thresholded using the original intensity image to reduce the effect of outlier points, and a 
4th order polynomial is fitted to this line (Eqn. 6.4), which tries to find the average path 
through these points, and is set aside as Topy .  
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The bottom point mask and fitted curve is similarly created (Eqn. 6.4), instead using the 
last detected peak, and using a separation window with a starting value 3 times greater 
than the top curve. This allows for proper detection of points in deeper areas of the 
image where sparse scatterers, detector roll-off, and low SNR play a larger role than 
near the zero-delay or top of the image in the OCT system. Functionally, this ensures 
areas of low-scattering fluid in OCT images are more likely to be detected. The fitted 




Once these two polynomial curves are generated, the radial thickness of each A-line is 
calculated by translating across each point on the top line, using these known points 
1: , 1: ,( , )m Top n Topx y   to find a solution on the bottom curve. This occurs in one of two ways 
depending on the curvature local to each point. First, a normal line from the top curve is 
calculated (Eqns. 6.5, 6.6), and intersection point(s) with the bottom curve are identified 
if possible (Eqn. 6.7). The Radial thickness (Eqn. 6.8) ensures that the thickness of this 
region of tissue is more accurately mapped. Empirically, this has been found to be more 
accurate and have a lower standard deviation across the tissue than the axial thickness, 
as shown in Figure 6.3D. While each point on the top curve has a solution on the 













  (6.5) 
 , ,( )NormTop n Top NormTop m Topy y m x x     (6.6) 
 , ,( , ); 0solution Bot solution Bot NormTop BotSolve x y y y     (6.7) 
 2 2
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If no solution exists within at the current position along the top line, a second method is 
employed to find the closest point on the bottom curve. Typically, this occurs when the 
point of analysis on the top line is near the edge of the imaging window, and a normal 
line from the top curve doesn’t have sufficient space to intersect with the bottom curve. 
In this case, the shortest distance is found from the analysis point to the bottom curve 















  (6.10) 
The distance to the analysis point is then computed (see Eqn. 6.8), and is compared 
against both the equivalent axial thickness value for this same position (see Eqn. 6.2) 
and the thickness value from the previous iteration 
, , 1, 1,(( , ) ( , ))m Top n Top solution Bot solution Botdist x y x y   if it exists. The minimum these three values is 
then selected. A final check analyzes slope of the top line. If it is near 0, this indicates 
the analysis point is near a peak or valley and ensures the axial thickness is used.   
This second part of the fitting process prevents some 
A-lines, typically near the edge of the image, from fitting 
to image data that would stretch past the edge of 
known data, and instead locks to the corner point on 
the bottom line. However, this may lead to a slight 
increase in thickness. While the function of the lines 
that define the segmented area could still be calculated 
past the image boundaries, the points in these regions 
are undefined and could lead to significant errors. A 
comparison of these methods is shown in Figure 6.4. 
Ignoring these edge points reduces the overall dataset 
size by 20% (from 25,479 to 20,327 entries overall) and 
does not change the measured thickness values significantly. However, loss of data in 
this limited database will detrimentally impact short-term future performance, especially 
Figure 6.4: Comparison of two 
radial fitting schema. A: 
Including the edge cases 
increases the dataset size by 
20%, which in the short term 
will improve the performance of 
the platform. B: Long-term, 
these points can be ignored 
from analysis and only the 
tangentially-extracted A-lines 




considering the overall accuracy of this platform was not significantly improved from this 
change. The results of this comparison are shown later in the results section. Since the 
current dataset is limited, including as many data points is of immediate interest to 
ensure the flexibility and stability of this system. As a larger dataset is constructed in 
future experiments, these edge cases can be easily removed and only include radial fits 
that do not include the edge cases. The results from these two methods are compared 
in the results section.  
After processing, each OCT data vector (A-line) extracted from the radial segmentation 
process above is also processed to extract other metrics to differentiate infection states:  
The peak-finding algorithm used in this platform indirectly quantifies the density and 
distribution of tissue based on the positioning of the peaks detected from scatterers in a 
particular A-line. This can compare the amount and type of tissue when comparing 
infection states with varying amounts of solid tissue, fluid, and biofilms.  
2: Standard deviation of peak-position location: The distribution of scatterers in depth 
relates to the amount of tissue detected by the OCT system and the relative distribution 
in depth. In healthy ears, only a small number of peaks will be identified within a 100 
µmrange, whereas in cases with an effusion or biofilm present, this value will be larger.  
3: Mean of peak width: Peak width statistics may refer to the size and distribution of the 
scatterers, as with OCT it has been observed that MEF typically becomes more purulent 
as an OM infection progresses. The mean peak width may correlate to the average 




4: Standard deviation of peak width: The standard deviation of peak width may correlate 
to the distribution of physical sizes of scatterers in a scan.  
5: Mean peak prominence: Peak prominence statistics may relate to the optical 
composition and distribution of scatterers, as interfaces of larger differences in the local 
refractive index differences give rise to more intense OCT signals. During OM infection, 
the TM becomes inflamed with interstitial fluid and blood7 which have different optical 
properties to that of bacteria and mucous, and scatterers within any effusion. Mean 
peak prominence may correlate to the different optical properties of scatterers 
compared to the incident medium.  
6: Standard deviation of peak prominence: The standard deviation of peak prominence 
correlates to the distribution of optical composition in a single scan.  
7: Total number of peaks: The total number of peaks is expected to follow the density of 
tissue, and increase with the presence of any fluid or biofilm during infection. Scattering 
distributions or profiles of normal and abnormal cases have been detailed in previous 
publications14,228,325, or similarly in Figure 6.1. 
8: Optical attenuation maximum: OCT provides depth-resolved quantitative structural 
and functional information. The optical attenuation can be calculated by utilizing a 
previously developed method that calculates the depth-wise attenuation coefficient at 



















where ∆ is the (depth) pixel size, and [ ]I i  is the intensity value at any given depth 
location i. This formula was applied over the previously fitted region of interest identified 
using the radial fitting from feature #1 to ensure it is calculated over valid points. This 
method provides numerical discrimination of the different scattering properties of 
different tissue types. The maximum attenuation in a single depth scan may differ 
between infection groups, related to the properties of differential components in healthy 
ears and in cases of infection.   
9: Optical attenuation, Mean value in depth: The mean attenuation differential between 
infection groups will differ based on the additional presence of MEF and biofilm 
components.   
10: Attenuation sum over peak-detected depth: This value will provide a measure of the 
overall signal attenuation in the depth scan. Scans with additional biomass are expected 
to have higher attenuation than scans from a healthy subject.  
11: Fourier width of central peak: Fourier analysis of OCT A-line data may provide 
information regarding periodic or structured features in tissue, represented numerically 
by analysis of each peak width and prominence. The width of the central peak may 
provide differential frequency-based information related to the optical properties or size 
of present structures, such as sparse scatterers within a fluid (high freq.) or large 
instances of biofilm and fluid (low freq.).  
12: Central Fourier peak prominence: The prominence of different scans may correlate 
to the ratio of low and medium frequency terms in an image, related to the optical 




Features Available to the Physician 
Physicians perform a physical exam on each patient to assess their overall state of 
infection. This includes at minimum viewing the ear with an otoscope to assess the TM 
for infection, and often including a comprehensive physical that reviews overall health.  
13: Otoscopy graded score / OMGRADE: To simulate and quantify the otoscopic 
evaluation process here, otoscopy images were analyzed using the OMGRADE 
scale327, which numerically grades the state of infection of the middle ear based on 
features identified with otoscopy. This scale ranges from 0 - 6 to distinguish different 
pathological conditions. Grade 0 is a transparent TM 
in normal position, Grade 1 shows an identifiable fluid 
level, Grade 2 is an opaque identifiable fluid level in 
the MEC. Skipping ahead, Grade 4 is a bulging TM, 
and Grade 6 is a perforation in the TM caused by 
infection-derived pressure buildup in the MEC, 
although none appear in this study. This scale was 
directly converted to a 0-6 point scale for use in this 
platform.  
14: Physician’s report score: Physician’s reports are vital to properly correlate image-
based features with clinical symptoms. Available reports were parsed for keywords328 
that provide some indication of a healthy control or instances of otitis media infection 
and related risk factors. Each keyword was given a numerical value and an overall 
score was tabulated for each subject. Cues related to normal healthy controls or from 
Table 6.3: Patient report 
keywords and point value.  





OM-unrelated visits to the physician were awarded 0 points, such as ‘unremarkable 
ears’ or ‘clear TM’. Keywords assigned 1 point include ‘inflammation’, ‘effusion’, 
‘erythema’, ‘inflamed’, ‘smoke’, ‘family history of OM’. 2 points were awarded to 
keywords such as ‘Antibiotics’, ‘referral’, ‘persistent’, or ‘purulent’. A complete list of the 
terms used for scoring is shown in Table 6.3. Higher scores typically relate to more 
advanced infections. While this metric is empirical and specific to the language used in 
these reports, the composite score represents the clinical findings of the physicians 
involved in this study, and by extension the inherent difficulty in diagnosing OM. Other 
risk factors328, such as the time of year of the report, age of the subject, and 
audiological exams (if available), were considered in this scoring system, but ultimately 
not included due to the complexity in assigning a score to multi-factorial data.  
While not directly (numerically) reviewed and compared by the physician, metrics from 
digital otoscopy329,330 were used to discriminate normal and abnormal tissue given 
different color profiles of the TM typically observed as part of the physical exam. Digital 
otoscopy images were collected using the same digital otoscope tool which ensured 
consistent illumination and sensor performance between imaging sessions. Ear wax 
acts as a confounding factor, often leading to bright regions in the image unrelated to 
infection state and were manually segmented out. Images were then converted to HSL 






15: Hue – average value across otoscopy image: The various values calculated from 
the hue of the image relate to the color of overall redness, injection, or erythema from 
the surface of the TM. The average value of hue across an otoscopy image relates to 
the average color shade across the image of the TM.  
16: Hue – median value across otoscopy image: The median value of hue may provide 
differential information from the average, especially in cases where the TM coloration is 
skewed (non-uniform) across the image.  
17: Hue - median absolute distance across otoscopy image: The median absolute 
distance provides a measure of spread, statistical dispersion, or in essence the width of 
the distribution of color shades in a single image.   
18: Saturation - average value across otoscopy image: The various values calculated 
from the saturation of the image relate to the intensity of the color of overall redness, 
injection, or erythema from the surface of the TM. The average value of saturation 
provides another measure of the intensity of color, which likely relates to infection state.  
19: Saturation - median value across otoscopy image: The median value of saturation 
provides another related measure of the uniformity of the intensity of color.  
20: Saturation - median absolute distance across otoscopy image: The median absolute 
distance provides a measure of spread, statistical dispersion, or in essence the width of 
the distribution of the intensity of color in a single image.   
With these twenty features defined, each A-line in an OCT image will have 20 




6.2.4: Classifier selection and testing 
In choosing a classifier for this application, a main consideration was to avoid 
injecting bias into the classification process for OM, which could inadvertently and 
artificially limit its performance to currently accepted methods of thinking. Therefore, a 
custom programmed RF classifier was chosen as the main method to attempt to classify 
this dataset given its advantageous properties189,331 for this specific application of ML. 
An RF-based classifier can reduce error in unbalanced datasets where data may be 
limited, is not sensitive to incomplete data within a specific data vector, such as missing 
otoscopy images or physician’s notes, and can even rank the most useful features for 
classification, using the out of bag error as described previously.  
The RF classifier is implemented with a “leave-one out” testing strategy319,321, or 
cross validation where K = N images. This works by splitting N total images into a 
training set (N-1 images) and setting aside one image for testing. Each image in the 
dataset is tested on the trained classifier, and the mean accuracy is calculated across 
all loops or “folds”, which serves to estimate the expected future performance on 
untrained data. In addition, the 95% confidence interval was calculated to validate and 
demonstrate consistency in performance.  
Twenty-two techniques (available at the time of writing) within the classification 
learner app in MATLAB were utilized to classify the dataset. This added software 
package streamlines the implementation of different classification subtypes and was 






6.2.5: System requirements and suggestions for data collection 
To abstract the use of this platform with any comparable system, guidelines for 
OCT images and otoscopy images were defined and evaluated. In general, all OCT 
data should be of similar quality in regards to resolution, SNR, wavelength, and other 
imaging properties, such that comparisons can be made of the underlying physical 
features that are being detected. While B-scans are advantageous to utilize information 
from adjacent A-lines, such as for window-averaging, fitting, and analysis as described 
above, it is not strictly required as this system ultimately relies on A-line data to classify 
these infectious states.  
Additional pre-processing steps can be undertaken that help to reduce the 
discrepancies when using multiple systems to collect data that feed into a common 
database, such as cropping images to remove artifacts (OCT), segmenting data to 
remove unrelated image features such as earwax, or by reducing illumination variances 
(otoscopy). OCT data must be free of wrapping, back-reflections, saturations, scanning 
or other optical artifacts. For consistency, images should be taken and compared from 
the same region of the ear. The light-reflex region is easily identifiable in most subjects 
and was chosen as the physical landmark on the TM for images in this study.  
While the intensity values in the OCT data is not used for classification, the SNR 
of an OCT system image must be of sufficient quality to clearly resolve tissue features 
throughout the imaging window, and also ensure that the image SNR is of sufficient 
quality for later analysis metrics to be successfully detected and computed. This was 
determined empirically by taking high-quality scans from the currently used system and 




noise. These degraded images were fed back into the classifier to observe performance 
degradation. SNR was calculated using a 20 pixel square region of interest for both 
signal and background from a set of representative OCT images (Eqn. 6.12). Current 
data empirically suggests that 55 dB is the approximate lower limit before fitting and 
classification performance begins to seriously degrade as demonstrated in Figure 6.5, 









   (6.12) 
 
  
Figure 6.5: Synthetically decreased signal-to-noise ratio (SNR) and 
fitting performance. Using additive Gaussian white noise, the SNR of 
test images was synthetically decreased and classified to empirically 
determine estimated SNR requirements for this platform. Fitting 
performance severely degrades near 33 dB, leaving 55 dB as the 





A minimum resolution for the OCT system is difficult to define, as the features of 
interest for classification must be detected and discriminated between each 
classification group, such as sparsely scattering MEF or thin biofilm structures. Still, in 
the current implementation, it was again empirically determined when degrading OCT 
image resolution using a Gaussian blur function that the resolution can be as low as 
12.5% of the original system resolution (effectively 19.2 μm, originally 2.4 μm) and still 
achieve adequate classification results. This is visually demonstrated in Figure 6.6. 
However, as more data and classification groups are added for more complex 











Figure 6.6: Synthetically decreased resolution and classification 
performance. Using additive Gaussian blurring, test images were 
classified to empirically determine resolution requirements for this 
platform. Classification accuracy seems to degrade when 
resolution is near 12.5% of the original. R: Original resolution.  




Digital otoscopy images should show as much of the TM under sufficient yet non-
saturating illumination as possible, ensuring the same lighting spectrum is used (cool, 
warm, etc.) across imaging sessions and subjects. In practice any otoscope or surgical 
microscope image could be used. Quantitatively, the saturation value (S channel in the 
HSL color scale) should be greater than 10% but less than 95% to ensure accurate 
color detection. These values ensure the color spectrum does not contain dim and gray 
(lower bound), or overly saturated (upper bound) data. Standard-of-care protocols do 
not call for the removal of earwax unless it significantly impedes assessment of the TM 
and middle ear57. Still, the physical removal of earwax is suggested, if possible, to 
collect higher quality digital otoscopy images. Software-based algorithms are being 
developed that can alleviate this need and segment out earwax from images329,332, 
although complete blockages do occur.  
 
6.2.6: Computational hardware 
All results from this work were computed using an off-the-shelf PC with a Core i7-
5960X 3 GHz CPU, 32 GB 2666 MHz Ram, and a 7200 RPM HDD. Data was stored 
remotely on a local network server, which somewhat limited data transfer and recall 
during processing, adding to computation time. Platform runtime can be further 




6.3: Results and Discussion 
A breakdown of the overall platform operation is shown in Figure 6.7. The 
automated platform first begins feature extraction on the database, which generates a 
large data table to be used for classification. Feature extraction for each subject’s 
dataset required approximately 40 seconds. This table is then split into training and test 
groups to assess performance of the classifier using 58-fold leave one out  
cross-validation. Using all 20 available features for the training set, the RF classifier has 
an expected future performance of 95.82%, while requiring only ~0.6 seconds per 
image for classification. Utilizing feature reduction strategies that ignore the worst 5 
performing features (Least useful five removed, LU5R), estimated using the out-of-bag 
error, accuracy remains relatively unchanged at 95.39%, yet the overall classifier 
training runtime is reduced by approximately 17%. Representative classified images 
from each group are shown (rightmost panel) of Figure 6.7.  
  
Figure 6.7: Program overview. OCT images, digital otoscopy images, and de-identified patient 
reports were used to create a database with 25,479 entries. Using this database, the 58-fold 
cross validation is performed to train and test the classifier. This yields an average expected 
future performance for untrained data at 95.82%. Representative classified (100%) OCT scans 





Figure 6.8 demonstrates the two display modes and annotations provided for 
each A-line when recombined into OCT B-mode images. Two viewing modes are 
currently implemented that annotate the OCT image with different amounts of 
information, including the classifier prediction and/or accuracy at the top of the image (if 
known). The “Reader view” is the default output, which annotates the OCT image with 
the predicted class of each A-line and allows for quick visual interpretation of classifier 
results. Overall, the expected class of the image and expected accuracy are displayed, 
ranging from High (greater than 80%), Medium (greater than 50%), Low (greater than 
20%), and error. In “Developer View”, the exact classification accuracy is shown, which 
compares the expected class to the provided group labels in the training set data. This 
mode is useful when modifying feature detection or adding new features, to ensure 
proper functionality and performance. Uncropped OCT images are shown in Figure 6.8 
in contrast to those in Figure 6.1, demonstrating the limited preprocessing needed for 












With the development of the platform workflow and classifier pipeline, applied 
questions and challenges can be explored. To begin, a simple challenge was explored – 
can the platform detect MEF using OCT data as effectively as a clinician using 
otoscopy? To begin, the data must be sorted and labeled to accurately reflect the 
clinical indications of the subject using OCT metrics. This is done by choosing the 
ground truth basis, which can be derived from either the original clinical reports, or from 
the consensus of 3 readers analyzing OCT images (as shown in Table 6.2). The data 
originated from subjects visiting for physicals or unrelated complaints (normal controls), 
or from subjects diagnosed with MEF or other indications related to a diagnosis of OM 
(abnormal). An overview of this setup is shown in Figure 6.9. 
 
 
Figure 6.8: Display modes for classified OCT images. Classifier output can be 
tailored to suit information needs and expected use. “Reader” view is the default 
output, where the classifier prediction is color-coded at the top of the image. Since 
the class is known, accuracy can be computed and displayed in text at the bottom 
of the figure. For “Developer” view, additional accuracy information is shown, 
which can assist during the development of new features or classifiers to identify 
specific regions within an image. Color coding information is annotated on the 
right. Here, uncropped scans are utilized in the classifier, coded in blue, which 





The physician’s diagnosis using otoscopy was used as the ground truth to 
identify symptoms of infection using OCT features. The platform trained on 57 datasets 
and used the remaining dataset to test (cycling through the entire dataset) and 
compared its result to the ground truth labels. Averaging the accuracy of each trial, it 
calculated an estimated future performance of 91.50% to distinguish normal and 
abnormal OCT scans with the physician (DOC) as the basis. These results show that 
the automated classification platform using OCT metrics to identify infection is 
equivalent to a physician’s diagnosis with otoscopy 91.50% of the time.  
When using the same process, now with the ground truth derived from readers 
interpreting OCT data for abnormal scans, the predicted future performance increases 
to 99.16%. This result demonstrates that the platform can identify MEF in subjects as 
accurately as an expert human reader. Interpreting these results, the increased 
performance is likely due to the improved capability of OCT to detect depth-resolved 
microstructural changes that point to infection, with discrepancies shown in Table 6.1 
versus visual-only otoscopic observation where these infectious factors may be missed 
if subtle or unintentionally misinterpreted.  
 
Figure 6.9: Discriminating normal and 
fluid using OCT data. Using the 
physician’s diagnosis (DOC) to train 
the classifier yielded an estimated 
future accuracy of 91.50%. Using OCT 
(OCT) as the ground truth increased 
accuracy to 99.16% to identify 
abnormalities in OCT data related to 
infection. OCT can also distinguish 




These classification results alone represent a significant advancement for the 
diagnosis of OM using OCT, since accurately detecting signs of middle ear infection, 
including the presence of biofilms and fluid, is crucial to properly diagnose and 
subsequently treat any patient for OM3. OCT may therefore be a more noninvasive, 
effective, and unbiased tool to quantitatively detect signs of MEF and biofilms than 
otoscopy, especially without the need for an expert human reader with the addition of 
this automated analysis platform. Apart from identifying the clinical indications of fluid, 
further differentiation is possible between different types of abnormal scans based on 
depth-resolved OCT data, specifically between biofilms or MEF and MEB. 
With this additional capability, additional questions and situations were then 
explored and compared using this dataset, such as: which metrics are the best 
predictors for middle ear infection?, or how do otoscopy metrics compare to OCT 
performance?, with results detailed in Table 6.4. By isolating different clinical and OCT 
features for analysis, the utility of data from different sources (OCT or physician data) 
can be directly compared in identifying the likelihood of infection in subject datasets. 
 
 
Table 6.4: Custom-designed RF classifier performance for different data subsets 
and subset key. 95% confidence interval shown surrounding the average 
performance of the RF classifier. Subset 8 shows 95.39% accuracy when 




Feature subsets shown in Table 6.4 show how different pieces of information can 
be used to identify signs of infection in data. Subsets 1 (Clinical reports) and  
2 (OMGrade scale – otoscopy) show that a single piece of clinical information cannot be 
used to make a diagnosis. This also demonstrates difficulties when using a single 
feature for classification. Clinicians do not necessarily have access to the custom 
created digital otoscopy metrics, such as in subset 3, although they are perhaps visually 
interpreted. Yet, these 6 metrics alone cannot accurately identify signs of infection. 
When considered together (subset 4 or 5), reasonable performance is achieved. 
Classifier performance using data from the portable OCT imaging system is improved 
over subsets 1-3, likely due to the availability of more than a single feature available for 
classification. The 12 metrics extracted from OCT data (subset 6) perform well and are 
equivalent to the performance of combined clinical information (~80%+). When all 
features are used together (subset 7) optimal performance is found at 95.82%. Subset 8 
reduces the feature set by removing the worst performing features as determined by the 
out of bag error in Subset 7, which reduces computation time by 17% while maintaining 
equivalent performance (95.39%, - 0.43 %).  
To ensure the features developed in this study were useful with a broad range of 
classifiers, additional classification techniques were briefly tested. All 22 classifier 
algorithms from the MATLAB Classification learner app (MathWorks, USA) were tested 
on these 8 subsets of data (as shown in Table 6.4). The worst performing subtype from 
each major category – Ensemble, support vector machine (SVM), and k-nearest 
neighbor (kNN) – are presented in Table 6.5. Results show that performance is 




which indicates appropriate feature development and measurable differences inherent 
in the class groupings. At worst, subset 8 performance is at 90.00%.  
 
As mentioned in the Methods section, the fitting program may unintentionally 
increase the radial thickness value of some A-lines near the edges of the OCT image, 
perhaps leading to an improper characterization of thickness. Edge A-lines comprise of 
20% of the entire dataset (25,479 A-lines, 5,152 edge A-lines) and in the short-term, 
removing these scans from the classifier would represent a significant loss of data. 
Therefore, all data was used in the previously described classification tests. However, 
as shown in the plot in Figure 6.10, the data with edge A-lines removed from 
processing (Orange line) only slightly reduces overall accuracy when compared against 
all data (Blue line). With sufficient additional data added to this classifier database in the 
future, losing some data from the edges is no longer a concern, and edge A-lines can 




Table 6.5: Performance comparison between different classifier types. SD: subspace 
discriminant; L: linear; CG: Coarse gradient; C: coarse. 
1 2 3 4 5 6 7 8
Random Forest (Custom) 68.97 53.45 68.97 84.48 86.21 81.29 95.82 95.39
Ensemble (ML) 74.60 74.70 56.00 74.50 81.60 78.70 88.90 90.00
Type SD SD SD SD SD SD SD SD
SVM (ML) 75.70 78.30 61.80 85.80 90.30 83.50 94.50 94.80
Type CG CG L CG L L CG CG
kNN (ML) 74.90 77.30 80.10 91.70 100.00 86.40 97.40 98.40
Type C* C* C* C* C* C* C C





Accurately diagnosing OM infection is a challenging task. Key factors to properly 
diagnose OM utilizing current national recommended practices include accurately 
identifying the length of time of infection, the determination of any bulging or retraction 
of the TM2,333, and perhaps most importantly, the presence and type of any MEF3. 
Children can be mostly asymptomatic with MEF, or OME3, which creates difficulty in 
establishing an infection timeline. Restless and uncomfortable children can similarly 
complicate otoscopic assessment and diagnosis. As previously discussed, most 
available tools to diagnose OM, such as otoscopy, tympanometry, acoustic 
reflectometry, provide limited and qualitative information. These metrics must then be 
interpreted, which may not provide a clear diagnostic conclusion. Once a diagnosis is 
reached, physicians must then rapidly determine the best course of treatment, as time 
in the exam room with each patient can be limited to less than 20 minutes334 in some 
clinics. As such, OM is one of the leading reasons for children to be prescribed broad-
spectrum antibiotics63.  
 
Figure 6.10:  The removal of edge A-
lines and classifier performance 
across feature subsets. While 
performance marginally decreases, 
this is likely due to 20% of all data 
being removed from the platform. 
With additional future data added 
from new subjects, this can quickly be 
performed. Blue line: All data. Orange 




Currently, there is no accepted method to identify the presence of MEB, although 
it is likely that biofilms are one component that increases the opacity of the TM during 
infection and is visible with otoscopy. Clinicians can on average reliably identify the 
presence of MEF with otoscopy and describe the general qualities and presence of 
fluid. However, the differentiation between normal and MEB and MEF and MEB was 
made possible by observing the image-based features in OCT data in this and past 
studies. Subjects with MEF most often have an accompanying MEB, raising additional 
questions about the formation characteristics of MEB during OM.   
OCT provides quantitative identification of biofilms and fluid, as well as additional 
characterization of the purulence or scattering of the fluid. In chronic cases, it is 
common to see this biofilm layer and purulent, highly scattering fluid, and occasionally 
dense fluid depending on the length of infection. This is likely due to increasing amounts 
of immune cell activity and biofilm dispersal within the MEC333 as the infection 
progresses. Ultimately, clinicians do not diagnose or treat middle ear biofilms in the 
current treatment paradigm. There is no accepted diagnostic tool, and furthermore no 
established and tested/verified treatment regimen. With these limitations in mind, this 
platform can be immediately used to identify the presence of MEF.  
There are other tools in development that can improve the diagnostic process for 
OM. MEF can be detected through several means, including gold-standard pneumatic 
otoscopy, Ultrasound53, and a recently developed short-wave infra-red otoscope54. The 
position of the TM can similarly be detected using light-field imaging56. However, 
knowledge of the presence of fluid or position of the TM is not sufficient to diagnose 




does not share many of the limitations of the aforementioned techniques.  By providing 
simultaneous high-resolution, depth-resolved, and quantitative structural, functional, and 
optical characterization of tissue and MEF, OCT imaging can be performed non-
invasively on awake subjects without any preparation of the subject or tissue for 
imaging. This automated classification pipeline can similarly be integrated to run 
alongside the imaging system and provide an on-the-spot classification. 
The use of ML analysis to classify OCT imaging data of subjects with OM can 
provide a means to automatically classify data and provide a probable diagnostic 
outcome. If an image is successfully collected, ML-platforms could ensure the user 
would have a minimum baseline skill for detecting diagnostic markers for OM as in other 
diseases. This tool is not intended to replace critical thinking or clinical expertise, but 
rather to supplement the assessment of the numerous quantitative details within data 
and apparent in tissue, and integrate statistical measures to help guide decision 
making. In turn, with an accurate diagnosis, it may then be possible to provide the most 
appropriate and effective treatment for the current state of infection. In this sense, 
antibiotics could be properly prescribed when most effective, especially if no biofilm is 
present. Or, if a biofilm is identified with a lengthy infection history, evidence-based 
referral to a specialist could be possible. Finally, there may be other indications that an 
infection will clear and do not require treatment, which would require significant 
exploration and verification. With future testing and validation on a larger subject pool, 
this platform may allow for any non-expert user unfamiliar with OM and OCT to pick up 
this tool, collect a scan of the ear, and receive a probable clinical assessment or 





The classifiers used in MATLAB software utilized 5-fold cross-validation and the 
entire dataset to train the classifier. As a result, the accuracy results are considered to 
be overly optimistic in regards to future performance on untrained data. This is in 
contrast to the custom-designed RF classifier, which used a “Leave one subject-out” 
strategy, with K=N=58-fold cross-validation. The classifier is discarded after each 
training iteration rather than continuously retrained on all data, and recreated for the 
next iteration. This strategy attempts to more accurately simulate expected future use 
and performance of this platform, where an untrained and unknown dataset will be 
investigated using the classifier. This may explain why the kNN and other MATLAB 
classifiers occasionally outperform the custom RF classifier. Different feature sets were 
also used to test the performance of features extracted from OCT data and clinical data. 
The best performance is found when all features are used, indicating that both OCT and 
currently utilized clinical information together provide advantageous and necessary 
classification information. 
In the future, additional improvements and features can be added to this platform 
to improve its versatility and robustness. For instance, data collection can be improved 
to allow for the calculation of the viscosity of any characterization of the detected 
scattering properties of in vivo MEF with OCT, which may allow for further discrimination 
of serous and mucoid fluid. To ensure usability for real-time analysis, algorithms that 
ensure rejection of unintended or unwanted imaging artifacts and reflections can be 
implemented, along with a notification system to kindly request the user to retake the 




otoscopy analysis to include other metrics related to TM coloration, transparency, or 
opacity327. The presentation of data an also be scaled to suit the expected use. In clinics 
with technicians or situations where a simpler screening or evaluation is needed, 
perhaps a simple binary output for ‘normal’ or ‘recommend for clinical evaluation’ can be 
assigned, along with a ‘retake data’ notification. In a more traditional clinical setting, 
some physicians may desire to see an expanded set of relevant information, which can 
be set to include metrics described above and full image data as needed.  
There are several points in this study that merit further discussion and 
clarification. The three class output labels that were used in this platform take into 
consideration immediately useful clinical information. In the future, many more infection 
states of OM and diseases or conditions of the TM can be added, such as TM 
perforations335, dimeric TMs from previous surgical interventions212, 
cholesteatoma213,336, or myringo-/tympanosclerosis 212. This platform can easily expand 
to accommodate these additional states, although additional testing with appropriate 
and sufficient training data for each newly added condition will be required to assess 
accuracy. An example of a dimeric TM and a TM with myringosclerosis is shown in 








While OCT imaging can identify biofilms, there is currently no clinically accepted 
diagnostic method to noninvasively identify biofilms in the middle ear8, or any 
recommended course of action for treatment of a biofilm within current guidelines. Since 
biofilm-related infections are persistent due to their innate ability to resist antibiotic 
treatment and host immune response253,337, it is expected that management strategies 
for chronic OM will follow treatment strategies used for other biofilm-mediated 
infections, such as cystic fibrosis269 or other respiratory infections64. Finally, our group is 
currently developing systems with more reasonable total off-the-shelf costs231,338 that 





Figure 6.11: OCT images that 
demonstrate potential confounding 
pathology. A: A dimeric TM that shows 
thinning of the fibrous region. B: A TM 
with myringosclerosis. These datasets 
may inadvertently confuse the classifier 
in its current state, due to segmentation 
issues in thin regions or 
misclassification of myringosclerosis as 
biofilms and fluid. With the addition of 
additional data and features to represent 
these cases, accurate classification can 




In this work, metrics for an automated classification algorithm were developed 
and tested on OCT images of human subject data for the classification of OCT-based 
datasets and images of OM. This platform was demonstrated and shown to have a 
predicted future accuracy of 95.39% with feature Subset 8 (LU5R). With further 
development and testing of this platform, this framework could one day assist any 
untrained user to collect OCT data and receive a prediction for the presence of MEF 
and/or MEB, both diagnostically relevant information for the current management of 
OM. More broadly, this classification method may be a useful tool for the automated 





Chapter 7: Conclusion and Future Directions 
This dissertation explored the optical and biological characterization of middle 
ear biofilms, the effects of standard-of-care treatment on middle ear biofilms, and 
automated classification of OCT images and OM to automatically identify middle ear 
fluid and biofilms. Here, a brief summary is provided of these seminal advancements, as 
well as thoughts for potential avenues of future exploration and expansion of this work.  
 
7.1: Contributions made in this work 
Bioengineering at its core is the synthesis of multiple fields of study to 
accomplish interdisciplinary research projects. This thesis describes an overall goal 
better diagnose OM, including the identification, characterization, and verification of 
middle ear biofilms adhered to the TM using OCT. This work provides clinicians with 
one of the only proven tools, portable OCT imaging systems, available to noninvasively 
assess for the presence of biofilms in the middle ear cavity. This affords further 
exploration of the clinical management of OM using this tool, and related justification for 
further commercial exploration to disseminate this technology, although perhaps the 
overall cost of an OCT system is a more critical concern. With the expected increase in 
patients in primary care with implementation of the new healthcare laws soon to be in 
effect, fast and accurate tools that increase the efficiency and accuracy of physicians 
are desperately needed, especially those that provide additional information not 




With these advancements, there are many avenues that can now be explored, 
such as different treatment strategies that take into account the significantly different 
factors of managing a biofilm-mediated disease. For other biofilm-mediated diseases, 
such as those found in patients with implanted medical devices, prosthetics, or 
catheters, single relatively weak courses of antibiotics are ineffective, and stronger 
doses and longer courses of antibiotics are typically prescribed.  Ideally, the infected 
biomass or device (in the case of a catheter or implanted device) is completely removed 
from the subject. There are also numerous other options that can target biofilm quorum 
sensing, such as surfactants or emulsifiers that would break up or permeabilize the 
biofilm to allow antibiotics to more efficiently penetrate and combat the bacteria. 
Development of such treatments would of course require significant testing to ensure no 
permanent or long-term effects in human subjects, especially since the patient 
population for OM is mostly children, however, OCT could be used as a monitoring tool 
to test for these effects in vitro or in situ in animal models. Still, for a case like OM, TT 
surgery may be the best option, not only because it is already part of the clinical 
pathway for OM, but also since it forcibly alters the local microenvironment for those 
bacteria. Perhaps a treatment can be conceived that has the same effect on the MEC 
without the need for surgery and anesthesia.   
The development of an automated platform for analysis of OCT images of OM is 
a seminal advancement and will greatly impact the future translation of this work. This 
framework provides any user with the ability to interpret OCT data, if properly collected, 
without prior knowledge of OM or OCT. Short term, with the collection of additional data 




ear disease, this overall package can evolve into a flexible tool to supplement a 
physician’s skill and improve the management of OM. Long-term, since this is primarily 
a software-based addition and the use of OCT is expected to continue increasing in 
primary care and in many other clinical subspecialties, this platform can be easily 
deployed and distributed to multiple clinical sites to expand data collection and provide 
classification anywhere an OCT system is utilized. Testing and validation of these 
capabilities will be a crucial advancement in the dissemination of this work.  
In the future, the inclusion of this platform could allow for technicians or staff, 
such as in convenient care clinics in supermarkets, to acquire images and refer patients 
appropriately. This greatly improves the utility of this device, as expert OCT knowledge 
no longer needs to accompany the use of the system. However, to advance this device 
into an FDA approved diagnostic tool as envisioned, substantial testing, development, 
and documentation, must be rigorously performed. True clinical trials for both imaging 
and classification by this algorithm are needed to show clinical efficacy or utility, 
accuracy, and ideally a small margin of error.  
Overall, the advancements in this dissertation alter the course of OM diagnostic 
tools, techniques, and knowledge, allow for the improved future study of novel 







7.2: Expanding on the work presented in this dissertation 
Following this work, there are various peripheral future projects that can be 
undertaken. MEE characterization with OCT could provide a clinical indication of the 
state of infection. Similarly, the continued investigation of middle ear biofilms is also a 
natural extension to this work. Little is currently known about their formation and role in 
recurrent infection, and especially the interplay with middle ear fluid, given biofilm 
dispersal mechanisms. Undoubtedly, one or several quantitative analysis metrics could 
be calculated or created from that data to be added to the ML platform for further 
analysis, depending on the scattering or attenuation properties. With OCT, it is also 
possible to longitudinally follow OM throughout the entire progression, treatment, and 
regression of the disease, and perhaps provide a more complete understanding of this 
infection to physicians and medical scientists interested in the infection pathways.   
The ultimate deployment of the ML algorithm on a portable system and blinded 
testing comparing the platform, physician’s diagnosis, and an OCT expert human reader 
will provide important verification that this platform is viable for future use. It will also 
demonstrate that a technician can have equivalent skill to that of a highly trained 
physician, and empower decision making and referral capabilities with justified 
quantitative evidence and metrics.   
To expand and disseminate this work even further, larger patient studies in 
different geographic regions are needed to determine the consistency of OCT-based 
signs and symptoms compared to what has been established in this dissertation, which 




subpopulations of humans have a predisposition to severe bouts of OM, but it seems to 
be correlated more with genetic factors than specific regions in the USA.  
A reduction in overall cost of such systems, while retaining or even improving 
system capability, will allow more users to have access to this high-quality and useful 
tool, which is currently being explored in collaboration with other members of BIL136. 
Clinically, further exploration can be performed to assess for the efficacy of existing 
antibiotic treatments to manage fluid and biofilms, much like what was done for TT 
surgery as previously discussed in Chapter 3.  
 
7.3: Open research questions in OM 
Finally, there are several research questions that remain unanswered or were 
newly discovered by this work. First, it is unclear what the identified presence of a 
middle ear biofilm with OCT in an asymptomatic subject means clinically. Several 
subjects were identified as “normal” by the physician and their own self-diagnosis, but 
clearly had a middle ear biofilm in an OCT scan of their ear(s). At present, the resources 
to longitudinally track such a subject and image their ears for an extended period of 
time, as well as have access to their clinical records, was not possible. Still, was this 
biofilm from an old infection that is resolving? Will this biofilm persist and cause an 
infection months or a year later? Or is this a new biofilm forming as a precursor to future 
serious infections? In essence, the presence of a biofilm is still not well understood in 




The analysis of middle ear fluid is an important related question, as qualitatively 
the purulence and concentration of scatterers seems to track with infection state, 
perhaps biofilm formation deeper in the MEC, although no study has quantitatively 
confirmed this. Could it be possible to stage an infection based on the type and quality 
of fluid observed?  
 
7.4: Additional avenues of exploration 
More broadly, there are other avenues to pursue that may improve OM diagnosis 
using alternate methods to answer related or new questions.  
The systems currently utilized for these studies can be improved. With the 
development of high-speed MEMS scanners, useful 3D volumes have not yet been 
collected in every subject simply due to the difficulty of acquiring scans in the ear given 
the imaging configuration. However, new scan patterns that utilize a circular radial-scan 
pattern, or likewise a Lissajous or Bowditch curve, could rapidly acquire a volume. This 
would be interesting to view in normal and infected cases.  
The addition of functional parameters gleaned from OCT data, such as in situ 
absorption or attenuation coefficient measurements339 or Doppler processing340, may 
show a detectable metric for either distinguishing various tissue components or 
quantifying local blood flow properties in subjects with normal ears, and acute, and 
chronic cases of OM with varying levels of injection (redness) or middle ear fluid. 
Phase-sensitive OCT measurements for blood flow in an adult TM was attempted in a 




primarily the movement of the handheld probe prevented any signal from being 
identified. In the future, more stable systems, or one utilizing a rigid positioning arm for 
the handheld probe, could improve the phase stability of the system and allow for these 
functional parameters of the human ear to be properly observed.  
Similarly, spectroscopic (S)-OCT processing341 could provide a general measure 
of the absorption and other differential spectral properties of the sample that could be 
performed on some broad-bandwidth OCT systems. However, S-OCT systems have an 
inherent tradeoff between spectral and axial resolution, and require significant signal 
processing and analysis. Moreover, S-OCT systems provide useful contrast if and only 
if the optical properties of different components of the sample significantly vary over the 
limited bandwidth of the OCT system, unless exogenous dyes or contrast agents can be 
used. In wavelength ranges typically used for OCT, differential optical targets such as 
hemoglobin / blood oxygen saturation absorption342 and atherosclerotic plaques against 
arterial tissue343 are often used.  
 Polarization-sensitive optical coherence tomography (PS-OCT) is another 
unexplored OCT variant that could provide additional metrics to differentiate different 
structures in the ear and during infection. PS-OCT modifies a traditional OCT system to 
be sensitive to not only the intensity of light, but also the polarization states of light 
returning from the sample344. In our portable OCT systems, the outgoing polarization 
state is inconsistent through time and effectively randomized given the flexibility of the 
optical fiber in the handheld probe. This plays a small role in modulating the SNR of the 
system if the polarization states of the sample and reference arm are not roughly 




certain structures occasionally appear less clearly, such as interfaces in layered 
structures. With control of the outgoing polarization of the beam in a PS-OCT system, 
the optical properties of the sample or human subject can be more precisely 
determined. This is of particular interest in this research because the eardrum has a 
fibrous layer that consists of a collagen mesh network of type-II and type-III132 that could 
be visualized using differing jones matrix, phase retardation, or birefringence values. It 
should be possible to differentiate the TM from any present biofilms, since the biofilm 
and its constituent EPS fibers are different sizes than collagen and with a different 
spatial orientation, layout, and density. One challenge to this work will be maintaining 
the polarization state of the outgoing beam in a handheld probe given the use of a 
flexible optical fiber. 
While it has been theorized, our group has not developed a SS-OCT system that 
can visualize deeper regions of the mucosa. It would be of great utility to see the 
presence of a biofilm in all regions of the MEC, and track the formation of the biofilm as 
it spreads around the MEC, likely starting from somewhere near the Eustachian tube 
and encompassing the MEC, and finally on the TM. On a similar note, Raman or other 
optical techniques that can take advantage of chemical or biological information may 
provide additional avenues of contrast for quantification or characterization310. Providing 
an antibiotic based on the specific strains currently active in an infection may ensure 
patients get the best and most effective care. Although a system was developed for this 
exact aim310, further experiments have not yet been planned. The local bacterial 
microenvironment of the middle ear is not well understood. There are likely bacteria that 




concentrations to avoid detection by the body, or as part of the normal flora. Do these 
bacteria cause an infection when thrown out of balance? The immune system relies on 
a complex system of feedback mechanisms to operate, and can be inadvertently 
activated in response to allergens, or reactivated following a subsequent infection due 
to immunological memory. In the case of OM, existing bacteria may have learned to 
transition to a biofilm state as it causes the body to excrete additional mucous, although 
the more likely explanation is that foreign bacteria invade and cause infections.  
This work has spanned many years, involved many collaborators, and solved 
many interesting and difficult challenges for OM, clinical research, and OCT system 
development and image analysis. New questions have been raised as a result of this 
work, and as always, there are further avenues to pursue.  With a clear understanding 
of the efforts outlined here, and a firm view of important tasks to accomplish in the 
future, further progress toward revolutionizing diagnostic paradigms for OM will be 
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